| 1 | -induced | 1,277 |
| 2 | immunosorbent | 1,242 |
| 3 | -based | 697 |
| 4 | .the | 411 |
| 5 | colony-forming | 399 |
| 6 | -positive | 354 |
| 7 | -dependent | 302 |
| 8 | -mediated | 295 |
| 9 | -treated | 244 |
| 10 | -related | 240 |
| 11 | -negative | 211 |
| 12 | -adrenergic | 207 |
| 13 | -associated | 180 |
| 14 | -guided | 159 |
| 15 | -like | 151 |
| 16 | -containing | 143 |
| 17 | -infected | 140 |
| 18 | -stimulated | 133 |
| 19 | -lowering | 123 |
| 20 | -producing | 115 |
| 21 | -specific | 112 |
| 22 | -2,5-diphenyltetrazolium | 107 |
| 23 | -derived | 101 |
| 24 | -activated | 93 |
| 25 | .we | 88 |
| 26 | -catalyzed | 87 |
| 27 | -resistant | 78 |
| 28 | -ar | 77 |
| 29 | -binding | 75 |
| 30 | -type | 74 |
| 31 | -deficient | 71 |
| 32 | -doped | 71 |
| 33 | -nitro-l-arginine | 67 |
| 34 | /akt | 65 |
| 35 | -free | 62 |
| 36 | -rich | 58 |
| 37 | .one | 57 |
| 38 | .for | 56 |
| 39 | c-urea | 56 |
| 40 | -adjuvanted | 54 |
| 41 | -sensitive | 54 |
| 42 | .no | 52 |
| 43 | -controlled | 51 |
| 44 | -enriched | 48 |
| 45 | -labeled | 46 |
| 46 | -and | 43 |
| 47 | -approved | 42 |
| 48 | .two | 42 |
| 49 | -selective | 40 |
| 50 | -targeted | 40 |
| 51 | -pcr | 39 |
| 52 | .a | 38 |
| 53 | c-labeled | 33 |
| 54 | plaque-forming | 33 |
| 55 | -naive | 31 |
| 56 | -exposed | 30 |
| 57 | -expressing | 29 |
| 58 | -the | 29 |
| 59 | -weighted | 29 |
| 60 | β₃ | 29 |
| 61 | -defined | 28 |
| 62 | .this | 28 |
| 63 | -linked | 27 |
| 64 | immunospot | 27 |
| 65 | -assisted | 26 |
| 66 | -refractory | 25 |
| 67 | .when | 25 |
| 68 | -2,5-diphenyl | 24 |
| 69 | -channel | 24 |
| 70 | -terminal | 24 |
| 71 | -coated | 23 |
| 72 | -enhanced | 23 |
| 73 | f-labeled | 23 |
| 74 | -evoked | 21 |
| 75 | -modified | 21 |
| 76 | -connected | 20 |
| 77 | -fed | 20 |
| 78 | -triggered | 20 |
| 79 | .three | 20 |
| 80 | /angiotensin | 20 |
| 81 | c-acetate | 20 |
| 82 | -driven | 19 |
| 83 | -gated | 19 |
| 84 | -reducing | 19 |
| 85 | -regulated | 19 |
| 86 | /protein | 19 |
| 87 | -funded | 18 |
| 88 | -sensitized | 18 |
| 89 | tc-labeled | 18 |
| 90 | -releasing | 17 |
| 91 | .four | 17 |
| 92 | -akt | 15 |
| 93 | -matched | 15 |
| 94 | .adverse | 15 |
| 95 | .all | 15 |
| 96 | .these | 15 |
| 97 | å. | 15 |
| 98 | -codoped | 14 |
| 99 | -handling | 14 |
| 100 | -substituted | 14 |
| 101 | -supplemented | 14 |
| 102 | /american | 14 |
| 103 | y-ibritumomab | 14 |
| 104 | -bound | 13 |
| 105 | -salt | 13 |
| 106 | /high | 13 |
| 107 | /hiv | 13 |
| 108 | immunometric | 13 |
| 109 | pmd09 | 13 |
| 110 | -confirmed | 12 |
| 111 | -conjugated | 12 |
| 112 | -mutated | 12 |
| 113 | -on | 12 |
| 114 | -saturated | 12 |
| 115 | -sponsored | 12 |
| 116 | .five | 12 |
| 117 | /+ | 12 |
| 118 | /total | 12 |
| 119 | but-3-en-1-yl | 12 |
| 120 | -16/18 | 11 |
| 121 | -acquired | 11 |
| 122 | -inhibiting | 11 |
| 123 | -mevalonate | 11 |
| 124 | -naïve | 11 |
| 125 | -scavenging | 11 |
| 126 | -strand | 11 |
| 127 | /acquired | 11 |
| 128 | /akt/mammalian | 11 |
| 129 | /mammalian | 11 |
| 130 | 2-mediated | 11 |
| 131 | in-labeled | 11 |
| 132 | tc-dpd | 11 |
| 133 | -benzodiazepine | 10 |
| 134 | -blocking | 10 |
| 135 | -challenged | 10 |
| 136 | -contaminated | 10 |
| 137 | -coupled | 10 |
| 138 | -injected | 10 |
| 139 | -phosphate | 10 |
| 140 | -reactive | 10 |
| 141 | -responsive | 10 |
| 142 | -transformed | 10 |
| 143 | /calmodulin-dependent | 10 |
| 144 | /extracellular | 10 |
| 145 | immunoadsorbent | 10 |
| 146 | p-induced | 10 |
| 147 | ↔ | 10 |
| 148 | -ad | 9 |
| 149 | -assessed | 9 |
| 150 | -augmented | 9 |
| 151 | -c5 | 9 |
| 152 | -corrected | 9 |
| 153 | -loaded | 9 |
| 154 | -prlr | 9 |
| 155 | -reduced | 9 |
| 156 | -sparing | 9 |
| 157 | -tagged | 9 |
| 158 | .after | 9 |
| 159 | .secondary | 9 |
| 160 | .• | 9 |
| 161 | /low | 9 |
| 162 | immunosorbant | 9 |
| 163 | -activating | 8 |
| 164 | -an | 8 |
| 165 | -at | 8 |
| 166 | -bearing | 8 |
| 167 | -cell | 8 |
| 168 | -determined | 8 |
| 169 | -directed | 8 |
| 170 | -enhancing | 8 |
| 171 | -hydroxide | 8 |
| 172 | -labelled | 8 |
| 173 | -nta | 8 |
| 174 | -preserved | 8 |
| 175 | -promoted | 8 |
| 176 | -release | 8 |
| 177 | -seropositive | 8 |
| 178 | /calmodulin | 8 |
| 179 | /met | 8 |
| 180 | f-sodium | 8 |
| 181 | r-mediated | 8 |
| 182 | -2,5-diphenyl-tetrazolium | 7 |
| 183 | -boosted | 7 |
| 184 | -catalysed | 7 |
| 185 | -delivered | 7 |
| 186 | -depleted | 7 |
| 187 | -detected | 7 |
| 188 | -first | 7 |
| 189 | -gapdh | 7 |
| 190 | -inducible | 7 |
| 191 | -initiated | 7 |
| 192 | -measured | 7 |
| 193 | -mi | 7 |
| 194 | -nitroarginine | 7 |
| 195 | -pretreated | 7 |
| 196 | -recommended | 7 |
| 197 | -susceptible | 7 |
| 198 | .an | 7 |
| 199 | .both | 7 |
| 200 | .most | 7 |
| 201 | .six | 7 |
| 202 | /acute | 7 |
| 203 | /european | 7 |
| 204 | /mas | 7 |
| 205 | 322-325 | 7 |
| 206 | cytome | 7 |
| 207 | h-labeled | 7 |
| 208 | m-free | 7 |
| 209 | n-labeled | 7 |
| 210 | p-binding | 7 |
| 211 | h | 7 |
| 212 | -administered | 6 |
| 213 | -chop | 6 |
| 214 | -compliant | 6 |
| 215 | -coordinated | 6 |
| 216 | -desaturase | 6 |
| 217 | -diabetic | 6 |
| 218 | -encoding | 6 |
| 219 | -helix | 6 |
| 220 | -injured | 6 |
| 221 | -led | 6 |
| 222 | -monomethyl | 6 |
| 223 | -null | 6 |
| 224 | -oriented | 6 |
| 225 | -oxide | 6 |
| 226 | -risk | 6 |
| 227 | .comparing | 6 |
| 228 | .other | 6 |
| 229 | .our | 6 |
| 230 | /aids | 6 |
| 231 | /chi | 6 |
| 232 | /control | 6 |
| 233 | /uv | 6 |
| 234 | 1.3.3 | 6 |
| 235 | c-enriched | 6 |
| 236 | cr-release | 6 |
| 237 | ga-labeled | 6 |
| 238 | tc-labelled | 6 |
| 239 | vacuum-cast | 6 |
| 240 | -1h-imidazol-3-ium | 5 |
| 241 | -2,5-diphenyl-2h-tetrazolium | 5 |
| 242 | -acs | 5 |
| 243 | -arterial | 5 |
| 244 | -barrel | 5 |
| 245 | -c-reactive | 5 |
| 246 | -cprggsvc | 5 |
| 247 | -degrading | 5 |
| 248 | -elicited | 5 |
| 249 | -fortified | 5 |
| 250 | -helical | 5 |
| 251 | -inducing | 5 |
| 252 | -inhibitory | 5 |
| 253 | -interacting | 5 |
| 254 | -methanocarba | 5 |
| 255 | -mobilized | 5 |
| 256 | -mutant | 5 |
| 257 | -overexpressing | 5 |
| 258 | -propelled | 5 |
| 259 | -proven | 5 |
| 260 | -restricted | 5 |
| 261 | -stained | 5 |
| 262 | -suppressive | 5 |
| 263 | -yd5 | 5 |
| 264 | .low-quality | 5 |
| 265 | .total | 5 |
| 266 | /cnt | 5 |
| 267 | /igf-ii | 5 |
| 268 | /million | 5 |
| 269 | /tdf | 5 |
| 270 | 1/th2 | 5 |
| 271 | 5ec | 5 |
| 272 | =vkm | 5 |
| 273 | c-hed | 5 |
| 274 | goldblatt | 5 |
| 275 | ide-naïve | 5 |
| 276 | immunoabsorbent | 5 |
| 277 | ne30d | 5 |
| 278 | β₃-dxtl-pd | 5 |
| 279 | -accumulating | 4 |
| 280 | -active | 4 |
| 281 | -added | 4 |
| 282 | -ahsv4 | 4 |
| 283 | -alkene | 4 |
| 284 | -ampkalpha | 4 |
| 285 | -anchored | 4 |
| 286 | -bridged | 4 |
| 287 | -calculated | 4 |
| 288 | -covered | 4 |
| 289 | -functionalized | 4 |
| 290 | -generated | 4 |
| 291 | -generating | 4 |
| 292 | -graphene | 4 |
| 293 | -histamine | 4 |
| 294 | -hydroxyl | 4 |
| 295 | -immunized | 4 |
| 296 | -imprinted | 4 |
| 297 | -inhibited | 4 |
| 298 | -knockout | 4 |
| 299 | -loading | 4 |
| 300 | -m17 | 4 |
| 301 | -mobilizing | 4 |
| 302 | -platinum | 4 |
| 303 | -protopanaxadiol-type | 4 |
| 304 | -qi | 4 |
| 305 | -regulatory | 4 |
| 306 | -replete | 4 |
| 307 | -restriction | 4 |
| 308 | -secreting | 4 |
| 309 | -soluble | 4 |
| 310 | -sql | 4 |
| 311 | -supported | 4 |
| 312 | -tac | 4 |
| 313 | -tailed | 4 |
| 314 | -tolerant | 4 |
| 315 | -α-mediated | 4 |
| 316 | -γ-fe2o3 | 4 |
| 317 | .generally | 4 |
| 318 | .nine | 4 |
| 319 | .pooled | 4 |
| 320 | .seven | 4 |
| 321 | .thirteen | 4 |
| 322 | /cyclic | 4 |
| 323 | /free | 4 |
| 324 | /long-acting | 4 |
| 325 | /minimum | 4 |
| 326 | /mitogen-activated | 4 |
| 327 | /mno | 4 |
| 328 | /naf | 4 |
| 329 | /o2 | 4 |
| 330 | /smad | 4 |
| 331 | /t-cell | 4 |
| 332 | 12-400 | 4 |
| 333 | 4-catalyzed | 4 |
| 334 | al2o4 | 4 |
| 335 | c-labeling | 4 |
| 336 | cnmr | 4 |
| 337 | cr-labeled | 4 |
| 338 | cr1-gfp | 4 |
| 339 | enalapril-fa | 4 |
| 340 | hyperpolarised | 4 |
| 341 | i-higf-i | 4 |
| 342 | i-labeled | 4 |
| 343 | immuno-sorbent | 4 |
| 344 | lu-labeled | 4 |
| 345 | methionine-labeled | 4 |
| 346 | nπ∗ | 4 |
| 347 | p-labeled | 4 |
| 348 | tg-agtko | 4 |
| 349 | trimethine | 4 |
| 350 | µg/108 | 4 |
| 351 | δ1 | 4 |
| 352 | ππ∗ | 4 |
| 353 | ‑induced | 4 |
| 354 | ₂d₃-induced | 4 |
| 355 | -28b | 3 |
| 356 | -2h3 | 3 |
| 357 | -3,5-di-phenytetrazoliumromide | 3 |
| 358 | -3-octyloxymethyl | 3 |
| 359 | -5-hydroxypyrazole | 3 |
| 360 | -accbeta | 3 |
| 361 | -accredited | 3 |
| 362 | -acid | 3 |
| 363 | -adult | 3 |
| 364 | -attenuated | 3 |
| 365 | -aβ | 3 |
| 366 | -bay | 3 |
| 367 | -carbonyl | 3 |
| 368 | -clinical | 3 |
| 369 | -clopidogrel | 3 |
| 370 | -combined | 3 |
| 371 | -complexed | 3 |
| 372 | -defining | 3 |
| 373 | -deleted | 3 |
| 374 | -diode | 3 |
| 375 | -diol | 3 |
| 376 | -documented | 3 |
| 377 | -electrolyte | 3 |
| 378 | -elevating | 3 |
| 379 | -eligible | 3 |
| 380 | -encapsulated | 3 |
| 381 | -encoded | 3 |
| 382 | -expanded | 3 |
| 383 | -ferrous | 3 |
| 384 | -filtered | 3 |
| 385 | -immunoreactive | 3 |
| 386 | -impregnated | 3 |
| 387 | -indexed | 3 |
| 388 | -ion | 3 |
| 389 | -line | 3 |
| 390 | -localized | 3 |
| 391 | -luciferase | 3 |
| 392 | -medicated | 3 |
| 393 | -modulated | 3 |
| 394 | -mouth | 3 |
| 395 | -nicotinamide | 3 |
| 396 | -noradrenergic | 3 |
| 397 | -olive | 3 |
| 398 | -oxo | 3 |
| 399 | -pk | 3 |
| 400 | -polyethylene | 3 |
| 401 | -prevention | 3 |
| 402 | -processed | 3 |
| 403 | -pumping | 3 |
| 404 | -raising | 3 |
| 405 | -resident | 3 |
| 406 | -ribose | 3 |
| 407 | -salt-induced | 3 |
| 408 | -sensitised | 3 |
| 409 | -sensitizing | 3 |
| 410 | -sodium | 3 |
| 411 | -stage | 3 |
| 412 | -steered | 3 |
| 413 | -style | 3 |
| 414 | -targeting | 3 |
| 415 | -transfected | 3 |
| 416 | -urea | 3 |
| 417 | -vaccinated | 3 |
| 418 | -α-induced | 3 |
| 419 | .cognitive | 3 |
| 420 | .eight | 3 |
| 421 | .eleven | 3 |
| 422 | .limited | 3 |
| 423 | .percutaneous | 3 |
| 424 | .single | 3 |
| 425 | .systemic | 3 |
| 426 | /adenosine | 3 |
| 427 | /atp | 3 |
| 428 | /atypical | 3 |
| 429 | /calcium | 3 |
| 430 | /chronic | 3 |
| 431 | /fat-1 | 3 |
| 432 | /human | 3 |
| 433 | /hzsm-5 | 3 |
| 434 | /ki-67 | 3 |
| 435 | /long-chain | 3 |
| 436 | /lower | 3 |
| 437 | /map | 3 |
| 438 | /national | 3 |
| 439 | /other | 3 |
| 440 | /p38 | 3 |
| 441 | /pvk | 3 |
| 442 | /sb | 3 |
| 443 | /who | 3 |
| 444 | dinp-treated | 3 |
| 445 | f-fdg-labeled | 3 |
| 446 | f-fluoromisonidazole | 3 |
| 447 | i-coumarin | 3 |
| 448 | i-labelled | 3 |
| 449 | i13/2 | 3 |
| 450 | lu-imp288 | 3 |
| 451 | n-labeling | 3 |
| 452 | n7-methyl | 3 |
| 453 | no-based | 3 |
| 454 | o-labeled | 3 |
| 455 | p-postlabeling | 3 |
| 456 | p2-specific | 3 |
| 457 | r-induced | 3 |
| 458 | receptor-evoked | 3 |
| 459 | tc-hmpao-labelled | 3 |
| 460 | unassessed | 3 |
| 461 | π0g | 3 |
| 462 | ‑stimulated | 3 |
| 463 | *-weighted | 2 |
| 464 | +lipo | 2 |
| 465 | +partial | 2 |
| 466 | -1,4-naphthoquinones | 2 |
| 467 | -1-associated | 2 |
| 468 | -1-ethyl-3-methylimidazolium | 2 |
| 469 | -1-infected | 2 |
| 470 | -1-mediated | 2 |
| 471 | -11b | 2 |
| 472 | -1h-pyrrolidin-1-ium | 2 |
| 473 | -2,3-oxidosqualene | 2 |
| 474 | -2,5- | 2 |
| 475 | -2,5-diphenyl-2h | 2 |
| 476 | -2-furancarboxaldehyde | 2 |
| 477 | -2-octyloxymethyl | 2 |
| 478 | -2-positive | 2 |
| 479 | -293 | 2 |
| 480 | -3-1e | 2 |
| 481 | -3-methoxy | 2 |
| 482 | -3-methoxy-3-oxo-2-stearamidopropyl | 2 |
| 483 | -4-methylmorpholinium | 2 |
| 484 | -5b | 2 |
| 485 | -99m | 2 |
| 486 | -absorbing | 2 |
| 487 | -acl | 2 |
| 488 | -adf | 2 |
| 489 | -adrenoceptor-selective | 2 |
| 490 | -affected | 2 |
| 491 | -agonist-induced | 2 |
| 492 | -alkyl | 2 |
| 493 | -alpha-induced | 2 |
| 494 | -among | 2 |
| 495 | -amplified | 2 |
| 496 | -amygdala | 2 |
| 497 | -antihistaminic | 2 |
| 498 | -antioxidant | 2 |
| 499 | -as03 | 2 |
| 500 | -b/gastrin | 2 |
| 501 | -blocker-naïve | 2 |
| 502 | -bridging | 2 |
| 503 | -calmodulin-dependent | 2 |
| 504 | -camkii | 2 |
| 505 | -camphorate | 2 |
| 506 | -capped | 2 |
| 507 | -caused | 2 |
| 508 | -centered | 2 |
| 509 | -certified | 2 |
| 510 | -chelated | 2 |
| 511 | -chelating | 2 |
| 512 | -colocalized | 2 |
| 513 | -comparable | 2 |
| 514 | -conducting | 2 |
| 515 | -continuous | 2 |
| 516 | -corynoxine | 2 |
| 517 | -cscl | 2 |
| 518 | -cts-sea | 2 |
| 519 | -cyclic | 2 |
| 520 | -decorated | 2 |
| 521 | -detoxifying | 2 |
| 522 | -diagnosed | 2 |
| 523 | -differentiated | 2 |
| 524 | -diminished | 2 |
| 525 | -dna-binding | 2 |
| 526 | -elevated | 2 |
| 527 | -enrichment | 2 |
| 528 | -equivalent | 2 |
| 529 | -facilitated | 2 |
| 530 | -family | 2 |
| 531 | -filled | 2 |
| 532 | -gmp | 2 |
| 533 | -grade | 2 |
| 534 | -grafted | 2 |
| 535 | -guaiacylglycerol | 2 |
| 536 | -hospitalized | 2 |
| 537 | -hydroxycarboxylato | 2 |
| 538 | -hypertensive | 2 |
| 539 | -i/ii | 2 |
| 540 | -ibritumomab | 2 |
| 541 | -ifn | 2 |
| 542 | -immobilized | 2 |
| 543 | -incorporated | 2 |
| 544 | -interstitial | 2 |
| 545 | -intoxicated | 2 |
| 546 | -involved | 2 |
| 547 | -irradiated | 2 |
| 548 | -killed | 2 |
| 549 | -knockin | 2 |
| 550 | -l-nitro-arginine | 2 |
| 551 | -lariciresinol | 2 |
| 552 | -luc | 2 |
| 553 | -lv | 2 |
| 554 | -mammalian | 2 |
| 555 | -marked | 2 |
| 556 | -mas | 2 |
| 557 | -metabolizing | 2 |
| 558 | -mimetic | 2 |
| 559 | -mitochondrial | 2 |
| 560 | -modifying | 2 |
| 561 | -monitored | 2 |
| 562 | -mpc | 2 |
| 563 | -mrsa | 2 |
| 564 | -multi-hivb | 2 |
| 565 | -normalized | 2 |
| 566 | -oxyhydroxide | 2 |
| 567 | -patch | 2 |
| 568 | -phor21-treated | 2 |
| 569 | -phosphorylated | 2 |
| 570 | -photodynamic | 2 |
| 571 | -physical | 2 |
| 572 | -polarized | 2 |
| 573 | -polypropylene | 2 |
| 574 | -positive/human | 2 |
| 575 | -primed | 2 |
| 576 | -programmed | 2 |
| 577 | -prophylaxis | 2 |
| 578 | -propylene | 2 |
| 579 | -protective | 2 |
| 580 | -pulsed | 2 |
| 581 | -pz-cl | 2 |
| 582 | -quinolizidine | 2 |
| 583 | -rated | 2 |
| 584 | -receptor-preferring | 2 |
| 585 | -renin | 2 |
| 586 | -rtms | 2 |
| 587 | -separated | 2 |
| 588 | -shift | 2 |
| 589 | -signalling | 2 |
| 590 | -smad2/3 | 2 |
| 591 | -smads | 2 |
| 592 | -soaked | 2 |
| 593 | -staged | 2 |
| 594 | -standardized | 2 |
| 595 | -starved | 2 |
| 596 | -stay | 2 |
| 597 | -stereospecific | 2 |
| 598 | -stored | 2 |
| 599 | -tcr | 2 |
| 600 | -thiophene | 2 |
| 601 | -tio2 | 2 |
| 602 | -to-lv | 2 |
| 603 | -transport | 2 |
| 604 | -transporting | 2 |
| 605 | -truncated | 2 |
| 606 | -tubule | 2 |
| 607 | -tween-80 | 2 |
| 608 | -typing | 2 |
| 609 | -unselected | 2 |
| 610 | -vascular | 2 |
| 611 | -vegf | 2 |
| 612 | -yang | 2 |
| 613 | -α-based | 2 |
| 614 | -α-kdo | 2 |
| 615 | -β-glucanase-silenced | 2 |
| 616 | .act | 2 |
| 617 | .asthma-related | 2 |
| 618 | .average | 2 |
| 619 | .dopamine | 2 |
| 620 | .early | 2 |
| 621 | .educational | 2 |
| 622 | .few | 2 |
| 623 | .fourteen | 2 |
| 624 | .individual | 2 |
| 625 | .inhaled | 2 |
| 626 | .material | 2 |
| 627 | .mild | 2 |
| 628 | .partial | 2 |
| 629 | .postoperative | 2 |
| 630 | .primary | 2 |
| 631 | .serum | 2 |
| 632 | .significant | 2 |
| 633 | .study | 2 |
| 634 | .suicide-related | 2 |
| 635 | .thirty-one | 2 |
| 636 | .twenty-eight | 2 |
| 637 | .twenty-seven | 2 |
| 638 | /ag-coated | 2 |
| 639 | /akt/mtor | 2 |
| 640 | /aortic | 2 |
| 641 | /b3lyp | 2 |
| 642 | /benzodiazepine | 2 |
| 643 | /bovine | 2 |
| 644 | /c-jun | 2 |
| 645 | /c-reactive | 2 |
| 646 | /calcineurin-dependent | 2 |
| 647 | /cancer | 2 |
| 648 | /cds | 2 |
| 649 | /clearfil | 2 |
| 650 | /clinical | 2 |
| 651 | /corticosteroid | 2 |
| 652 | /dbp | 2 |
| 653 | /direct | 2 |
| 654 | /endothelial | 2 |
| 655 | /haemophilus | 2 |
| 656 | /heart | 2 |
| 657 | /heparin | 2 |
| 658 | /high-frequency | 2 |
| 659 | /il-23 | 2 |
| 660 | /inspiratory | 2 |
| 661 | /larger | 2 |
| 662 | /lipid | 2 |
| 663 | /lovastatin | 2 |
| 664 | /lymphokine-activated | 2 |
| 665 | /multi-walled | 2 |
| 666 | /nadh | 2 |
| 667 | /obese | 2 |
| 668 | /oral | 2 |
| 669 | /pcr | 2 |
| 670 | /popc | 2 |
| 671 | /progesterone | 2 |
| 672 | /reduced | 2 |
| 673 | /s6 | 2 |
| 674 | /serine-threonine | 2 |
| 675 | /silver | 2 |
| 676 | /sps | 2 |
| 677 | /std | 2 |
| 678 | /th2 | 2 |
| 679 | /tpra | 2 |
| 680 | /β-catenin | 2 |
| 681 | /βcdp | 2 |
| 682 | /∆pgi∆zwf∆usha | 2 |
| 683 | 2-catalyzed | 2 |
| 684 | 2tcnq | 2 |
| 685 | 3tc-treated | 2 |
| 686 | 90203 | 2 |
| 687 | 9907 | 2 |
| 688 | :0.005 | 2 |
| 689 | :81 | 2 |
| 690 | =151 | 2 |
| 691 | =ccug | 2 |
| 692 | acas-ineligible | 2 |
| 693 | amx/ca-treated | 2 |
| 694 | a″ | 2 |
| 695 | batio₃-paraffin | 2 |
| 696 | benzimidazolium | 2 |
| 697 | bisbenzimidazole | 2 |
| 698 | bnnt-sh | 2 |
| 699 | boc4h6 | 2 |
| 700 | bromide-catalyzed | 2 |
| 701 | c-methacetin | 2 |
| 702 | c-percentage | 2 |
| 703 | cagelike | 2 |
| 704 | catechin-related | 2 |
| 705 | cholesterol-labelled | 2 |
| 706 | co-heating | 2 |
| 707 | cr1-deficient | 2 |
| 708 | ctn-0037 | 2 |
| 709 | cu-labeled | 2 |
| 710 | dihydrochloride-induced | 2 |
| 711 | drug/metabolite | 2 |
| 712 | e*3-leiden | 2 |
| 713 | el-free | 2 |
| 714 | f-labelled | 2 |
| 715 | ftc-treated | 2 |
| 716 | g4™ | 2 |
| 717 | gullon | 2 |
| 718 | ide-naive | 2 |
| 719 | immune-sorbent | 2 |
| 720 | in-diethylenetriaminepentaacetic | 2 |
| 721 | iv-based | 2 |
| 722 | k-k373d | 2 |
| 723 | k-mr | 2 |
| 724 | k-pkb-foxo | 2 |
| 725 | laryngoscope-specific | 2 |
| 726 | methanide | 2 |
| 727 | microbouquet | 2 |
| 728 | needle-insertion | 2 |
| 729 | nh- | 2 |
| 730 | nijmegen-bethesda | 2 |
| 731 | nmoles/g | 2 |
| 732 | o-stimulated | 2 |
| 733 | og1 | 2 |
| 734 | p-catalyzed | 2 |
| 735 | p2-dependent | 2 |
| 736 | pdtc-treated | 2 |
| 737 | phosphoesterase | 2 |
| 738 | psychophysically-anchored | 2 |
| 739 | purospher | 2 |
| 740 | r-overexpressing | 2 |
| 741 | radical-bridged | 2 |
| 742 | rc/cl | 2 |
| 743 | re-labeled | 2 |
| 744 | reducing/eliminating | 2 |
| 745 | s-producing | 2 |
| 746 | sham+pdtc | 2 |
| 747 | si-nmr | 2 |
| 748 | std6 | 2 |
| 749 | tc-maa | 2 |
| 750 | tc-radiolabeled | 2 |
| 751 | tetrathiafulvalene | 2 |
| 752 | triethoxysilane-treated | 2 |
| 753 | vre/g | 2 |
| 754 | y-labeled | 2 |
| 755 | zr-conjugated | 2 |
| 756 | zr2p3o12 | 2 |
| 757 | ···ar | 2 |
| 758 | ×ho | 2 |
| 759 | β1.3-induced | 2 |
| 760 | πω | 2 |
| 761 | ‑2,5‑diphenyltetrazolium | 2 |
| 762 | ₂so₄ | 2 |
| 763 | →b*+ | 2 |
| 764 | '-ib-cr | 1 |
| 765 | 'coral | 1 |
| 766 | *-allyl | 1 |
| 767 | +/progesterone | 1 |
| 768 | +an | 1 |
| 769 | +anti-rankl | 1 |
| 770 | +bv | 1 |
| 771 | +exe | 1 |
| 772 | +flt-3 | 1 |
| 773 | +h2o2-induced | 1 |
| 774 | +hae | 1 |
| 775 | +metastatic | 1 |
| 776 | +npx | 1 |
| 777 | +one | 1 |
| 778 | +prometrium™ | 1 |
| 779 | +propofol | 1 |
| 780 | +sodium | 1 |
| 781 | ,2- | 1 |
| 782 | ,24-dien-3beta-yl | 1 |
| 783 | -/progesterone | 1 |
| 784 | -001 | 1 |
| 785 | -0401 | 1 |
| 786 | -1,1,3,3-tetramethyluronium | 1 |
| 787 | -1,2,3,4-tetra-hydro | 1 |
| 788 | -1,2,3,4-tetrazolate | 1 |
| 789 | -1,2,3-trihydroxybutyl | 1 |
| 790 | -1,2,4-benzotriazine | 1 |
| 791 | -1,3,4-oxazepine-4,7-dione | 1 |
| 792 | -1,3-dimethyl | 1 |
| 793 | -1,4,7,10-tetraazacyclododecane-1,4,7-triacetic | 1 |
| 794 | -1,4-dihydro-2,6-dimethyl-1-substituted | 1 |
| 795 | -1-arylethanones | 1 |
| 796 | -1-dependent | 1 |
| 797 | -1-ethoxycarbonyl-3- | 1 |
| 798 | -1-ethylcarbodiimide | 1 |
| 799 | -1-methylpiperidinium | 1 |
| 800 | -1-methylpyrrolidinium | 1 |
| 801 | -1-risk | 1 |
| 802 | -1/3 | 1 |
| 803 | -1/et | 1 |
| 804 | -14±5 | 1 |
| 805 | -15n | 1 |
| 806 | -17a-induced | 1 |
| 807 | -1h-1,2,4-triazole | 1 |
| 808 | -1h-5,6-dimethyl-benzimidazolium | 1 |
| 809 | -1α-modifying | 1 |
| 810 | -1β-expressing | 1 |
| 811 | -1β-induced | 1 |
| 812 | -2,3-dihydro-1h-indol-2-one | 1 |
| 813 | -2,4-dinitrobenzeneamines | 1 |
| 814 | -2,5-dimethoxy-4-iodoamphetamine | 1 |
| 815 | -2,5-dimethyl | 1 |
| 816 | -2,5-diphenol | 1 |
| 817 | -2,5-diphenyl-2-h-tetrazolium | 1 |
| 818 | -2-derived | 1 |
| 819 | -2-en-1,4-dicarbonyl | 1 |
| 820 | -2-olefin | 1 |
| 821 | -2-overexpressing | 1 |
| 822 | -2/2x | 1 |
| 823 | -202a/c | 1 |
| 824 | -20mmol/l | 1 |
| 825 | -22-producing | 1 |
| 826 | -27±6.7 | 1 |
| 827 | -2g-o-α-d-xylopyranosyl-2h-geranilan-8',10'-dioic | 1 |
| 828 | -2β-carbon | 1 |
| 829 | -3'-thioguanosine | 1 |
| 830 | -3,4'-dimethoxy | 1 |
| 831 | -3,4-dihydro-2h-1-benzopyran-3-yl | 1 |
| 832 | -3,4-dihydropyrimidine | 1 |
| 833 | -3,4:9,10-perylenetetra-carboxylic | 1 |
| 834 | -3,5-lutidinium | 1 |
| 835 | -3-aminomethyl-5-methyl | 1 |
| 836 | -3-aryl | 1 |
| 837 | -3-butylimidazolium | 1 |
| 838 | -3-hydroxy-4-oxoquinaldine | 1 |
| 839 | -3-hydroxyacyl-acyl | 1 |
| 840 | -3-isobutyl | 1 |
| 841 | -3-mediated | 1 |
| 842 | -3-methyl | 1 |
| 843 | -3-phenylisoxazole | 1 |
| 844 | -3-substituted | 1 |
| 845 | -33/st2 | 1 |
| 846 | -4,5-dihydro-1h-pyrazole-1-carbothioic | 1 |
| 847 | -4-aryl-6-indolylnicotinonitriles | 1 |
| 848 | -4-carboxylates | 1 |
| 849 | -4-oxobut-2-enoic | 1 |
| 850 | -4-picolinium | 1 |
| 851 | -4-substituted | 1 |
| 852 | -5,7,5'-trihydroxyflavanone | 1 |
| 853 | -5-methyl-10,11-dihydro-5h-debenzocyclhepten-5,10-imine | 1 |
| 854 | -5-phenyl-1,3,4- | 1 |
| 855 | -555 | 1 |
| 856 | -6-null | 1 |
| 857 | -6-positive | 1 |
| 858 | -6a | 1 |
| 859 | -6a-hydroxymaackiain | 1 |
| 860 | -6rα | 1 |
| 861 | -6t8 | 1 |
| 862 | -7:00 | 1 |
| 863 | -9'-fluoro | 1 |
| 864 | -9'-heptyl | 1 |
| 865 | -9,19-cyclolanosta-3 | 1 |
| 866 | -9-hydroxy | 1 |
| 867 | -a/vegfr-2 | 1 |
| 868 | -aab | 1 |
| 869 | -adenovirus | 1 |
| 870 | -aderergic | 1 |
| 871 | -adrenoceptor-desensitized | 1 |
| 872 | -adrenoceptor-mediated | 1 |
| 873 | -agonist-randomised | 1 |
| 874 | -agonists.a | 1 |
| 875 | -agonistthe | 1 |
| 876 | -akt/total | 1 |
| 877 | -alcohol-diethylamine | 1 |
| 878 | -alfa-based | 1 |
| 879 | -alkylidyne | 1 |
| 880 | -amido | 1 |
| 881 | -amp | 1 |
| 882 | -ampk | 1 |
| 883 | -ampkalpha2 | 1 |
| 884 | -annexin | 1 |
| 885 | -arm-treated | 1 |
| 886 | -artificial | 1 |
| 887 | -as160 | 1 |
| 888 | -association | 1 |
| 889 | -atpase-2a | 1 |
| 890 | -atpase-linked | 1 |
| 891 | -attached | 1 |
| 892 | -b27-associated | 1 |
| 893 | -beta-d-glucopyranoside-oleanolic | 1 |
| 894 | -bontl | 1 |
| 895 | -booster | 1 |
| 896 | -bornyl | 1 |
| 897 | -bromanyl | 1 |
| 898 | -butadienyl | 1 |
| 899 | -butenyl | 1 |
| 900 | -bzd | 1 |
| 901 | -c-induced | 1 |
| 902 | -ca1 | 1 |
| 903 | -calcium | 1 |
| 904 | -cancerous | 1 |
| 905 | -carene | 1 |
| 906 | -causing | 1 |
| 907 | -ccaat | 1 |
| 908 | -centred | 1 |
| 909 | -changes | 1 |
| 910 | -chelator | 1 |
| 911 | -child | 1 |
| 912 | -chlorhexidene | 1 |
| 913 | -chloromethyl-2',7'-dichlorodihydrofluorescein | 1 |
| 914 | -chloromethyl-2',7'-dichlorofluorescein | 1 |
| 915 | -cholesterol-labeled | 1 |
| 916 | -cin1 | 1 |
| 917 | -cine | 1 |
| 918 | -citalopram-binding | 1 |
| 919 | -clearing | 1 |
| 920 | -cluster-substituted | 1 |
| 921 | -cmx-vaccinated | 1 |
| 922 | -co-doped | 1 |
| 923 | -coding | 1 |
| 924 | -coinfected | 1 |
| 925 | -compatible | 1 |
| 926 | -competitive | 1 |
| 927 | -composed | 1 |
| 928 | -condensed | 1 |
| 929 | -conditioned | 1 |
| 930 | -configured | 1 |
| 931 | -connect | 1 |
| 932 | -consistent | 1 |
| 933 | -constitutive | 1 |
| 934 | -contained | 1 |
| 935 | -cooled | 1 |
| 936 | -copd | 1 |
| 937 | -created | 1 |
| 938 | -cullin4 | 1 |
| 939 | -cycloocta-1,3-diene | 1 |
| 940 | -dc | 1 |
| 941 | -decoupled | 1 |
| 942 | -delta8'-7-acetoxy-3,4,3',5'-tetramethoxy-8- | 1 |
| 943 | -depletion | 1 |
| 944 | -detecting | 1 |
| 945 | -detrz | 1 |
| 946 | -dianiline | 1 |
| 947 | -diet-induced | 1 |
| 948 | -difluorophenyl | 1 |
| 949 | -digested | 1 |
| 950 | -digitonin | 1 |
| 951 | -dimethylated | 1 |
| 952 | -dimethylthiazoy1-3,5-diphenyltetrazolium | 1 |
| 953 | -diol-3- | 1 |
| 954 | -distal | 1 |
| 955 | -docosahexaenoyl | 1 |
| 956 | -domain-containing | 1 |
| 957 | -dominated | 1 |
| 958 | -dosing | 1 |
| 959 | -dpot | 1 |
| 960 | -dqa1 | 1 |
| 961 | -drinking | 1 |
| 962 | -effector | 1 |
| 963 | -eicosapentaenoyl | 1 |
| 964 | -engineered | 1 |
| 965 | -enolide | 1 |
| 966 | -entrapped | 1 |
| 967 | -erk1/2 | 1 |
| 968 | -ethinyl | 1 |
| 969 | -exchanged | 1 |
| 970 | -expansion | 1 |
| 971 | -eye | 1 |
| 972 | -eyed | 1 |
| 973 | -failing | 1 |
| 974 | -favor | 1 |
| 975 | -female | 1 |
| 976 | -fibrinogen | 1 |
| 977 | -filed | 1 |
| 978 | -fluoren-9-ylidene | 1 |
| 979 | -fluorescence | 1 |
| 980 | -fluoroalkylated | 1 |
| 981 | -foam | 1 |
| 982 | -folfiri | 1 |
| 983 | -formato | 1 |
| 984 | -functionalised | 1 |
| 985 | -g1 | 1 |
| 986 | -gamma-producing | 1 |
| 987 | -gemmenos65 | 1 |
| 988 | -gene-mutant | 1 |
| 989 | -generation | 1 |
| 990 | -gestational | 1 |
| 991 | -gfp-identified | 1 |
| 992 | -ginsenoside | 1 |
| 993 | -glucan-pretreated | 1 |
| 994 | -glucanase-positive | 1 |
| 995 | -glucanosyltransferase | 1 |
| 996 | -gold | 1 |
| 997 | -golgi | 1 |
| 998 | -green | 1 |
| 999 | -growing | 1 |
| 1000 | -gβγ-mediated | 1 |
| 1001 | -h/n-h | 1 |
| 1002 | -h/s-h | 1 |
| 1003 | -harboring | 1 |
| 1004 | -hcb | 1 |
| 1005 | -hctz | 1 |
| 1006 | -hd4 | 1 |
| 1007 | -healed | 1 |
| 1008 | -heatsynch | 1 |
| 1009 | -heremans-schmid | 1 |
| 1010 | -heteroscorpionate | 1 |
| 1011 | -hhtre | 1 |
| 1012 | -hilic | 1 |
| 1013 | -homologous | 1 |
| 1014 | -hurag | 1 |
| 1015 | -hydrated | 1 |
| 1016 | -hydroperoxyflavin | 1 |
| 1017 | -hydrosaline | 1 |
| 1018 | -hypnotic | 1 |
| 1019 | -h···nh2-r | 1 |
| 1020 | -ifna | 1 |
| 1021 | -ii-selective | 1 |
| 1022 | -iia/nptii-specific | 1 |
| 1023 | -ila | 1 |
| 1024 | -imi | 1 |
| 1025 | -independent/dids-sensitive | 1 |
| 1026 | -induce | 1 |
| 1027 | -inducer | 1 |
| 1028 | -induction | 1 |
| 1029 | -inhibitable | 1 |
| 1030 | -inhibitor/angiotensin | 1 |
| 1031 | -inoculated | 1 |
| 1032 | -intended | 1 |
| 1033 | -internal | 1 |
| 1034 | -isolaricireinol-2 | 1 |
| 1035 | -ius | 1 |
| 1036 | -k373 | 1 |
| 1037 | -l2/3 | 1 |
| 1038 | -lesioned | 1 |
| 1039 | -li+ | 1 |
| 1040 | -licensed | 1 |
| 1041 | -ligament | 1 |
| 1042 | -ligated | 1 |
| 1043 | -lmp1 | 1 |
| 1044 | -locking | 1 |
| 1045 | -machine | 1 |
| 1046 | -made | 1 |
| 1047 | -managed | 1 |
| 1048 | -mapk | 1 |
| 1049 | -mb-defined | 1 |
| 1050 | -meal | 1 |
| 1051 | -mediating | 1 |
| 1052 | -menc-tt | 1 |
| 1053 | -mepivacaine | 1 |
| 1054 | -mercaptopropyl | 1 |
| 1055 | -methionine-labeled | 1 |
| 1056 | -methylenamino | 1 |
| 1057 | -military | 1 |
| 1058 | -mimic | 1 |
| 1059 | -mitogen/extracellular | 1 |
| 1060 | -mobilised | 1 |
| 1061 | -modificated | 1 |
| 1062 | -molten | 1 |
| 1063 | -monoinfected | 1 |
| 1064 | -more | 1 |
| 1065 | -muscarinic | 1 |
| 1066 | -n'-ethylcarbodiimide | 1 |
| 1067 | -n'-phenylthiourea | 1 |
| 1068 | -n-ethylcarbodiimide | 1 |
| 1069 | -n111g | 1 |
| 1070 | -neomycin | 1 |
| 1071 | -nf-κb | 1 |
| 1072 | -ninhydrin | 1 |
| 1073 | -non-yds | 1 |
| 1074 | -nootkatone-treated | 1 |
| 1075 | -nrf2/are | 1 |
| 1076 | -observer | 1 |
| 1077 | -octane | 1 |
| 1078 | -olefin | 1 |
| 1079 | -one-1,3,4-oxadiazole | 1 |
| 1080 | -one-mediated | 1 |
| 1081 | -origin | 1 |
| 1082 | -oxadiazole-5- | 1 |
| 1083 | -oxadiazoline | 1 |
| 1084 | -oxidative-induced | 1 |
| 1085 | -p53-ros | 1 |
| 1086 | -percent | 1 |
| 1087 | -peroxo | 1 |
| 1088 | -pge2 | 1 |
| 1089 | -ph | 1 |
| 1090 | -phosphine-bound | 1 |
| 1091 | -photodiode | 1 |
| 1092 | -phytantriol-based | 1 |
| 1093 | -plus-statin | 1 |
| 1094 | -poisoned | 1 |
| 1095 | -polarity | 1 |
| 1096 | -polystylene | 1 |
| 1097 | -positive/her2-negative | 1 |
| 1098 | -ppase | 1 |
| 1099 | -printed | 1 |
| 1100 | -pro-inflammatory | 1 |
| 1101 | -progesterone | 1 |
| 1102 | -proliferation | 1 |
| 1103 | -propanehydrazonoyl | 1 |
| 1104 | -propano | 1 |
| 1105 | -propofol-opioid | 1 |
| 1106 | -protect | 1 |
| 1107 | -protected | 1 |
| 1108 | -protopanaxatriol-type | 1 |
| 1109 | -purified | 1 |
| 1110 | -pyridazinone | 1 |
| 1111 | -pyridino-phane | 1 |
| 1112 | -qinglishengjing | 1 |
| 1113 | -quantified | 1 |
| 1114 | -quinazoliniminium | 1 |
| 1115 | -quinolone | 1 |
| 1116 | -quinoxaline-2-carbonitrile | 1 |
| 1117 | -r. | 1 |
| 1118 | -r30°-ch3s | 1 |
| 1119 | -rat | 1 |
| 1120 | -reca | 1 |
| 1121 | -received | 1 |
| 1122 | -receiving | 1 |
| 1123 | -receptor-associated | 1 |
| 1124 | -receptor-coated | 1 |
| 1125 | -receptor-deficient | 1 |
| 1126 | -receptor-interacting | 1 |
| 1127 | -registered | 1 |
| 1128 | -rendered | 1 |
| 1129 | -replicated | 1 |
| 1130 | -reporter | 1 |
| 1131 | -responder | 1 |
| 1132 | -responding | 1 |
| 1133 | -ret | 1 |
| 1134 | -retained | 1 |
| 1135 | -retrotransposon | 1 |
| 1136 | -rg₃-induced | 1 |
| 1137 | -ribulo | 1 |
| 1138 | -s2 | 1 |
| 1139 | -salicin-mediated | 1 |
| 1140 | -scaling | 1 |
| 1141 | -se-phenyl | 1 |
| 1142 | -secretagogue | 1 |
| 1143 | -sensing | 1 |
| 1144 | -sensitive- | 1 |
| 1145 | -seroprevalence | 1 |
| 1146 | -sestamibi | 1 |
| 1147 | -shogaol-induced | 1 |
| 1148 | -short | 1 |
| 1149 | -sided | 1 |
| 1150 | -signalling-mediated | 1 |
| 1151 | -single-strand | 1 |
| 1152 | -sired | 1 |
| 1153 | -smad | 1 |
| 1154 | -solid | 1 |
| 1155 | -solubilized | 1 |
| 1156 | -sometimes | 1 |
| 1157 | -speaking | 1 |
| 1158 | -stented | 1 |
| 1159 | -storage | 1 |
| 1160 | -stress-induced | 1 |
| 1161 | -stressed | 1 |
| 1162 | -substitution | 1 |
| 1163 | -superovulated | 1 |
| 1164 | -suppressed | 1 |
| 1165 | -suppressible | 1 |
| 1166 | -sustaining | 1 |
| 1167 | -sweetened | 1 |
| 1168 | -symmetry | 1 |
| 1169 | -sympathetic | 1 |
| 1170 | -sympathomimetic | 1 |
| 1171 | -tdf | 1 |
| 1172 | -temospho-treated | 1 |
| 1173 | -tetramer-positive | 1 |
| 1174 | -thalassemic | 1 |
| 1175 | -thiolate | 1 |
| 1176 | -thymoma | 1 |
| 1177 | -tlr3-induced | 1 |
| 1178 | -to-bnx | 1 |
| 1179 | -to-green | 1 |
| 1180 | -to-lewis | 1 |
| 1181 | -to-metal | 1 |
| 1182 | -to-mouse | 1 |
| 1183 | -to-total | 1 |
| 1184 | -towards | 1 |
| 1185 | -tpn | 1 |
| 1186 | -traceable | 1 |
| 1187 | -tricalcium | 1 |
| 1188 | -triethylammonium | 1 |
| 1189 | -trinodal | 1 |
| 1190 | -tta | 1 |
| 1191 | -underwent | 1 |
| 1192 | -undetectable | 1 |
| 1193 | -up-regulated | 1 |
| 1194 | -utilizing | 1 |
| 1195 | -v-akt | 1 |
| 1196 | -vectored | 1 |
| 1197 | -venus | 1 |
| 1198 | -verified | 1 |
| 1199 | -via | 1 |
| 1200 | -vitrified | 1 |
| 1201 | -vps34 | 1 |
| 1202 | -watch | 1 |
| 1203 | -wistar | 1 |
| 1204 | -xylulo | 1 |
| 1205 | -zmrfp1 | 1 |
| 1206 | -α-activated | 1 |
| 1207 | -α-stimulated | 1 |
| 1208 | -αvβ3 | 1 |
| 1209 | -β/ribavirin | 1 |
| 1210 | -β1/smad | 1 |
| 1211 | -γ-induced | 1 |
| 1212 | -γ-secreting | 1 |
| 1213 | -κappab | 1 |
| 1214 | -κb-dependent | 1 |
| 1215 | .00713optimal | 1 |
| 1216 | .abciximab | 1 |
| 1217 | .additional | 1 |
| 1218 | .anastomotic | 1 |
| 1219 | .another | 1 |
| 1220 | .antibiotic | 1 |
| 1221 | .antidepressants | 1 |
| 1222 | .antioxidant | 1 |
| 1223 | .antiretroviral | 1 |
| 1224 | .ascaris | 1 |
| 1225 | .authors’ | 1 |
| 1226 | .behavioural | 1 |
| 1227 | .bronchial | 1 |
| 1228 | .cetirizine | 1 |
| 1229 | .ciclesonide | 1 |
| 1230 | .combination | 1 |
| 1231 | .community-dwelling | 1 |
| 1232 | .confirmed | 1 |
| 1233 | .custom-made | 1 |
| 1234 | .dexamethasone | 1 |
| 1235 | .direct | 1 |
| 1236 | .disulfiram | 1 |
| 1237 | .electronicwe | 1 |
| 1238 | .extended | 1 |
| 1239 | .feedback | 1 |
| 1240 | .fewer | 1 |
| 1241 | .fifty-five | 1 |
| 1242 | .final | 1 |
| 1243 | .gradual | 1 |
| 1244 | .hematologic | 1 |
| 1245 | .initiating | 1 |
| 1246 | .intensive | 1 |
| 1247 | .intervention | 1 |
| 1248 | .irs | 1 |
| 1249 | .isocaloric | 1 |
| 1250 | .low | 1 |
| 1251 | .main | 1 |
| 1252 | .misoprostol | 1 |
| 1253 | .motor | 1 |
| 1254 | .multidisciplinary | 1 |
| 1255 | .multifactorial | 1 |
| 1256 | .multiple-component | 1 |
| 1257 | .nineteen | 1 |
| 1258 | .non-bismuth | 1 |
| 1259 | .older | 1 |
| 1260 | .operative | 1 |
| 1261 | .oral | 1 |
| 1262 | .oxytocin | 1 |
| 1263 | .paralytic | 1 |
| 1264 | .perioperative | 1 |
| 1265 | .pfmt | 1 |
| 1266 | .phase-specific | 1 |
| 1267 | .proven | 1 |
| 1268 | .recent | 1 |
| 1269 | .recombinant | 1 |
| 1270 | .regarding | 1 |
| 1271 | .regional | 1 |
| 1272 | .remifentanil | 1 |
| 1273 | .reported | 1 |
| 1274 | .sildenafil | 1 |
| 1275 | .solifenacin | 1 |
| 1276 | .ten | 1 |
| 1277 | .tg | 1 |
| 1278 | .therapeutic | 1 |
| 1279 | .thirty | 1 |
| 1280 | .twenty-five | 1 |
| 1281 | .twenty-nine | 1 |
| 1282 | .twenty-one | 1 |
| 1283 | .unstable | 1 |
| 1284 | /100ml | 1 |
| 1285 | /141 | 1 |
| 1286 | /4π | 1 |
| 1287 | /6-keto | 1 |
| 1288 | /absence | 1 |
| 1289 | /absorbable | 1 |
| 1290 | /acetone | 1 |
| 1291 | /acridine | 1 |
| 1292 | /adiponutrin | 1 |
| 1293 | /akt-dependent | 1 |
| 1294 | /akt/ | 1 |
| 1295 | /akt/extracellular | 1 |
| 1296 | /akt/mitogen-activated | 1 |
| 1297 | /alumina | 1 |
| 1298 | /amp-dependent | 1 |
| 1299 | /angiotensin-ii | 1 |
| 1300 | /anhydroxylose | 1 |
| 1301 | /anti-hdv | 1 |
| 1302 | /ataxia | 1 |
| 1303 | /baculovirus-based | 1 |
| 1304 | /baseline | 1 |
| 1305 | /bdz | 1 |
| 1306 | /beta-catenin | 1 |
| 1307 | /buffer | 1 |
| 1308 | /c-c | 1 |
| 1309 | /c-met | 1 |
| 1310 | /c/f/taf | 1 |
| 1311 | /calcium-calmodulin-dependent | 1 |
| 1312 | /calmodulin-regulated | 1 |
| 1313 | /cd137 | 1 |
| 1314 | /cdc42/actin-related | 1 |
| 1315 | /cetylpyridinium | 1 |
| 1316 | /chemokine | 1 |
| 1317 | /citrullinated | 1 |
| 1318 | /cochaperone | 1 |
| 1319 | /cognitive | 1 |
| 1320 | /copper | 1 |
| 1321 | /core | 1 |
| 1322 | /cr2o3 | 1 |
| 1323 | /cryopyrin | 1 |
| 1324 | /cryptogenic | 1 |
| 1325 | /cxc | 1 |
| 1326 | /cyclin | 1 |
| 1327 | /degraded | 1 |
| 1328 | /dextran | 1 |
| 1329 | /dihydropyridine | 1 |
| 1330 | /dose-limiting | 1 |
| 1331 | /drug | 1 |
| 1332 | /e7-induced | 1 |
| 1333 | /ectopic | 1 |
| 1334 | /emphysema | 1 |
| 1335 | /erk | 1 |
| 1336 | /erk1/2 | 1 |
| 1337 | /ethinyl | 1 |
| 1338 | /eular | 1 |
| 1339 | /exproline | 1 |
| 1340 | /extended | 1 |
| 1341 | /family | 1 |
| 1342 | /fcμr | 1 |
| 1343 | /fenton | 1 |
| 1344 | /fgf | 1 |
| 1345 | /floortime™ | 1 |
| 1346 | /follicular/oxyphilic/anaplastic | 1 |
| 1347 | /genipin | 1 |
| 1348 | /glassy | 1 |
| 1349 | /glaucoma | 1 |
| 1350 | /glucose | 1 |
| 1351 | /h+ | 1 |
| 1352 | /healthy | 1 |
| 1353 | /hemolytic | 1 |
| 1354 | /heterocyclic | 1 |
| 1355 | /hf | 1 |
| 1356 | /histone | 1 |
| 1357 | /hollow | 1 |
| 1358 | /hs-related | 1 |
| 1359 | /hsv-2-coinfected | 1 |
| 1360 | /hyperactive-impulsive | 1 |
| 1361 | /i2-mediated | 1 |
| 1362 | /intra | 1 |
| 1363 | /intravenous | 1 |
| 1364 | /ionic | 1 |
| 1365 | /ipt | 1 |
| 1366 | /italian | 1 |
| 1367 | /iv | 1 |
| 1368 | /japanese | 1 |
| 1369 | /laser | 1 |
| 1370 | /learning | 1 |
| 1371 | /lectin-like | 1 |
| 1372 | /less-dense | 1 |
| 1373 | /lgs | 1 |
| 1374 | /lignin | 1 |
| 1375 | /lipopolysaccharide-induced | 1 |
| 1376 | /liver | 1 |
| 1377 | /low-calorie | 1 |
| 1378 | /low-dose | 1 |
| 1379 | /lsat | 1 |
| 1380 | /machado-joseph | 1 |
| 1381 | /maximal | 1 |
| 1382 | /mdr1-expressing | 1 |
| 1383 | /mechanistic | 1 |
| 1384 | /mer | 1 |
| 1385 | /methacholine | 1 |
| 1386 | /methoprene | 1 |
| 1387 | /micronised | 1 |
| 1388 | /minimal | 1 |
| 1389 | /mitogen‑activated | 1 |
| 1390 | /mll-aff1 | 1 |
| 1391 | /mo | 1 |
| 1392 | /modified | 1 |
| 1393 | /motor-evoked | 1 |
| 1394 | /mpa | 1 |
| 1395 | /mri | 1 |
| 1396 | /multicellular | 1 |
| 1397 | /muscle | 1 |
| 1398 | /myd88-dependent | 1 |
| 1399 | /naf/sncl₂ | 1 |
| 1400 | /neurovascular | 1 |
| 1401 | /nf-κb | 1 |
| 1402 | /niacin | 1 |
| 1403 | /nicotinamide | 1 |
| 1404 | /nitinol | 1 |
| 1405 | /nitrotyrosine | 1 |
| 1406 | /non-erosive | 1 |
| 1407 | /non-gcb | 1 |
| 1408 | /non-inhibitor | 1 |
| 1409 | /non-luminal | 1 |
| 1410 | /normoxic | 1 |
| 1411 | /oxidative | 1 |
| 1412 | /p16-positive | 1 |
| 1413 | /p38/mitf | 1 |
| 1414 | /p38/mitf/tyrosinase | 1 |
| 1415 | /p70 | 1 |
| 1416 | /pcy3-catalyzed | 1 |
| 1417 | /pda | 1 |
| 1418 | /pervasive | 1 |
| 1419 | /photodiode | 1 |
| 1420 | /polyvinyl | 1 |
| 1421 | /prednisone | 1 |
| 1422 | /premenstrual | 1 |
| 1423 | /pro-apoptotic | 1 |
| 1424 | /processed | 1 |
| 1425 | /progressive | 1 |
| 1426 | /propidium | 1 |
| 1427 | /ps1 | 1 |
| 1428 | /pulseless | 1 |
| 1429 | /rank | 1 |
| 1430 | /recommended | 1 |
| 1431 | /reflective | 1 |
| 1432 | /reflux | 1 |
| 1433 | /right | 1 |
| 1434 | /safety | 1 |
| 1435 | /signal-regulated | 1 |
| 1436 | /siloxane | 1 |
| 1437 | /sir/prednisone | 1 |
| 1438 | /smads | 1 |
| 1439 | /small | 1 |
| 1440 | /soluble | 1 |
| 1441 | /spliced | 1 |
| 1442 | /stat-3 | 1 |
| 1443 | /ste20/sps1-related | 1 |
| 1444 | /tam | 1 |
| 1445 | /th66 | 1 |
| 1446 | /thermal | 1 |
| 1447 | /thromboxane | 1 |
| 1448 | /tio₂ | 1 |
| 1449 | /triclosan | 1 |
| 1450 | /triclosan/copolymer | 1 |
| 1451 | /trka | 1 |
| 1452 | /ucl | 1 |
| 1453 | /unconfirmed | 1 |
| 1454 | /universal | 1 |
| 1455 | /urban | 1 |
| 1456 | /usual | 1 |
| 1457 | /valve | 1 |
| 1458 | /vegf | 1 |
| 1459 | /vocal | 1 |
| 1460 | /wo₃ | 1 |
| 1461 | /α-sarcomeric | 1 |
| 1462 | /β-catenin/cyclin | 1 |
| 1463 | /β-tricalcium | 1 |
| 1464 | /δblood | 1 |
| 1465 | 0.05/kg | 1 |
| 1466 | 0201-restricted | 1 |
| 1467 | 09.02 | 1 |
| 1468 | 1-family | 1 |
| 1469 | 1-favoured | 1 |
| 1470 | 1-person | 1 |
| 1471 | 1-promoting | 1 |
| 1472 | 1.1-ml | 1 |
| 1473 | 1.2-mediated | 1 |
| 1474 | 1.3-dependent | 1 |
| 1475 | 1.3-ml | 1 |
| 1476 | 1.3-targeted | 1 |
| 1477 | 1.7-blocking | 1 |
| 1478 | 1.8-expressing | 1 |
| 1479 | 1/2-related | 1 |
| 1480 | 1/2/p90 | 1 |
| 1481 | 1/th2/th17-type | 1 |
| 1482 | 11-conjugated | 1 |
| 1483 | 141+/-12fmol/mg | 1 |
| 1484 | 17-polarized | 1 |
| 1485 | 17.937 | 1 |
| 1486 | 1ysa/ysarbrc | 1 |
| 1487 | 2-biased | 1 |
| 1488 | 2-kbro3 | 1 |
| 1489 | 2-θσ2 | 1 |
| 1490 | 2.3/ | 1 |
| 1491 | 2.increasing | 1 |
| 1492 | 2/3-dependent | 1 |
| 1493 | 2/c | 1 |
| 1494 | 2/et3n/1:1 | 1 |
| 1495 | 20mmol/l | 1 |
| 1496 | 26866138-mmy-3006 | 1 |
| 1497 | 2⋅4 | 1 |
| 1498 | 3*leiden | 1 |
| 1499 | 3,4-dimethylpyrazole | 1 |
| 1500 | 3,6-bridged-glycosyl | 1 |
| 1501 | 3-adsorbed | 1 |
| 1502 | 3-complexed | 1 |
| 1503 | 3-diethylenetriamine | 1 |
| 1504 | 3.2-targeting | 1 |
| 1505 | 3.24+/-2.71 | 1 |
| 1506 | 3.38-5.05 | 1 |
| 1507 | 3.57ml/kg | 1 |
| 1508 | 3.75mug | 1 |
| 1509 | 3.98+/-2.51 | 1 |
| 1510 | 3/carbon | 1 |
| 1511 | 3/hgo | 1 |
| 1512 | 30scha/j | 1 |
| 1513 | 36,711 | 1 |
| 1514 | 37+/-2.31 | 1 |
| 1515 | 3a-mediated | 1 |
| 1516 | 3l3 | 1 |
| 1517 | 3·1.5h2o | 1 |
| 1518 | 4-carboxylatobenzoxyl | 1 |
| 1519 | 4-myeloid | 1 |
| 1520 | 44.00±64.00 | 1 |
| 1521 | 4mtt | 1 |
| 1522 | 5,199 | 1 |
| 1523 | 5-aminoisoxazole | 1 |
| 1524 | 612-like | 1 |
| 1525 | 6274not | 1 |
| 1526 | 65-expressing | 1 |
| 1527 | 7,462 | 1 |
| 1528 | 75-day | 1 |
| 1529 | 8-induced | 1 |
| 1530 | 82bc | 1 |
| 1531 | 92-gene | 1 |
| 1532 | 9601 | 1 |
| 1533 | :147. | 1 |
| 1534 | :852-861. | 1 |
| 1535 | =-3/2 | 1 |
| 1536 | =13.9 | 1 |
| 1537 | =178 | 1 |
| 1538 | =19.34μm | 1 |
| 1539 | =193.537 | 1 |
| 1540 | =316 | 1 |
| 1541 | =82.0-0.62 | 1 |
| 1542 | =cect | 1 |
| 1543 | =cgmcc | 1 |
| 1544 | =hg/arm | 1 |
| 1545 | a-gypsum | 1 |
| 1546 | aampc | 1 |
| 1547 | aand | 1 |
| 1548 | aceto- | 1 |
| 1549 | acetone+bonding | 1 |
| 1550 | acetonitrile-glacial | 1 |
| 1551 | adaptativos | 1 |
| 1552 | adrenoceptor-blocking | 1 |
| 1553 | ahr+/+ | 1 |
| 1554 | ak/pd | 1 |
| 1555 | algae-mediated | 1 |
| 1556 | all-invasive | 1 |
| 1557 | allopathy- | 1 |
| 1558 | alpha/delta/gamma | 1 |
| 1559 | amine-induced | 1 |
| 1560 | amino-2-oxoethyl | 1 |
| 1561 | aminobenzoate | 1 |
| 1562 | aminocombretastatin | 1 |
| 1563 | aminomethyl-1,4-benzodioxane | 1 |
| 1564 | aml17 | 1 |
| 1565 | ampicillin/sulbactam-treated | 1 |
| 1566 | ampk/mtor-driven | 1 |
| 1567 | analogue/human | 1 |
| 1568 | and/orspecific | 1 |
| 1569 | andpparαgene | 1 |
| 1570 | anilinide | 1 |
| 1571 | anti-t-lymphoma/leukemia | 1 |
| 1572 | antimineralisation | 1 |
| 1573 | antituberulosis-naïve | 1 |
| 1574 | ap3b1-derived | 1 |
| 1575 | ar-expressing | 1 |
| 1576 | ar-induced | 1 |
| 1577 | ar-knockout | 1 |
| 1578 | ar-transfected | 1 |
| 1579 | arachidonate-stimulated | 1 |
| 1580 | arsonium | 1 |
| 1581 | artery/first | 1 |
| 1582 | aryl-monothio-1,3-diketone | 1 |
| 1583 | at-anti-murine | 1 |
| 1584 | attention-control/pharmacologic | 1 |
| 1585 | ayurvedic- | 1 |
| 1586 | b*5701 | 1 |
| 1587 | b-48-containing | 1 |
| 1588 | b/ann | 1 |
| 1589 | balugrastim-treated | 1 |
| 1590 | bearman | 1 |
| 1591 | benga | 1 |
| 1592 | benzendiazonium | 1 |
| 1593 | benzene-1,3-diols | 1 |
| 1594 | benzene-diazonium | 1 |
| 1595 | benzimidazolyl | 1 |
| 1596 | benzo-yloxy | 1 |
| 1597 | benzodiazepine-dose | 1 |
| 1598 | benzylamide | 1 |
| 1599 | beta5-expressing | 1 |
| 1600 | better-specified | 1 |
| 1601 | better/more | 1 |
| 1602 | between-areal | 1 |
| 1603 | bi-type | 1 |
| 1604 | blockade-treated | 1 |
| 1605 | bms-936557-treated | 1 |
| 1606 | br10 | 1 |
| 1607 | brevetoxin/no | 1 |
| 1608 | c*6 | 1 |
| 1609 | c-ii-dependent | 1 |
| 1610 | c-labaled | 1 |
| 1611 | c-metabolomics | 1 |
| 1612 | c-methionine | 1 |
| 1613 | c-octanoate | 1 |
| 1614 | c-retinol | 1 |
| 1615 | c3-arylated | 1 |
| 1616 | c57bl/10scnj | 1 |
| 1617 | c57br/cdj | 1 |
| 1618 | cadmium+betaine | 1 |
| 1619 | cao-xsro | 1 |
| 1620 | carbamoyl-4-aryl-1,4-dihydropyridine | 1 |
| 1621 | care.81 | 1 |
| 1622 | carrière | 1 |
| 1623 | cases.a | 1 |
| 1624 | cattt | 1 |
| 1625 | ceftriaxone/cefuroxime-treated | 1 |
| 1626 | cell-alginate | 1 |
| 1627 | cells/1.5 | 1 |
| 1628 | cells/b | 1 |
| 1629 | center-based/home-based | 1 |
| 1630 | chitosan-encapsulated | 1 |
| 1631 | chloride-phenanthroline | 1 |
| 1632 | chlorophosphate | 1 |
| 1633 | cholesterol-labeled | 1 |
| 1634 | cicletanine-treated | 1 |
| 1635 | cl-treated | 1 |
| 1636 | clarires | 1 |
| 1637 | clones/8386 | 1 |
| 1638 | cncps | 1 |
| 1639 | co-substituted | 1 |
| 1640 | cobalamin-catalyzed | 1 |
| 1641 | cognitive-behavioral/pharmacologic | 1 |
| 1642 | colometric | 1 |
| 1643 | colonographic | 1 |
| 1644 | colonyforming | 1 |
| 1645 | colposcopically-negative | 1 |
| 1646 | colposcopy-positive | 1 |
| 1647 | committee-established | 1 |
| 1648 | comp-treated | 1 |
| 1649 | compatibility-single | 1 |
| 1650 | con-no | 1 |
| 1651 | coronary/cardiac | 1 |
| 1652 | corticosteroid-primed | 1 |
| 1653 | count/100 | 1 |
| 1654 | cr1-expressing | 1 |
| 1655 | crt+placebo | 1 |
| 1656 | csa-challenged | 1 |
| 1657 | ct/hrct | 1 |
| 1658 | cycloaddition/ring | 1 |
| 1659 | cysteine-labeled | 1 |
| 1660 | cytogenetics® | 1 |
| 1661 | cytoscan | 1 |
| 1662 | daptomycin-treated | 1 |
| 1663 | davydovae | 1 |
| 1664 | dc-pmma | 1 |
| 1665 | decolorisation | 1 |
| 1666 | ded142808 | 1 |
| 1667 | defence-enhanced | 1 |
| 1668 | delivered/theoretical | 1 |
| 1669 | delta/akt | 1 |
| 1670 | descrbiing | 1 |
| 1671 | di-imide | 1 |
| 1672 | dinucleotide-length | 1 |
| 1673 | dioxocine | 1 |
| 1674 | distal/extensive | 1 |
| 1675 | domain-inverted | 1 |
| 1676 | double-cyclized | 1 |
| 1677 | drb1*11 | 1 |
| 1678 | drug-manufacturing | 1 |
| 1679 | dyscoordinated | 1 |
| 1680 | dyspenic | 1 |
| 1681 | e749-57 | 1 |
| 1682 | easibreathe | 1 |
| 1683 | echocardographic | 1 |
| 1684 | ee2-induced | 1 |
| 1685 | efflux-containing | 1 |
| 1686 | efv/ftc/tdf-treated | 1 |
| 1687 | embryonal/botryoid | 1 |
| 1688 | enrolling1506 | 1 |
| 1689 | envolvidos | 1 |
| 1690 | enzyme-linked-immunospot | 1 |
| 1691 | ep+lc | 1 |
| 1692 | ewca | 1 |
| 1693 | exit-an | 1 |
| 1694 | f-fluoropropansulfonyl | 1 |
| 1695 | f-radiolabeled | 1 |
| 1696 | factsheets-a | 1 |
| 1697 | fama-based | 1 |
| 1698 | fe-core-labeled | 1 |
| 1699 | fe-oxyhydroxide | 1 |
| 1700 | fe-particle-induced | 1 |
| 1701 | fiber-coating | 1 |
| 1702 | flor-opal® | 1 |
| 1703 | fluorodeoxy | 1 |
| 1704 | fo+ | 1 |
| 1705 | for-avn-abl | 1 |
| 1706 | fourth-fifth-order | 1 |
| 1707 | fullerene-based | 1 |
| 1708 | furoxan-3-carbonitrile | 1 |
| 1709 | g-positive | 1 |
| 1710 | ga-based | 1 |
| 1711 | gaata | 1 |
| 1712 | gemifloxacin-treated | 1 |
| 1713 | gene-carrying | 1 |
| 1714 | genes-namely | 1 |
| 1715 | genetically-targeted | 1 |
| 1716 | genotype-corrected | 1 |
| 1717 | gik/control | 1 |
| 1718 | glycyl | 1 |
| 1719 | gorgonensis | 1 |
| 1720 | group/d | 1 |
| 1721 | gtp-γ-s | 1 |
| 1722 | gyraseb | 1 |
| 1723 | h-cholesterol-labeled | 1 |
| 1724 | h-cholesterol-labelled | 1 |
| 1725 | h-derived | 1 |
| 1726 | h-digoxin | 1 |
| 1727 | h-labelled | 1 |
| 1728 | h-steered | 1 |
| 1729 | haematodermic | 1 |
| 1730 | harbourd | 1 |
| 1731 | hbeag-seronegative | 1 |
| 1732 | head-head | 1 |
| 1733 | heat-powered | 1 |
| 1734 | heated/ | 1 |
| 1735 | hexachloridostannate | 1 |
| 1736 | hexanylpiperazine | 1 |
| 1737 | hfd-lab | 1 |
| 1738 | hg-u133-plus-2.0 | 1 |
| 1739 | hg-u219 | 1 |
| 1740 | hhp+hae | 1 |
| 1741 | hhp+non-hae | 1 |
| 1742 | high-repetitive | 1 |
| 1743 | hklm-stimulated | 1 |
| 1744 | holstein/friesian | 1 |
| 1745 | homo-arm | 1 |
| 1746 | hoxyb0.05nbo4 | 1 |
| 1747 | hydroborato | 1 |
| 1748 | hydromagnetic | 1 |
| 1749 | hyperglycemia/insulin | 1 |
| 1750 | hypertension/no | 1 |
| 1751 | hypo-active | 1 |
| 1752 | hypomethylate | 1 |
| 1753 | i-alone | 1 |
| 1754 | i-beta-methyl-iodophenyl | 1 |
| 1755 | i-beta-methyl-p-iodophenyl | 1 |
| 1756 | i-fit | 1 |
| 1757 | i-radiolabeled | 1 |
| 1758 | ib-producing | 1 |
| 1759 | il-17-secreting | 1 |
| 1760 | immmunosorbent | 1 |
| 1761 | immune-absorbent | 1 |
| 1762 | immune-adsorbent | 1 |
| 1763 | immunesorbent | 1 |
| 1764 | immunoadsordent | 1 |
| 1765 | immunospecific | 1 |
| 1766 | immunumetric | 1 |
| 1767 | in101consecutive | 1 |
| 1768 | inclused | 1 |
| 1769 | incontinuous | 1 |
| 1770 | induced-scd14 | 1 |
| 1771 | infants-a | 1 |
| 1772 | inhaler.seven | 1 |
| 1773 | inhibitedcaspase-3 | 1 |
| 1774 | inhibitors-specifically | 1 |
| 1775 | injection-dosing | 1 |
| 1776 | inperi-operative | 1 |
| 1777 | intercladding | 1 |
| 1778 | intra-abdominal-inguinal | 1 |
| 1779 | iodomoeba | 1 |
| 1780 | ipro™2 | 1 |
| 1781 | j-difference | 1 |
| 1782 | j.-e. | 1 |
| 1783 | k-a-binding | 1 |
| 1784 | k-ras-positive | 1 |
| 1785 | k14-creer2 | 1 |
| 1786 | kalül | 1 |
| 1787 | kinase-ii-induced | 1 |
| 1788 | knee-muscle | 1 |
| 1789 | kyn2 | 1 |
| 1790 | l-mtad | 1 |
| 1791 | laxative-treated | 1 |
| 1792 | lectinosorbent | 1 |
| 1793 | levels⩾17.9 | 1 |
| 1794 | lib/illa | 1 |
| 1795 | lid+potassium | 1 |
| 1796 | lidocaine-experimental | 1 |
| 1797 | literacy-appropriate | 1 |
| 1798 | lithe | 1 |
| 1799 | lt-polyphenol | 1 |
| 1800 | lysis-causing | 1 |
| 1801 | m1-null | 1 |
| 1802 | mab-defined | 1 |
| 1803 | macro-fingerprinting | 1 |
| 1804 | malachra | 1 |
| 1805 | marcin | 1 |
| 1806 | markovnikov-type | 1 |
| 1807 | massextend | 1 |
| 1808 | mems-based | 1 |
| 1809 | mercaptopropionyl | 1 |
| 1810 | methane-ligated | 1 |
| 1811 | methaniminium | 1 |
| 1812 | methanol-water-glacial | 1 |
| 1813 | methyl-3,4,5 | 1 |
| 1814 | micro/macro | 1 |
| 1815 | mid-laser | 1 |
| 1816 | mitochondria-based | 1 |
| 1817 | mkp-l | 1 |
| 1818 | mnc-like | 1 |
| 1819 | mol/microg | 1 |
| 1820 | monomol | 1 |
| 1821 | moribund.the | 1 |
| 1822 | mother-allotted | 1 |
| 1823 | mpv17-like | 1 |
| 1824 | mycorradicin | 1 |
| 1825 | n3h | 1 |
| 1826 | n=1-5 | 1 |
| 1827 | nanocube-assembled | 1 |
| 1828 | nanodandelion | 1 |
| 1829 | nanofibre | 1 |
| 1830 | narcotic-related | 1 |
| 1831 | nasicon-related | 1 |
| 1832 | naïve/experienced | 1 |
| 1833 | niedenzu | 1 |
| 1834 | nitrogen-ligand | 1 |
| 1835 | nivolumab-treated | 1 |
| 1836 | non-haia | 1 |
| 1837 | non-hhp+hae | 1 |
| 1838 | non-nitric | 1 |
| 1839 | non-original | 1 |
| 1840 | non-platinum-containing | 1 |
| 1841 | non-sugared | 1 |
| 1842 | nonazole | 1 |
| 1843 | nonvitrified | 1 |
| 1844 | non–placebo-controlled | 1 |
| 1845 | norbornane-2-carboxylate | 1 |
| 1846 | normal-group | 1 |
| 1847 | normal/reactive | 1 |
| 1848 | northern-hemisphere | 1 |
| 1849 | nps-induced | 1 |
| 1850 | nws-based | 1 |
| 1851 | o-0.24 | 1 |
| 1852 | o-forming | 1 |
| 1853 | o-isotope | 1 |
| 1854 | o-labeling | 1 |
| 1855 | o-mediated | 1 |
| 1856 | o2/ar | 1 |
| 1857 | o3-0.3pbtio3 | 1 |
| 1858 | oa+attend | 1 |
| 1859 | oasis-treated | 1 |
| 1860 | oil-resistant | 1 |
| 1861 | omeprazole/sodium | 1 |
| 1862 | omt+medication | 1 |
| 1863 | onphotosynthetic | 1 |
| 1864 | organosiloxane | 1 |
| 1865 | osmogent | 1 |
| 1866 | outcomes-illicit | 1 |
| 1867 | outer-ring | 1 |
| 1868 | over-secretes | 1 |
| 1869 | oxide-bridged | 1 |
| 1870 | oxyethyl | 1 |
| 1871 | oxyhydroxy | 1 |
| 1872 | p-exposed | 1 |
| 1873 | p-mri | 1 |
| 1874 | p2-metabolizing | 1 |
| 1875 | p2-positive | 1 |
| 1876 | p2-related | 1 |
| 1877 | p3-based | 1 |
| 1878 | p3-btk | 1 |
| 1879 | p3-degrading | 1 |
| 1880 | p3-independent | 1 |
| 1881 | papilionoid | 1 |
| 1882 | park-director | 1 |
| 1883 | patients.analgesia-based | 1 |
| 1884 | patients.forty | 1 |
| 1885 | pc100 | 1 |
| 1886 | pegloticase-treated | 1 |
| 1887 | pennvax®-b | 1 |
| 1888 | perfusion-imaging | 1 |
| 1889 | periodate-sensitive | 1 |
| 1890 | perovskite-structure | 1 |
| 1891 | perovskite/tio₂ | 1 |
| 1892 | phage-based | 1 |
| 1893 | pharmo-netherlands | 1 |
| 1894 | phenacyloxy- | 1 |
| 1895 | phenothiazin-5-ium | 1 |
| 1896 | phosphorus-labeled | 1 |
| 1897 | pinkerton | 1 |
| 1898 | placebo+tc | 1 |
| 1899 | placebo-tested | 1 |
| 1900 | plaiv-primed | 1 |
| 1901 | plasma-pretreated | 1 |
| 1902 | poisoning-induced | 1 |
| 1903 | polymerase-related | 1 |
| 1904 | posivite | 1 |
| 1905 | post-primary/adjuvant | 1 |
| 1906 | postcystolic | 1 |
| 1907 | posteducational | 1 |
| 1908 | postmeeting | 1 |
| 1909 | pourable | 1 |
| 1910 | pre-electrophoretic | 1 |
| 1911 | precursor.the | 1 |
| 1912 | prelabeling | 1 |
| 1913 | prolamin-primed | 1 |
| 1914 | propane-dinitrile | 1 |
| 1915 | prostaglandin-treated | 1 |
| 1916 | pseudobinary | 1 |
| 1917 | pt-treated | 1 |
| 1918 | ptx™ | 1 |
| 1919 | p₂-mediated | 1 |
| 1920 | questionnaire.we | 1 |
| 1921 | r-related | 1 |
| 1922 | r/csq | 1 |
| 1923 | ranibizumab-naïve | 1 |
| 1924 | re-rume | 1 |
| 1925 | reabsorbs | 1 |
| 1926 | reactor-three | 1 |
| 1927 | real-time™ | 1 |
| 1928 | receptor-than | 1 |
| 1929 | refined-wheat | 1 |
| 1930 | registretion | 1 |
| 1931 | regranex-treated | 1 |
| 1932 | release.forty-six | 1 |
| 1933 | replication-another | 1 |
| 1934 | repressor-encoding | 1 |
| 1935 | respectively.interpersonal | 1 |
| 1936 | responded.seventy-two | 1 |
| 1937 | reviews-the | 1 |
| 1938 | reñma | 1 |
| 1939 | risk.ezetimibe | 1 |
| 1940 | rpv/ftc/tdf-treated | 1 |
| 1941 | rr-bound | 1 |
| 1942 | rti-sparing | 1 |
| 1943 | rvi-negative | 1 |
| 1944 | s-labeled | 1 |
| 1945 | s2n2o2 | 1 |
| 1946 | scan-based | 1 |
| 1947 | score-driven | 1 |
| 1948 | se-labeled | 1 |
| 1949 | self-aggregating | 1 |
| 1950 | self-drying | 1 |
| 1951 | sequencial | 1 |
| 1952 | severity-by-duration | 1 |
| 1953 | sf33-infected | 1 |
| 1954 | sham+medication | 1 |
| 1955 | silane+bonding | 1 |
| 1956 | simpson- | 1 |
| 1957 | skinmedica® | 1 |
| 1958 | sn0.99 | 1 |
| 1959 | sn=0-100 | 1 |
| 1960 | sn=25-90 | 1 |
| 1961 | sn=36-8 | 1 |
| 1962 | sn=58-96 | 1 |
| 1963 | sn=60-67 | 1 |
| 1964 | snar-terminated | 1 |
| 1965 | snu182 | 1 |
| 1966 | software.five | 1 |
| 1967 | software.we | 1 |
| 1968 | spectrosocopy | 1 |
| 1969 | spiramycin-treated | 1 |
| 1970 | st30 | 1 |
| 1971 | states.typically | 1 |
| 1972 | steric/chemical | 1 |
| 1973 | sterols/steroid | 1 |
| 1974 | stiffness-pathophysiologic | 1 |
| 1975 | store-depleting | 1 |
| 1976 | study-contacted | 1 |
| 1977 | subporphyrazine | 1 |
| 1978 | t2w-ssfse | 1 |
| 1979 | t309g | 1 |
| 1980 | tablets-two | 1 |
| 1981 | tc-antimicrobial | 1 |
| 1982 | tc-diethylenetriaminepenta | 1 |
| 1983 | tc-ethylcysteinate | 1 |
| 1984 | tc-hynic-octreotide | 1 |
| 1985 | tc-radiometal | 1 |
| 1986 | tc-ubiquicidin-derived | 1 |
| 1987 | tekensis | 1 |
| 1988 | test—the | 1 |
| 1989 | texture-nutrient | 1 |
| 1990 | tfa/acetonitrile/water | 1 |
| 1991 | third-/fourth-line | 1 |
| 1992 | tolterodine.fesoterodine | 1 |
| 1993 | toma6-negative | 1 |
| 1994 | toxic-related | 1 |
| 1995 | translocation-generated | 1 |
| 1996 | travelling-wave-tube | 1 |
| 1997 | tri-carbide | 1 |
| 1998 | tridoped | 1 |
| 1999 | trihydride | 1 |
| 2000 | trimethyltransferase | 1 |
| 2001 | trivial-to-small | 1 |
| 2002 | trophoblast-specific | 1 |
| 2003 | tso-treated | 1 |
| 2004 | turbidity-reducing | 1 |
| 2005 | type1a | 1 |
| 2006 | u74av2 | 1 |
| 2007 | unfired | 1 |
| 2008 | units·the | 1 |
| 2009 | v-like-as03 | 1 |
| 2010 | valvular-arterial | 1 |
| 2011 | vif-infected | 1 |
| 2012 | vip1-7 | 1 |
| 2013 | viserosomatic | 1 |
| 2014 | vlv | 1 |
| 2015 | vslatanoprost/timolol | 1 |
| 2016 | weighing-based | 1 |
| 2017 | witrür | 1 |
| 2018 | xe-washout | 1 |
| 2019 | y-it-treated | 1 |
| 2020 | yalo3 | 1 |
| 2021 | ±pep | 1 |
| 2022 | ×fasting | 1 |
| 2023 | α-positive | 1 |
| 2024 | β₃-expressing | 1 |
| 2025 | β₃-mediated | 1 |
| 2026 | β₃-pfc | 1 |
| 2027 | π1,2 | 1 |
| 2028 | ‑2,5‑diphenyl | 1 |
| 2029 | ‑depleted | 1 |
| 2030 | ‑expressing | 1 |
| 2031 | ‑β‑induced | 1 |
| 2032 | –lowering | 1 |
| 2033 | –with | 1 |
| 2034 | “some | 1 |
| 2035 | ₂d₃-treated | 1 |
| 2036 | ₃o₄ | 1 |
| 2037 | ₈-barrel | 1 |
| 2038 | €12.50-worth | 1 |
| 2039 | ≤2.4-steered | 1 |
| 2040 | ≤two | 1 |
| 1 | '-ib-cr | 1 |
| 2 | 'coral | 1 |
| 3 | *-allyl | 1 |
| 4 | *-weighted | 2 |
| 5 | +/progesterone | 1 |
| 6 | +an | 1 |
| 7 | +anti-rankl | 1 |
| 8 | +bv | 1 |
| 9 | +exe | 1 |
| 10 | +flt-3 | 1 |
| 11 | +h2o2-induced | 1 |
| 12 | +hae | 1 |
| 13 | +lipo | 2 |
| 14 | +metastatic | 1 |
| 15 | +npx | 1 |
| 16 | +one | 1 |
| 17 | +partial | 2 |
| 18 | +prometrium™ | 1 |
| 19 | +propofol | 1 |
| 20 | +sodium | 1 |
| 21 | ,2- | 1 |
| 22 | ,24-dien-3beta-yl | 1 |
| 23 | -/progesterone | 1 |
| 24 | -001 | 1 |
| 25 | -0401 | 1 |
| 26 | -1,1,3,3-tetramethyluronium | 1 |
| 27 | -1,2,3,4-tetra-hydro | 1 |
| 28 | -1,2,3,4-tetrazolate | 1 |
| 29 | -1,2,3-trihydroxybutyl | 1 |
| 30 | -1,2,4-benzotriazine | 1 |
| 31 | -1,3,4-oxazepine-4,7-dione | 1 |
| 32 | -1,3-dimethyl | 1 |
| 33 | -1,4,7,10-tetraazacyclododecane-1,4,7-triacetic | 1 |
| 34 | -1,4-dihydro-2,6-dimethyl-1-substituted | 1 |
| 35 | -1,4-naphthoquinones | 2 |
| 36 | -1-arylethanones | 1 |
| 37 | -1-associated | 2 |
| 38 | -1-dependent | 1 |
| 39 | -1-ethoxycarbonyl-3- | 1 |
| 40 | -1-ethyl-3-methylimidazolium | 2 |
| 41 | -1-ethylcarbodiimide | 1 |
| 42 | -1-infected | 2 |
| 43 | -1-mediated | 2 |
| 44 | -1-methylpiperidinium | 1 |
| 45 | -1-methylpyrrolidinium | 1 |
| 46 | -1-risk | 1 |
| 47 | -1/3 | 1 |
| 48 | -1/et | 1 |
| 49 | -11b | 2 |
| 50 | -14±5 | 1 |
| 51 | -15n | 1 |
| 52 | -16/18 | 11 |
| 53 | -17a-induced | 1 |
| 54 | -1h-1,2,4-triazole | 1 |
| 55 | -1h-5,6-dimethyl-benzimidazolium | 1 |
| 56 | -1h-imidazol-3-ium | 5 |
| 57 | -1h-pyrrolidin-1-ium | 2 |
| 58 | -1α-modifying | 1 |
| 59 | -1β-expressing | 1 |
| 60 | -1β-induced | 1 |
| 61 | -2,3-dihydro-1h-indol-2-one | 1 |
| 62 | -2,3-oxidosqualene | 2 |
| 63 | -2,4-dinitrobenzeneamines | 1 |
| 64 | -2,5- | 2 |
| 65 | -2,5-dimethoxy-4-iodoamphetamine | 1 |
| 66 | -2,5-dimethyl | 1 |
| 67 | -2,5-diphenol | 1 |
| 68 | -2,5-diphenyl | 24 |
| 69 | -2,5-diphenyl-2-h-tetrazolium | 1 |
| 70 | -2,5-diphenyl-2h | 2 |
| 71 | -2,5-diphenyl-2h-tetrazolium | 5 |
| 72 | -2,5-diphenyl-tetrazolium | 7 |
| 73 | -2,5-diphenyltetrazolium | 107 |
| 74 | -2-derived | 1 |
| 75 | -2-en-1,4-dicarbonyl | 1 |
| 76 | -2-furancarboxaldehyde | 2 |
| 77 | -2-octyloxymethyl | 2 |
| 78 | -2-olefin | 1 |
| 79 | -2-overexpressing | 1 |
| 80 | -2-positive | 2 |
| 81 | -2/2x | 1 |
| 82 | -202a/c | 1 |
| 83 | -20mmol/l | 1 |
| 84 | -22-producing | 1 |
| 85 | -27±6.7 | 1 |
| 86 | -28b | 3 |
| 87 | -293 | 2 |
| 88 | -2g-o-α-d-xylopyranosyl-2h-geranilan-8',10'-dioic | 1 |
| 89 | -2h3 | 3 |
| 90 | -2β-carbon | 1 |
| 91 | -3'-thioguanosine | 1 |
| 92 | -3,4'-dimethoxy | 1 |
| 93 | -3,4-dihydro-2h-1-benzopyran-3-yl | 1 |
| 94 | -3,4-dihydropyrimidine | 1 |
| 95 | -3,4:9,10-perylenetetra-carboxylic | 1 |
| 96 | -3,5-di-phenytetrazoliumromide | 3 |
| 97 | -3,5-lutidinium | 1 |
| 98 | -3-1e | 2 |
| 99 | -3-aminomethyl-5-methyl | 1 |
| 100 | -3-aryl | 1 |
| 101 | -3-butylimidazolium | 1 |
| 102 | -3-hydroxy-4-oxoquinaldine | 1 |
| 103 | -3-hydroxyacyl-acyl | 1 |
| 104 | -3-isobutyl | 1 |
| 105 | -3-mediated | 1 |
| 106 | -3-methoxy | 2 |
| 107 | -3-methoxy-3-oxo-2-stearamidopropyl | 2 |
| 108 | -3-methyl | 1 |
| 109 | -3-octyloxymethyl | 3 |
| 110 | -3-phenylisoxazole | 1 |
| 111 | -3-substituted | 1 |
| 112 | -33/st2 | 1 |
| 113 | -4,5-dihydro-1h-pyrazole-1-carbothioic | 1 |
| 114 | -4-aryl-6-indolylnicotinonitriles | 1 |
| 115 | -4-carboxylates | 1 |
| 116 | -4-methylmorpholinium | 2 |
| 117 | -4-oxobut-2-enoic | 1 |
| 118 | -4-picolinium | 1 |
| 119 | -4-substituted | 1 |
| 120 | -5,7,5'-trihydroxyflavanone | 1 |
| 121 | -5-hydroxypyrazole | 3 |
| 122 | -5-methyl-10,11-dihydro-5h-debenzocyclhepten-5,10-imine | 1 |
| 123 | -5-phenyl-1,3,4- | 1 |
| 124 | -555 | 1 |
| 125 | -5b | 2 |
| 126 | -6-null | 1 |
| 127 | -6-positive | 1 |
| 128 | -6a | 1 |
| 129 | -6a-hydroxymaackiain | 1 |
| 130 | -6rα | 1 |
| 131 | -6t8 | 1 |
| 132 | -7:00 | 1 |
| 133 | -9'-fluoro | 1 |
| 134 | -9'-heptyl | 1 |
| 135 | -9,19-cyclolanosta-3 | 1 |
| 136 | -9-hydroxy | 1 |
| 137 | -99m | 2 |
| 138 | -a/vegfr-2 | 1 |
| 139 | -aab | 1 |
| 140 | -absorbing | 2 |
| 141 | -accbeta | 3 |
| 142 | -accredited | 3 |
| 143 | -accumulating | 4 |
| 144 | -acid | 3 |
| 145 | -acl | 2 |
| 146 | -acquired | 11 |
| 147 | -acs | 5 |
| 148 | -activated | 93 |
| 149 | -activating | 8 |
| 150 | -active | 4 |
| 151 | -ad | 9 |
| 152 | -added | 4 |
| 153 | -adenovirus | 1 |
| 154 | -aderergic | 1 |
| 155 | -adf | 2 |
| 156 | -adjuvanted | 54 |
| 157 | -administered | 6 |
| 158 | -adrenergic | 207 |
| 159 | -adrenoceptor-desensitized | 1 |
| 160 | -adrenoceptor-mediated | 1 |
| 161 | -adrenoceptor-selective | 2 |
| 162 | -adult | 3 |
| 163 | -affected | 2 |
| 164 | -agonist-induced | 2 |
| 165 | -agonist-randomised | 1 |
| 166 | -agonists.a | 1 |
| 167 | -agonistthe | 1 |
| 168 | -ahsv4 | 4 |
| 169 | -akt | 15 |
| 170 | -akt/total | 1 |
| 171 | -alcohol-diethylamine | 1 |
| 172 | -alfa-based | 1 |
| 173 | -alkene | 4 |
| 174 | -alkyl | 2 |
| 175 | -alkylidyne | 1 |
| 176 | -alpha-induced | 2 |
| 177 | -amido | 1 |
| 178 | -among | 2 |
| 179 | -amp | 1 |
| 180 | -ampk | 1 |
| 181 | -ampkalpha | 4 |
| 182 | -ampkalpha2 | 1 |
| 183 | -amplified | 2 |
| 184 | -amygdala | 2 |
| 185 | -an | 8 |
| 186 | -anchored | 4 |
| 187 | -and | 43 |
| 188 | -annexin | 1 |
| 189 | -antihistaminic | 2 |
| 190 | -antioxidant | 2 |
| 191 | -approved | 42 |
| 192 | -ar | 77 |
| 193 | -arm-treated | 1 |
| 194 | -arterial | 5 |
| 195 | -artificial | 1 |
| 196 | -as03 | 2 |
| 197 | -as160 | 1 |
| 198 | -assessed | 9 |
| 199 | -assisted | 26 |
| 200 | -associated | 180 |
| 201 | -association | 1 |
| 202 | -at | 8 |
| 203 | -atpase-2a | 1 |
| 204 | -atpase-linked | 1 |
| 205 | -attached | 1 |
| 206 | -attenuated | 3 |
| 207 | -augmented | 9 |
| 208 | -aβ | 3 |
| 209 | -b/gastrin | 2 |
| 210 | -b27-associated | 1 |
| 211 | -barrel | 5 |
| 212 | -based | 697 |
| 213 | -bay | 3 |
| 214 | -bearing | 8 |
| 215 | -benzodiazepine | 10 |
| 216 | -beta-d-glucopyranoside-oleanolic | 1 |
| 217 | -binding | 75 |
| 218 | -blocker-naïve | 2 |
| 219 | -blocking | 10 |
| 220 | -bontl | 1 |
| 221 | -boosted | 7 |
| 222 | -booster | 1 |
| 223 | -bornyl | 1 |
| 224 | -bound | 13 |
| 225 | -bridged | 4 |
| 226 | -bridging | 2 |
| 227 | -bromanyl | 1 |
| 228 | -butadienyl | 1 |
| 229 | -butenyl | 1 |
| 230 | -bzd | 1 |
| 231 | -c-induced | 1 |
| 232 | -c-reactive | 5 |
| 233 | -c5 | 9 |
| 234 | -ca1 | 1 |
| 235 | -calcium | 1 |
| 236 | -calculated | 4 |
| 237 | -calmodulin-dependent | 2 |
| 238 | -camkii | 2 |
| 239 | -camphorate | 2 |
| 240 | -cancerous | 1 |
| 241 | -capped | 2 |
| 242 | -carbonyl | 3 |
| 243 | -carene | 1 |
| 244 | -catalysed | 7 |
| 245 | -catalyzed | 87 |
| 246 | -caused | 2 |
| 247 | -causing | 1 |
| 248 | -ccaat | 1 |
| 249 | -cell | 8 |
| 250 | -centered | 2 |
| 251 | -centred | 1 |
| 252 | -certified | 2 |
| 253 | -challenged | 10 |
| 254 | -changes | 1 |
| 255 | -channel | 24 |
| 256 | -chelated | 2 |
| 257 | -chelating | 2 |
| 258 | -chelator | 1 |
| 259 | -child | 1 |
| 260 | -chlorhexidene | 1 |
| 261 | -chloromethyl-2',7'-dichlorodihydrofluorescein | 1 |
| 262 | -chloromethyl-2',7'-dichlorofluorescein | 1 |
| 263 | -cholesterol-labeled | 1 |
| 264 | -chop | 6 |
| 265 | -cin1 | 1 |
| 266 | -cine | 1 |
| 267 | -citalopram-binding | 1 |
| 268 | -clearing | 1 |
| 269 | -clinical | 3 |
| 270 | -clopidogrel | 3 |
| 271 | -cluster-substituted | 1 |
| 272 | -cmx-vaccinated | 1 |
| 273 | -co-doped | 1 |
| 274 | -coated | 23 |
| 275 | -coding | 1 |
| 276 | -codoped | 14 |
| 277 | -coinfected | 1 |
| 278 | -colocalized | 2 |
| 279 | -combined | 3 |
| 280 | -comparable | 2 |
| 281 | -compatible | 1 |
| 282 | -competitive | 1 |
| 283 | -complexed | 3 |
| 284 | -compliant | 6 |
| 285 | -composed | 1 |
| 286 | -condensed | 1 |
| 287 | -conditioned | 1 |
| 288 | -conducting | 2 |
| 289 | -configured | 1 |
| 290 | -confirmed | 12 |
| 291 | -conjugated | 12 |
| 292 | -connect | 1 |
| 293 | -connected | 20 |
| 294 | -consistent | 1 |
| 295 | -constitutive | 1 |
| 296 | -contained | 1 |
| 297 | -containing | 143 |
| 298 | -contaminated | 10 |
| 299 | -continuous | 2 |
| 300 | -controlled | 51 |
| 301 | -cooled | 1 |
| 302 | -coordinated | 6 |
| 303 | -copd | 1 |
| 304 | -corrected | 9 |
| 305 | -corynoxine | 2 |
| 306 | -coupled | 10 |
| 307 | -covered | 4 |
| 308 | -cprggsvc | 5 |
| 309 | -created | 1 |
| 310 | -cscl | 2 |
| 311 | -cts-sea | 2 |
| 312 | -cullin4 | 1 |
| 313 | -cyclic | 2 |
| 314 | -cycloocta-1,3-diene | 1 |
| 315 | -dc | 1 |
| 316 | -decorated | 2 |
| 317 | -decoupled | 1 |
| 318 | -deficient | 71 |
| 319 | -defined | 28 |
| 320 | -defining | 3 |
| 321 | -degrading | 5 |
| 322 | -deleted | 3 |
| 323 | -delivered | 7 |
| 324 | -delta8'-7-acetoxy-3,4,3',5'-tetramethoxy-8- | 1 |
| 325 | -dependent | 302 |
| 326 | -depleted | 7 |
| 327 | -depletion | 1 |
| 328 | -derived | 101 |
| 329 | -desaturase | 6 |
| 330 | -detected | 7 |
| 331 | -detecting | 1 |
| 332 | -determined | 8 |
| 333 | -detoxifying | 2 |
| 334 | -detrz | 1 |
| 335 | -diabetic | 6 |
| 336 | -diagnosed | 2 |
| 337 | -dianiline | 1 |
| 338 | -diet-induced | 1 |
| 339 | -differentiated | 2 |
| 340 | -difluorophenyl | 1 |
| 341 | -digested | 1 |
| 342 | -digitonin | 1 |
| 343 | -dimethylated | 1 |
| 344 | -dimethylthiazoy1-3,5-diphenyltetrazolium | 1 |
| 345 | -diminished | 2 |
| 346 | -diode | 3 |
| 347 | -diol | 3 |
| 348 | -diol-3- | 1 |
| 349 | -directed | 8 |
| 350 | -distal | 1 |
| 351 | -dna-binding | 2 |
| 352 | -docosahexaenoyl | 1 |
| 353 | -documented | 3 |
| 354 | -domain-containing | 1 |
| 355 | -dominated | 1 |
| 356 | -doped | 71 |
| 357 | -dosing | 1 |
| 358 | -dpot | 1 |
| 359 | -dqa1 | 1 |
| 360 | -drinking | 1 |
| 361 | -driven | 19 |
| 362 | -effector | 1 |
| 363 | -eicosapentaenoyl | 1 |
| 364 | -electrolyte | 3 |
| 365 | -elevated | 2 |
| 366 | -elevating | 3 |
| 367 | -elicited | 5 |
| 368 | -eligible | 3 |
| 369 | -encapsulated | 3 |
| 370 | -encoded | 3 |
| 371 | -encoding | 6 |
| 372 | -engineered | 1 |
| 373 | -enhanced | 23 |
| 374 | -enhancing | 8 |
| 375 | -enolide | 1 |
| 376 | -enriched | 48 |
| 377 | -enrichment | 2 |
| 378 | -entrapped | 1 |
| 379 | -equivalent | 2 |
| 380 | -erk1/2 | 1 |
| 381 | -ethinyl | 1 |
| 382 | -evoked | 21 |
| 383 | -exchanged | 1 |
| 384 | -expanded | 3 |
| 385 | -expansion | 1 |
| 386 | -exposed | 30 |
| 387 | -expressing | 29 |
| 388 | -eye | 1 |
| 389 | -eyed | 1 |
| 390 | -facilitated | 2 |
| 391 | -failing | 1 |
| 392 | -family | 2 |
| 393 | -favor | 1 |
| 394 | -fed | 20 |
| 395 | -female | 1 |
| 396 | -ferrous | 3 |
| 397 | -fibrinogen | 1 |
| 398 | -filed | 1 |
| 399 | -filled | 2 |
| 400 | -filtered | 3 |
| 401 | -first | 7 |
| 402 | -fluoren-9-ylidene | 1 |
| 403 | -fluorescence | 1 |
| 404 | -fluoroalkylated | 1 |
| 405 | -foam | 1 |
| 406 | -folfiri | 1 |
| 407 | -formato | 1 |
| 408 | -fortified | 5 |
| 409 | -free | 62 |
| 410 | -functionalised | 1 |
| 411 | -functionalized | 4 |
| 412 | -funded | 18 |
| 413 | -g1 | 1 |
| 414 | -gamma-producing | 1 |
| 415 | -gapdh | 7 |
| 416 | -gated | 19 |
| 417 | -gemmenos65 | 1 |
| 418 | -gene-mutant | 1 |
| 419 | -generated | 4 |
| 420 | -generating | 4 |
| 421 | -generation | 1 |
| 422 | -gestational | 1 |
| 423 | -gfp-identified | 1 |
| 424 | -ginsenoside | 1 |
| 425 | -glucan-pretreated | 1 |
| 426 | -glucanase-positive | 1 |
| 427 | -glucanosyltransferase | 1 |
| 428 | -gmp | 2 |
| 429 | -gold | 1 |
| 430 | -golgi | 1 |
| 431 | -grade | 2 |
| 432 | -grafted | 2 |
| 433 | -graphene | 4 |
| 434 | -green | 1 |
| 435 | -growing | 1 |
| 436 | -guaiacylglycerol | 2 |
| 437 | -guided | 159 |
| 438 | -gβγ-mediated | 1 |
| 439 | -h/n-h | 1 |
| 440 | -h/s-h | 1 |
| 441 | -handling | 14 |
| 442 | -harboring | 1 |
| 443 | -hcb | 1 |
| 444 | -hctz | 1 |
| 445 | -hd4 | 1 |
| 446 | -healed | 1 |
| 447 | -heatsynch | 1 |
| 448 | -helical | 5 |
| 449 | -helix | 6 |
| 450 | -heremans-schmid | 1 |
| 451 | -heteroscorpionate | 1 |
| 452 | -hhtre | 1 |
| 453 | -hilic | 1 |
| 454 | -histamine | 4 |
| 455 | -homologous | 1 |
| 456 | -hospitalized | 2 |
| 457 | -hurag | 1 |
| 458 | -hydrated | 1 |
| 459 | -hydroperoxyflavin | 1 |
| 460 | -hydrosaline | 1 |
| 461 | -hydroxide | 8 |
| 462 | -hydroxycarboxylato | 2 |
| 463 | -hydroxyl | 4 |
| 464 | -hypertensive | 2 |
| 465 | -hypnotic | 1 |
| 466 | -h···nh2-r | 1 |
| 467 | -i/ii | 2 |
| 468 | -ibritumomab | 2 |
| 469 | -ifn | 2 |
| 470 | -ifna | 1 |
| 471 | -ii-selective | 1 |
| 472 | -iia/nptii-specific | 1 |
| 473 | -ila | 1 |
| 474 | -imi | 1 |
| 475 | -immobilized | 2 |
| 476 | -immunized | 4 |
| 477 | -immunoreactive | 3 |
| 478 | -impregnated | 3 |
| 479 | -imprinted | 4 |
| 480 | -incorporated | 2 |
| 481 | -independent/dids-sensitive | 1 |
| 482 | -indexed | 3 |
| 483 | -induce | 1 |
| 484 | -induced | 1,277 |
| 485 | -inducer | 1 |
| 486 | -inducible | 7 |
| 487 | -inducing | 5 |
| 488 | -induction | 1 |
| 489 | -infected | 140 |
| 490 | -inhibitable | 1 |
| 491 | -inhibited | 4 |
| 492 | -inhibiting | 11 |
| 493 | -inhibitor/angiotensin | 1 |
| 494 | -inhibitory | 5 |
| 495 | -initiated | 7 |
| 496 | -injected | 10 |
| 497 | -injured | 6 |
| 498 | -inoculated | 1 |
| 499 | -intended | 1 |
| 500 | -interacting | 5 |
| 501 | -internal | 1 |
| 502 | -interstitial | 2 |
| 503 | -intoxicated | 2 |
| 504 | -involved | 2 |
| 505 | -ion | 3 |
| 506 | -irradiated | 2 |
| 507 | -isolaricireinol-2 | 1 |
| 508 | -ius | 1 |
| 509 | -k373 | 1 |
| 510 | -killed | 2 |
| 511 | -knockin | 2 |
| 512 | -knockout | 4 |
| 513 | -l-nitro-arginine | 2 |
| 514 | -l2/3 | 1 |
| 515 | -labeled | 46 |
| 516 | -labelled | 8 |
| 517 | -lariciresinol | 2 |
| 518 | -led | 6 |
| 519 | -lesioned | 1 |
| 520 | -li+ | 1 |
| 521 | -licensed | 1 |
| 522 | -ligament | 1 |
| 523 | -ligated | 1 |
| 524 | -like | 151 |
| 525 | -line | 3 |
| 526 | -linked | 27 |
| 527 | -lmp1 | 1 |
| 528 | -loaded | 9 |
| 529 | -loading | 4 |
| 530 | -localized | 3 |
| 531 | -locking | 1 |
| 532 | -lowering | 123 |
| 533 | -luc | 2 |
| 534 | -luciferase | 3 |
| 535 | -lv | 2 |
| 536 | -m17 | 4 |
| 537 | -machine | 1 |
| 538 | -made | 1 |
| 539 | -mammalian | 2 |
| 540 | -managed | 1 |
| 541 | -mapk | 1 |
| 542 | -marked | 2 |
| 543 | -mas | 2 |
| 544 | -matched | 15 |
| 545 | -mb-defined | 1 |
| 546 | -meal | 1 |
| 547 | -measured | 7 |
| 548 | -mediated | 295 |
| 549 | -mediating | 1 |
| 550 | -medicated | 3 |
| 551 | -menc-tt | 1 |
| 552 | -mepivacaine | 1 |
| 553 | -mercaptopropyl | 1 |
| 554 | -metabolizing | 2 |
| 555 | -methanocarba | 5 |
| 556 | -methionine-labeled | 1 |
| 557 | -methylenamino | 1 |
| 558 | -mevalonate | 11 |
| 559 | -mi | 7 |
| 560 | -military | 1 |
| 561 | -mimetic | 2 |
| 562 | -mimic | 1 |
| 563 | -mitochondrial | 2 |
| 564 | -mitogen/extracellular | 1 |
| 565 | -mobilised | 1 |
| 566 | -mobilized | 5 |
| 567 | -mobilizing | 4 |
| 568 | -modificated | 1 |
| 569 | -modified | 21 |
| 570 | -modifying | 2 |
| 571 | -modulated | 3 |
| 572 | -molten | 1 |
| 573 | -monitored | 2 |
| 574 | -monoinfected | 1 |
| 575 | -monomethyl | 6 |
| 576 | -more | 1 |
| 577 | -mouth | 3 |
| 578 | -mpc | 2 |
| 579 | -mrsa | 2 |
| 580 | -multi-hivb | 2 |
| 581 | -muscarinic | 1 |
| 582 | -mutant | 5 |
| 583 | -mutated | 12 |
| 584 | -n'-ethylcarbodiimide | 1 |
| 585 | -n'-phenylthiourea | 1 |
| 586 | -n-ethylcarbodiimide | 1 |
| 587 | -n111g | 1 |
| 588 | -naive | 31 |
| 589 | -naïve | 11 |
| 590 | -negative | 211 |
| 591 | -neomycin | 1 |
| 592 | -nf-κb | 1 |
| 593 | -nicotinamide | 3 |
| 594 | -ninhydrin | 1 |
| 595 | -nitro-l-arginine | 67 |
| 596 | -nitroarginine | 7 |
| 597 | -non-yds | 1 |
| 598 | -nootkatone-treated | 1 |
| 599 | -noradrenergic | 3 |
| 600 | -normalized | 2 |
| 601 | -nrf2/are | 1 |
| 602 | -nta | 8 |
| 603 | -null | 6 |
| 604 | -observer | 1 |
| 605 | -octane | 1 |
| 606 | -olefin | 1 |
| 607 | -olive | 3 |
| 608 | -on | 12 |
| 609 | -one-1,3,4-oxadiazole | 1 |
| 610 | -one-mediated | 1 |
| 611 | -oriented | 6 |
| 612 | -origin | 1 |
| 613 | -overexpressing | 5 |
| 614 | -oxadiazole-5- | 1 |
| 615 | -oxadiazoline | 1 |
| 616 | -oxidative-induced | 1 |
| 617 | -oxide | 6 |
| 618 | -oxo | 3 |
| 619 | -oxyhydroxide | 2 |
| 620 | -p53-ros | 1 |
| 621 | -patch | 2 |
| 622 | -pcr | 39 |
| 623 | -percent | 1 |
| 624 | -peroxo | 1 |
| 625 | -pge2 | 1 |
| 626 | -ph | 1 |
| 627 | -phor21-treated | 2 |
| 628 | -phosphate | 10 |
| 629 | -phosphine-bound | 1 |
| 630 | -phosphorylated | 2 |
| 631 | -photodiode | 1 |
| 632 | -photodynamic | 2 |
| 633 | -physical | 2 |
| 634 | -phytantriol-based | 1 |
| 635 | -pk | 3 |
| 636 | -platinum | 4 |
| 637 | -plus-statin | 1 |
| 638 | -poisoned | 1 |
| 639 | -polarity | 1 |
| 640 | -polarized | 2 |
| 641 | -polyethylene | 3 |
| 642 | -polypropylene | 2 |
| 643 | -polystylene | 1 |
| 644 | -positive | 354 |
| 645 | -positive/her2-negative | 1 |
| 646 | -positive/human | 2 |
| 647 | -ppase | 1 |
| 648 | -preserved | 8 |
| 649 | -pretreated | 7 |
| 650 | -prevention | 3 |
| 651 | -primed | 2 |
| 652 | -printed | 1 |
| 653 | -prlr | 9 |
| 654 | -pro-inflammatory | 1 |
| 655 | -processed | 3 |
| 656 | -producing | 115 |
| 657 | -progesterone | 1 |
| 658 | -programmed | 2 |
| 659 | -proliferation | 1 |
| 660 | -promoted | 8 |
| 661 | -propanehydrazonoyl | 1 |
| 662 | -propano | 1 |
| 663 | -propelled | 5 |
| 664 | -prophylaxis | 2 |
| 665 | -propofol-opioid | 1 |
| 666 | -propylene | 2 |
| 667 | -protect | 1 |
| 668 | -protected | 1 |
| 669 | -protective | 2 |
| 670 | -protopanaxadiol-type | 4 |
| 671 | -protopanaxatriol-type | 1 |
| 672 | -proven | 5 |
| 673 | -pulsed | 2 |
| 674 | -pumping | 3 |
| 675 | -purified | 1 |
| 676 | -pyridazinone | 1 |
| 677 | -pyridino-phane | 1 |
| 678 | -pz-cl | 2 |
| 679 | -qi | 4 |
| 680 | -qinglishengjing | 1 |
| 681 | -quantified | 1 |
| 682 | -quinazoliniminium | 1 |
| 683 | -quinolizidine | 2 |
| 684 | -quinolone | 1 |
| 685 | -quinoxaline-2-carbonitrile | 1 |
| 686 | -r. | 1 |
| 687 | -r30°-ch3s | 1 |
| 688 | -raising | 3 |
| 689 | -rat | 1 |
| 690 | -rated | 2 |
| 691 | -reactive | 10 |
| 692 | -reca | 1 |
| 693 | -received | 1 |
| 694 | -receiving | 1 |
| 695 | -receptor-associated | 1 |
| 696 | -receptor-coated | 1 |
| 697 | -receptor-deficient | 1 |
| 698 | -receptor-interacting | 1 |
| 699 | -receptor-preferring | 2 |
| 700 | -recommended | 7 |
| 701 | -reduced | 9 |
| 702 | -reducing | 19 |
| 703 | -refractory | 25 |
| 704 | -registered | 1 |
| 705 | -regulated | 19 |
| 706 | -regulatory | 4 |
| 707 | -related | 240 |
| 708 | -release | 8 |
| 709 | -releasing | 17 |
| 710 | -rendered | 1 |
| 711 | -renin | 2 |
| 712 | -replete | 4 |
| 713 | -replicated | 1 |
| 714 | -reporter | 1 |
| 715 | -resident | 3 |
| 716 | -resistant | 78 |
| 717 | -responder | 1 |
| 718 | -responding | 1 |
| 719 | -responsive | 10 |
| 720 | -restricted | 5 |
| 721 | -restriction | 4 |
| 722 | -ret | 1 |
| 723 | -retained | 1 |
| 724 | -retrotransposon | 1 |
| 725 | -rg₃-induced | 1 |
| 726 | -ribose | 3 |
| 727 | -ribulo | 1 |
| 728 | -rich | 58 |
| 729 | -risk | 6 |
| 730 | -rtms | 2 |
| 731 | -s2 | 1 |
| 732 | -salicin-mediated | 1 |
| 733 | -salt | 13 |
| 734 | -salt-induced | 3 |
| 735 | -saturated | 12 |
| 736 | -scaling | 1 |
| 737 | -scavenging | 11 |
| 738 | -se-phenyl | 1 |
| 739 | -secretagogue | 1 |
| 740 | -secreting | 4 |
| 741 | -selective | 40 |
| 742 | -sensing | 1 |
| 743 | -sensitised | 3 |
| 744 | -sensitive | 54 |
| 745 | -sensitive- | 1 |
| 746 | -sensitized | 18 |
| 747 | -sensitizing | 3 |
| 748 | -separated | 2 |
| 749 | -seropositive | 8 |
| 750 | -seroprevalence | 1 |
| 751 | -sestamibi | 1 |
| 752 | -shift | 2 |
| 753 | -shogaol-induced | 1 |
| 754 | -short | 1 |
| 755 | -sided | 1 |
| 756 | -signalling | 2 |
| 757 | -signalling-mediated | 1 |
| 758 | -single-strand | 1 |
| 759 | -sired | 1 |
| 760 | -smad | 1 |
| 761 | -smad2/3 | 2 |
| 762 | -smads | 2 |
| 763 | -soaked | 2 |
| 764 | -sodium | 3 |
| 765 | -solid | 1 |
| 766 | -solubilized | 1 |
| 767 | -soluble | 4 |
| 768 | -sometimes | 1 |
| 769 | -sparing | 9 |
| 770 | -speaking | 1 |
| 771 | -specific | 112 |
| 772 | -sponsored | 12 |
| 773 | -sql | 4 |
| 774 | -stage | 3 |
| 775 | -staged | 2 |
| 776 | -stained | 5 |
| 777 | -standardized | 2 |
| 778 | -starved | 2 |
| 779 | -stay | 2 |
| 780 | -steered | 3 |
| 781 | -stented | 1 |
| 782 | -stereospecific | 2 |
| 783 | -stimulated | 133 |
| 784 | -storage | 1 |
| 785 | -stored | 2 |
| 786 | -strand | 11 |
| 787 | -stress-induced | 1 |
| 788 | -stressed | 1 |
| 789 | -style | 3 |
| 790 | -substituted | 14 |
| 791 | -substitution | 1 |
| 792 | -superovulated | 1 |
| 793 | -supplemented | 14 |
| 794 | -supported | 4 |
| 795 | -suppressed | 1 |
| 796 | -suppressible | 1 |
| 797 | -suppressive | 5 |
| 798 | -susceptible | 7 |
| 799 | -sustaining | 1 |
| 800 | -sweetened | 1 |
| 801 | -symmetry | 1 |
| 802 | -sympathetic | 1 |
| 803 | -sympathomimetic | 1 |
| 804 | -tac | 4 |
| 805 | -tagged | 9 |
| 806 | -tailed | 4 |
| 807 | -targeted | 40 |
| 808 | -targeting | 3 |
| 809 | -tcr | 2 |
| 810 | -tdf | 1 |
| 811 | -temospho-treated | 1 |
| 812 | -terminal | 24 |
| 813 | -tetramer-positive | 1 |
| 814 | -thalassemic | 1 |
| 815 | -the | 29 |
| 816 | -thiolate | 1 |
| 817 | -thiophene | 2 |
| 818 | -thymoma | 1 |
| 819 | -tio2 | 2 |
| 820 | -tlr3-induced | 1 |
| 821 | -to-bnx | 1 |
| 822 | -to-green | 1 |
| 823 | -to-lewis | 1 |
| 824 | -to-lv | 2 |
| 825 | -to-metal | 1 |
| 826 | -to-mouse | 1 |
| 827 | -to-total | 1 |
| 828 | -tolerant | 4 |
| 829 | -towards | 1 |
| 830 | -tpn | 1 |
| 831 | -traceable | 1 |
| 832 | -transfected | 3 |
| 833 | -transformed | 10 |
| 834 | -transport | 2 |
| 835 | -transporting | 2 |
| 836 | -treated | 244 |
| 837 | -tricalcium | 1 |
| 838 | -triethylammonium | 1 |
| 839 | -triggered | 20 |
| 840 | -trinodal | 1 |
| 841 | -truncated | 2 |
| 842 | -tta | 1 |
| 843 | -tubule | 2 |
| 844 | -tween-80 | 2 |
| 845 | -type | 74 |
| 846 | -typing | 2 |
| 847 | -underwent | 1 |
| 848 | -undetectable | 1 |
| 849 | -unselected | 2 |
| 850 | -up-regulated | 1 |
| 851 | -urea | 3 |
| 852 | -utilizing | 1 |
| 853 | -v-akt | 1 |
| 854 | -vaccinated | 3 |
| 855 | -vascular | 2 |
| 856 | -vectored | 1 |
| 857 | -vegf | 2 |
| 858 | -venus | 1 |
| 859 | -verified | 1 |
| 860 | -via | 1 |
| 861 | -vitrified | 1 |
| 862 | -vps34 | 1 |
| 863 | -watch | 1 |
| 864 | -weighted | 29 |
| 865 | -wistar | 1 |
| 866 | -xylulo | 1 |
| 867 | -yang | 2 |
| 868 | -yd5 | 5 |
| 869 | -zmrfp1 | 1 |
| 870 | -α-activated | 1 |
| 871 | -α-based | 2 |
| 872 | -α-induced | 3 |
| 873 | -α-kdo | 2 |
| 874 | -α-mediated | 4 |
| 875 | -α-stimulated | 1 |
| 876 | -αvβ3 | 1 |
| 877 | -β-glucanase-silenced | 2 |
| 878 | -β/ribavirin | 1 |
| 879 | -β1/smad | 1 |
| 880 | -γ-fe2o3 | 4 |
| 881 | -γ-induced | 1 |
| 882 | -γ-secreting | 1 |
| 883 | -κappab | 1 |
| 884 | -κb-dependent | 1 |
| 885 | .00713optimal | 1 |
| 886 | .a | 38 |
| 887 | .abciximab | 1 |
| 888 | .act | 2 |
| 889 | .additional | 1 |
| 890 | .adverse | 15 |
| 891 | .after | 9 |
| 892 | .all | 15 |
| 893 | .an | 7 |
| 894 | .anastomotic | 1 |
| 895 | .another | 1 |
| 896 | .antibiotic | 1 |
| 897 | .antidepressants | 1 |
| 898 | .antioxidant | 1 |
| 899 | .antiretroviral | 1 |
| 900 | .ascaris | 1 |
| 901 | .asthma-related | 2 |
| 902 | .authors’ | 1 |
| 903 | .average | 2 |
| 904 | .behavioural | 1 |
| 905 | .both | 7 |
| 906 | .bronchial | 1 |
| 907 | .cetirizine | 1 |
| 908 | .ciclesonide | 1 |
| 909 | .cognitive | 3 |
| 910 | .combination | 1 |
| 911 | .community-dwelling | 1 |
| 912 | .comparing | 6 |
| 913 | .confirmed | 1 |
| 914 | .custom-made | 1 |
| 915 | .dexamethasone | 1 |
| 916 | .direct | 1 |
| 917 | .disulfiram | 1 |
| 918 | .dopamine | 2 |
| 919 | .early | 2 |
| 920 | .educational | 2 |
| 921 | .eight | 3 |
| 922 | .electronicwe | 1 |
| 923 | .eleven | 3 |
| 924 | .extended | 1 |
| 925 | .feedback | 1 |
| 926 | .few | 2 |
| 927 | .fewer | 1 |
| 928 | .fifty-five | 1 |
| 929 | .final | 1 |
| 930 | .five | 12 |
| 931 | .for | 56 |
| 932 | .four | 17 |
| 933 | .fourteen | 2 |
| 934 | .generally | 4 |
| 935 | .gradual | 1 |
| 936 | .hematologic | 1 |
| 937 | .individual | 2 |
| 938 | .inhaled | 2 |
| 939 | .initiating | 1 |
| 940 | .intensive | 1 |
| 941 | .intervention | 1 |
| 942 | .irs | 1 |
| 943 | .isocaloric | 1 |
| 944 | .limited | 3 |
| 945 | .low | 1 |
| 946 | .low-quality | 5 |
| 947 | .main | 1 |
| 948 | .material | 2 |
| 949 | .mild | 2 |
| 950 | .misoprostol | 1 |
| 951 | .most | 7 |
| 952 | .motor | 1 |
| 953 | .multidisciplinary | 1 |
| 954 | .multifactorial | 1 |
| 955 | .multiple-component | 1 |
| 956 | .nine | 4 |
| 957 | .nineteen | 1 |
| 958 | .no | 52 |
| 959 | .non-bismuth | 1 |
| 960 | .older | 1 |
| 961 | .one | 57 |
| 962 | .operative | 1 |
| 963 | .oral | 1 |
| 964 | .other | 6 |
| 965 | .our | 6 |
| 966 | .oxytocin | 1 |
| 967 | .paralytic | 1 |
| 968 | .partial | 2 |
| 969 | .percutaneous | 3 |
| 970 | .perioperative | 1 |
| 971 | .pfmt | 1 |
| 972 | .phase-specific | 1 |
| 973 | .pooled | 4 |
| 974 | .postoperative | 2 |
| 975 | .primary | 2 |
| 976 | .proven | 1 |
| 977 | .recent | 1 |
| 978 | .recombinant | 1 |
| 979 | .regarding | 1 |
| 980 | .regional | 1 |
| 981 | .remifentanil | 1 |
| 982 | .reported | 1 |
| 983 | .secondary | 9 |
| 984 | .serum | 2 |
| 985 | .seven | 4 |
| 986 | .significant | 2 |
| 987 | .sildenafil | 1 |
| 988 | .single | 3 |
| 989 | .six | 7 |
| 990 | .solifenacin | 1 |
| 991 | .study | 2 |
| 992 | .suicide-related | 2 |
| 993 | .systemic | 3 |
| 994 | .ten | 1 |
| 995 | .tg | 1 |
| 996 | .the | 411 |
| 997 | .therapeutic | 1 |
| 998 | .these | 15 |
| 999 | .thirteen | 4 |
| 1000 | .thirty | 1 |
| 1001 | .thirty-one | 2 |
| 1002 | .this | 28 |
| 1003 | .three | 20 |
| 1004 | .total | 5 |
| 1005 | .twenty-eight | 2 |
| 1006 | .twenty-five | 1 |
| 1007 | .twenty-nine | 1 |
| 1008 | .twenty-one | 1 |
| 1009 | .twenty-seven | 2 |
| 1010 | .two | 42 |
| 1011 | .unstable | 1 |
| 1012 | .we | 88 |
| 1013 | .when | 25 |
| 1014 | .• | 9 |
| 1015 | /+ | 12 |
| 1016 | /100ml | 1 |
| 1017 | /141 | 1 |
| 1018 | /4π | 1 |
| 1019 | /6-keto | 1 |
| 1020 | /absence | 1 |
| 1021 | /absorbable | 1 |
| 1022 | /acetone | 1 |
| 1023 | /acquired | 11 |
| 1024 | /acridine | 1 |
| 1025 | /acute | 7 |
| 1026 | /adenosine | 3 |
| 1027 | /adiponutrin | 1 |
| 1028 | /ag-coated | 2 |
| 1029 | /aids | 6 |
| 1030 | /akt | 65 |
| 1031 | /akt-dependent | 1 |
| 1032 | /akt/ | 1 |
| 1033 | /akt/extracellular | 1 |
| 1034 | /akt/mammalian | 11 |
| 1035 | /akt/mitogen-activated | 1 |
| 1036 | /akt/mtor | 2 |
| 1037 | /alumina | 1 |
| 1038 | /american | 14 |
| 1039 | /amp-dependent | 1 |
| 1040 | /angiotensin | 20 |
| 1041 | /angiotensin-ii | 1 |
| 1042 | /anhydroxylose | 1 |
| 1043 | /anti-hdv | 1 |
| 1044 | /aortic | 2 |
| 1045 | /ataxia | 1 |
| 1046 | /atp | 3 |
| 1047 | /atypical | 3 |
| 1048 | /b3lyp | 2 |
| 1049 | /baculovirus-based | 1 |
| 1050 | /baseline | 1 |
| 1051 | /bdz | 1 |
| 1052 | /benzodiazepine | 2 |
| 1053 | /beta-catenin | 1 |
| 1054 | /bovine | 2 |
| 1055 | /buffer | 1 |
| 1056 | /c-c | 1 |
| 1057 | /c-jun | 2 |
| 1058 | /c-met | 1 |
| 1059 | /c-reactive | 2 |
| 1060 | /c/f/taf | 1 |
| 1061 | /calcineurin-dependent | 2 |
| 1062 | /calcium | 3 |
| 1063 | /calcium-calmodulin-dependent | 1 |
| 1064 | /calmodulin | 8 |
| 1065 | /calmodulin-dependent | 10 |
| 1066 | /calmodulin-regulated | 1 |
| 1067 | /cancer | 2 |
| 1068 | /cd137 | 1 |
| 1069 | /cdc42/actin-related | 1 |
| 1070 | /cds | 2 |
| 1071 | /cetylpyridinium | 1 |
| 1072 | /chemokine | 1 |
| 1073 | /chi | 6 |
| 1074 | /chronic | 3 |
| 1075 | /citrullinated | 1 |
| 1076 | /clearfil | 2 |
| 1077 | /clinical | 2 |
| 1078 | /cnt | 5 |
| 1079 | /cochaperone | 1 |
| 1080 | /cognitive | 1 |
| 1081 | /control | 6 |
| 1082 | /copper | 1 |
| 1083 | /core | 1 |
| 1084 | /corticosteroid | 2 |
| 1085 | /cr2o3 | 1 |
| 1086 | /cryopyrin | 1 |
| 1087 | /cryptogenic | 1 |
| 1088 | /cxc | 1 |
| 1089 | /cyclic | 4 |
| 1090 | /cyclin | 1 |
| 1091 | /dbp | 2 |
| 1092 | /degraded | 1 |
| 1093 | /dextran | 1 |
| 1094 | /dihydropyridine | 1 |
| 1095 | /direct | 2 |
| 1096 | /dose-limiting | 1 |
| 1097 | /drug | 1 |
| 1098 | /e7-induced | 1 |
| 1099 | /ectopic | 1 |
| 1100 | /emphysema | 1 |
| 1101 | /endothelial | 2 |
| 1102 | /erk | 1 |
| 1103 | /erk1/2 | 1 |
| 1104 | /ethinyl | 1 |
| 1105 | /eular | 1 |
| 1106 | /european | 7 |
| 1107 | /exproline | 1 |
| 1108 | /extended | 1 |
| 1109 | /extracellular | 10 |
| 1110 | /family | 1 |
| 1111 | /fat-1 | 3 |
| 1112 | /fcμr | 1 |
| 1113 | /fenton | 1 |
| 1114 | /fgf | 1 |
| 1115 | /floortime™ | 1 |
| 1116 | /follicular/oxyphilic/anaplastic | 1 |
| 1117 | /free | 4 |
| 1118 | /genipin | 1 |
| 1119 | /glassy | 1 |
| 1120 | /glaucoma | 1 |
| 1121 | /glucose | 1 |
| 1122 | /h+ | 1 |
| 1123 | /haemophilus | 2 |
| 1124 | /healthy | 1 |
| 1125 | /heart | 2 |
| 1126 | /hemolytic | 1 |
| 1127 | /heparin | 2 |
| 1128 | /heterocyclic | 1 |
| 1129 | /hf | 1 |
| 1130 | /high | 13 |
| 1131 | /high-frequency | 2 |
| 1132 | /histone | 1 |
| 1133 | /hiv | 13 |
| 1134 | /hollow | 1 |
| 1135 | /hs-related | 1 |
| 1136 | /hsv-2-coinfected | 1 |
| 1137 | /human | 3 |
| 1138 | /hyperactive-impulsive | 1 |
| 1139 | /hzsm-5 | 3 |
| 1140 | /i2-mediated | 1 |
| 1141 | /igf-ii | 5 |
| 1142 | /il-23 | 2 |
| 1143 | /inspiratory | 2 |
| 1144 | /intra | 1 |
| 1145 | /intravenous | 1 |
| 1146 | /ionic | 1 |
| 1147 | /ipt | 1 |
| 1148 | /italian | 1 |
| 1149 | /iv | 1 |
| 1150 | /japanese | 1 |
| 1151 | /ki-67 | 3 |
| 1152 | /larger | 2 |
| 1153 | /laser | 1 |
| 1154 | /learning | 1 |
| 1155 | /lectin-like | 1 |
| 1156 | /less-dense | 1 |
| 1157 | /lgs | 1 |
| 1158 | /lignin | 1 |
| 1159 | /lipid | 2 |
| 1160 | /lipopolysaccharide-induced | 1 |
| 1161 | /liver | 1 |
| 1162 | /long-acting | 4 |
| 1163 | /long-chain | 3 |
| 1164 | /lovastatin | 2 |
| 1165 | /low | 9 |
| 1166 | /low-calorie | 1 |
| 1167 | /low-dose | 1 |
| 1168 | /lower | 3 |
| 1169 | /lsat | 1 |
| 1170 | /lymphokine-activated | 2 |
| 1171 | /machado-joseph | 1 |
| 1172 | /mammalian | 11 |
| 1173 | /map | 3 |
| 1174 | /mas | 7 |
| 1175 | /maximal | 1 |
| 1176 | /mdr1-expressing | 1 |
| 1177 | /mechanistic | 1 |
| 1178 | /mer | 1 |
| 1179 | /met | 8 |
| 1180 | /methacholine | 1 |
| 1181 | /methoprene | 1 |
| 1182 | /micronised | 1 |
| 1183 | /million | 5 |
| 1184 | /minimal | 1 |
| 1185 | /minimum | 4 |
| 1186 | /mitogen-activated | 4 |
| 1187 | /mitogen‑activated | 1 |
| 1188 | /mll-aff1 | 1 |
| 1189 | /mno | 4 |
| 1190 | /mo | 1 |
| 1191 | /modified | 1 |
| 1192 | /motor-evoked | 1 |
| 1193 | /mpa | 1 |
| 1194 | /mri | 1 |
| 1195 | /multi-walled | 2 |
| 1196 | /multicellular | 1 |
| 1197 | /muscle | 1 |
| 1198 | /myd88-dependent | 1 |
| 1199 | /nadh | 2 |
| 1200 | /naf | 4 |
| 1201 | /naf/sncl₂ | 1 |
| 1202 | /national | 3 |
| 1203 | /neurovascular | 1 |
| 1204 | /nf-κb | 1 |
| 1205 | /niacin | 1 |
| 1206 | /nicotinamide | 1 |
| 1207 | /nitinol | 1 |
| 1208 | /nitrotyrosine | 1 |
| 1209 | /non-erosive | 1 |
| 1210 | /non-gcb | 1 |
| 1211 | /non-inhibitor | 1 |
| 1212 | /non-luminal | 1 |
| 1213 | /normoxic | 1 |
| 1214 | /o2 | 4 |
| 1215 | /obese | 2 |
| 1216 | /oral | 2 |
| 1217 | /other | 3 |
| 1218 | /oxidative | 1 |
| 1219 | /p16-positive | 1 |
| 1220 | /p38 | 3 |
| 1221 | /p38/mitf | 1 |
| 1222 | /p38/mitf/tyrosinase | 1 |
| 1223 | /p70 | 1 |
| 1224 | /pcr | 2 |
| 1225 | /pcy3-catalyzed | 1 |
| 1226 | /pda | 1 |
| 1227 | /pervasive | 1 |
| 1228 | /photodiode | 1 |
| 1229 | /polyvinyl | 1 |
| 1230 | /popc | 2 |
| 1231 | /prednisone | 1 |
| 1232 | /premenstrual | 1 |
| 1233 | /pro-apoptotic | 1 |
| 1234 | /processed | 1 |
| 1235 | /progesterone | 2 |
| 1236 | /progressive | 1 |
| 1237 | /propidium | 1 |
| 1238 | /protein | 19 |
| 1239 | /ps1 | 1 |
| 1240 | /pulseless | 1 |
| 1241 | /pvk | 3 |
| 1242 | /rank | 1 |
| 1243 | /recommended | 1 |
| 1244 | /reduced | 2 |
| 1245 | /reflective | 1 |
| 1246 | /reflux | 1 |
| 1247 | /right | 1 |
| 1248 | /s6 | 2 |
| 1249 | /safety | 1 |
| 1250 | /sb | 3 |
| 1251 | /serine-threonine | 2 |
| 1252 | /signal-regulated | 1 |
| 1253 | /siloxane | 1 |
| 1254 | /silver | 2 |
| 1255 | /sir/prednisone | 1 |
| 1256 | /smad | 4 |
| 1257 | /smads | 1 |
| 1258 | /small | 1 |
| 1259 | /soluble | 1 |
| 1260 | /spliced | 1 |
| 1261 | /sps | 2 |
| 1262 | /stat-3 | 1 |
| 1263 | /std | 2 |
| 1264 | /ste20/sps1-related | 1 |
| 1265 | /t-cell | 4 |
| 1266 | /tam | 1 |
| 1267 | /tdf | 5 |
| 1268 | /th2 | 2 |
| 1269 | /th66 | 1 |
| 1270 | /thermal | 1 |
| 1271 | /thromboxane | 1 |
| 1272 | /tio₂ | 1 |
| 1273 | /total | 12 |
| 1274 | /tpra | 2 |
| 1275 | /triclosan | 1 |
| 1276 | /triclosan/copolymer | 1 |
| 1277 | /trka | 1 |
| 1278 | /ucl | 1 |
| 1279 | /unconfirmed | 1 |
| 1280 | /universal | 1 |
| 1281 | /urban | 1 |
| 1282 | /usual | 1 |
| 1283 | /uv | 6 |
| 1284 | /valve | 1 |
| 1285 | /vegf | 1 |
| 1286 | /vocal | 1 |
| 1287 | /who | 3 |
| 1288 | /wo₃ | 1 |
| 1289 | /α-sarcomeric | 1 |
| 1290 | /β-catenin | 2 |
| 1291 | /β-catenin/cyclin | 1 |
| 1292 | /β-tricalcium | 1 |
| 1293 | /βcdp | 2 |
| 1294 | /δblood | 1 |
| 1295 | /∆pgi∆zwf∆usha | 2 |
| 1296 | 0.05/kg | 1 |
| 1297 | 0201-restricted | 1 |
| 1298 | 09.02 | 1 |
| 1299 | 1-family | 1 |
| 1300 | 1-favoured | 1 |
| 1301 | 1-person | 1 |
| 1302 | 1-promoting | 1 |
| 1303 | 1.1-ml | 1 |
| 1304 | 1.2-mediated | 1 |
| 1305 | 1.3-dependent | 1 |
| 1306 | 1.3-ml | 1 |
| 1307 | 1.3-targeted | 1 |
| 1308 | 1.3.3 | 6 |
| 1309 | 1.7-blocking | 1 |
| 1310 | 1.8-expressing | 1 |
| 1311 | 1/2-related | 1 |
| 1312 | 1/2/p90 | 1 |
| 1313 | 1/th2 | 5 |
| 1314 | 1/th2/th17-type | 1 |
| 1315 | 11-conjugated | 1 |
| 1316 | 12-400 | 4 |
| 1317 | 141+/-12fmol/mg | 1 |
| 1318 | 17-polarized | 1 |
| 1319 | 17.937 | 1 |
| 1320 | 1ysa/ysarbrc | 1 |
| 1321 | 2-biased | 1 |
| 1322 | 2-catalyzed | 2 |
| 1323 | 2-kbro3 | 1 |
| 1324 | 2-mediated | 11 |
| 1325 | 2-θσ2 | 1 |
| 1326 | 2.3/ | 1 |
| 1327 | 2.increasing | 1 |
| 1328 | 2/3-dependent | 1 |
| 1329 | 2/c | 1 |
| 1330 | 2/et3n/1:1 | 1 |
| 1331 | 20mmol/l | 1 |
| 1332 | 26866138-mmy-3006 | 1 |
| 1333 | 2tcnq | 2 |
| 1334 | 2⋅4 | 1 |
| 1335 | 3*leiden | 1 |
| 1336 | 3,4-dimethylpyrazole | 1 |
| 1337 | 3,6-bridged-glycosyl | 1 |
| 1338 | 3-adsorbed | 1 |
| 1339 | 3-complexed | 1 |
| 1340 | 3-diethylenetriamine | 1 |
| 1341 | 3.2-targeting | 1 |
| 1342 | 3.24+/-2.71 | 1 |
| 1343 | 3.38-5.05 | 1 |
| 1344 | 3.57ml/kg | 1 |
| 1345 | 3.75mug | 1 |
| 1346 | 3.98+/-2.51 | 1 |
| 1347 | 3/carbon | 1 |
| 1348 | 3/hgo | 1 |
| 1349 | 30scha/j | 1 |
| 1350 | 322-325 | 7 |
| 1351 | 36,711 | 1 |
| 1352 | 37+/-2.31 | 1 |
| 1353 | 3a-mediated | 1 |
| 1354 | 3l3 | 1 |
| 1355 | 3tc-treated | 2 |
| 1356 | 3·1.5h2o | 1 |
| 1357 | 4-carboxylatobenzoxyl | 1 |
| 1358 | 4-catalyzed | 4 |
| 1359 | 4-myeloid | 1 |
| 1360 | 44.00±64.00 | 1 |
| 1361 | 4mtt | 1 |
| 1362 | 5,199 | 1 |
| 1363 | 5-aminoisoxazole | 1 |
| 1364 | 5ec | 5 |
| 1365 | 612-like | 1 |
| 1366 | 6274not | 1 |
| 1367 | 65-expressing | 1 |
| 1368 | 7,462 | 1 |
| 1369 | 75-day | 1 |
| 1370 | 8-induced | 1 |
| 1371 | 82bc | 1 |
| 1372 | 90203 | 2 |
| 1373 | 92-gene | 1 |
| 1374 | 9601 | 1 |
| 1375 | 9907 | 2 |
| 1376 | :0.005 | 2 |
| 1377 | :147. | 1 |
| 1378 | :81 | 2 |
| 1379 | :852-861. | 1 |
| 1380 | =-3/2 | 1 |
| 1381 | =13.9 | 1 |
| 1382 | =151 | 2 |
| 1383 | =178 | 1 |
| 1384 | =19.34μm | 1 |
| 1385 | =193.537 | 1 |
| 1386 | =316 | 1 |
| 1387 | =82.0-0.62 | 1 |
| 1388 | =ccug | 2 |
| 1389 | =cect | 1 |
| 1390 | =cgmcc | 1 |
| 1391 | =hg/arm | 1 |
| 1392 | =vkm | 5 |
| 1393 | a-gypsum | 1 |
| 1394 | aampc | 1 |
| 1395 | aand | 1 |
| 1396 | acas-ineligible | 2 |
| 1397 | aceto- | 1 |
| 1398 | acetone+bonding | 1 |
| 1399 | acetonitrile-glacial | 1 |
| 1400 | adaptativos | 1 |
| 1401 | adrenoceptor-blocking | 1 |
| 1402 | ahr+/+ | 1 |
| 1403 | ak/pd | 1 |
| 1404 | al2o4 | 4 |
| 1405 | algae-mediated | 1 |
| 1406 | all-invasive | 1 |
| 1407 | allopathy- | 1 |
| 1408 | alpha/delta/gamma | 1 |
| 1409 | amine-induced | 1 |
| 1410 | amino-2-oxoethyl | 1 |
| 1411 | aminobenzoate | 1 |
| 1412 | aminocombretastatin | 1 |
| 1413 | aminomethyl-1,4-benzodioxane | 1 |
| 1414 | aml17 | 1 |
| 1415 | ampicillin/sulbactam-treated | 1 |
| 1416 | ampk/mtor-driven | 1 |
| 1417 | amx/ca-treated | 2 |
| 1418 | analogue/human | 1 |
| 1419 | and/orspecific | 1 |
| 1420 | andpparαgene | 1 |
| 1421 | anilinide | 1 |
| 1422 | anti-t-lymphoma/leukemia | 1 |
| 1423 | antimineralisation | 1 |
| 1424 | antituberulosis-naïve | 1 |
| 1425 | ap3b1-derived | 1 |
| 1426 | ar-expressing | 1 |
| 1427 | ar-induced | 1 |
| 1428 | ar-knockout | 1 |
| 1429 | ar-transfected | 1 |
| 1430 | arachidonate-stimulated | 1 |
| 1431 | arsonium | 1 |
| 1432 | artery/first | 1 |
| 1433 | aryl-monothio-1,3-diketone | 1 |
| 1434 | at-anti-murine | 1 |
| 1435 | attention-control/pharmacologic | 1 |
| 1436 | ayurvedic- | 1 |
| 1437 | a″ | 2 |
| 1438 | b*5701 | 1 |
| 1439 | b-48-containing | 1 |
| 1440 | b/ann | 1 |
| 1441 | balugrastim-treated | 1 |
| 1442 | batio₃-paraffin | 2 |
| 1443 | bearman | 1 |
| 1444 | benga | 1 |
| 1445 | benzendiazonium | 1 |
| 1446 | benzene-1,3-diols | 1 |
| 1447 | benzene-diazonium | 1 |
| 1448 | benzimidazolium | 2 |
| 1449 | benzimidazolyl | 1 |
| 1450 | benzo-yloxy | 1 |
| 1451 | benzodiazepine-dose | 1 |
| 1452 | benzylamide | 1 |
| 1453 | beta5-expressing | 1 |
| 1454 | better-specified | 1 |
| 1455 | better/more | 1 |
| 1456 | between-areal | 1 |
| 1457 | bi-type | 1 |
| 1458 | bisbenzimidazole | 2 |
| 1459 | blockade-treated | 1 |
| 1460 | bms-936557-treated | 1 |
| 1461 | bnnt-sh | 2 |
| 1462 | boc4h6 | 2 |
| 1463 | br10 | 1 |
| 1464 | brevetoxin/no | 1 |
| 1465 | bromide-catalyzed | 2 |
| 1466 | but-3-en-1-yl | 12 |
| 1467 | c*6 | 1 |
| 1468 | c-acetate | 20 |
| 1469 | c-enriched | 6 |
| 1470 | c-hed | 5 |
| 1471 | c-ii-dependent | 1 |
| 1472 | c-labaled | 1 |
| 1473 | c-labeled | 33 |
| 1474 | c-labeling | 4 |
| 1475 | c-metabolomics | 1 |
| 1476 | c-methacetin | 2 |
| 1477 | c-methionine | 1 |
| 1478 | c-octanoate | 1 |
| 1479 | c-percentage | 2 |
| 1480 | c-retinol | 1 |
| 1481 | c-urea | 56 |
| 1482 | c3-arylated | 1 |
| 1483 | c57bl/10scnj | 1 |
| 1484 | c57br/cdj | 1 |
| 1485 | cadmium+betaine | 1 |
| 1486 | cagelike | 2 |
| 1487 | cao-xsro | 1 |
| 1488 | carbamoyl-4-aryl-1,4-dihydropyridine | 1 |
| 1489 | care.81 | 1 |
| 1490 | carrière | 1 |
| 1491 | cases.a | 1 |
| 1492 | catechin-related | 2 |
| 1493 | cattt | 1 |
| 1494 | ceftriaxone/cefuroxime-treated | 1 |
| 1495 | cell-alginate | 1 |
| 1496 | cells/1.5 | 1 |
| 1497 | cells/b | 1 |
| 1498 | center-based/home-based | 1 |
| 1499 | chitosan-encapsulated | 1 |
| 1500 | chloride-phenanthroline | 1 |
| 1501 | chlorophosphate | 1 |
| 1502 | cholesterol-labeled | 1 |
| 1503 | cholesterol-labelled | 2 |
| 1504 | cicletanine-treated | 1 |
| 1505 | cl-treated | 1 |
| 1506 | clarires | 1 |
| 1507 | clones/8386 | 1 |
| 1508 | cncps | 1 |
| 1509 | cnmr | 4 |
| 1510 | co-heating | 2 |
| 1511 | co-substituted | 1 |
| 1512 | cobalamin-catalyzed | 1 |
| 1513 | cognitive-behavioral/pharmacologic | 1 |
| 1514 | colometric | 1 |
| 1515 | colonographic | 1 |
| 1516 | colony-forming | 399 |
| 1517 | colonyforming | 1 |
| 1518 | colposcopically-negative | 1 |
| 1519 | colposcopy-positive | 1 |
| 1520 | committee-established | 1 |
| 1521 | comp-treated | 1 |
| 1522 | compatibility-single | 1 |
| 1523 | con-no | 1 |
| 1524 | coronary/cardiac | 1 |
| 1525 | corticosteroid-primed | 1 |
| 1526 | count/100 | 1 |
| 1527 | cr-labeled | 4 |
| 1528 | cr-release | 6 |
| 1529 | cr1-deficient | 2 |
| 1530 | cr1-expressing | 1 |
| 1531 | cr1-gfp | 4 |
| 1532 | crt+placebo | 1 |
| 1533 | csa-challenged | 1 |
| 1534 | ct/hrct | 1 |
| 1535 | ctn-0037 | 2 |
| 1536 | cu-labeled | 2 |
| 1537 | cycloaddition/ring | 1 |
| 1538 | cysteine-labeled | 1 |
| 1539 | cytogenetics® | 1 |
| 1540 | cytome | 7 |
| 1541 | cytoscan | 1 |
| 1542 | daptomycin-treated | 1 |
| 1543 | davydovae | 1 |
| 1544 | dc-pmma | 1 |
| 1545 | decolorisation | 1 |
| 1546 | ded142808 | 1 |
| 1547 | defence-enhanced | 1 |
| 1548 | delivered/theoretical | 1 |
| 1549 | delta/akt | 1 |
| 1550 | descrbiing | 1 |
| 1551 | di-imide | 1 |
| 1552 | dihydrochloride-induced | 2 |
| 1553 | dinp-treated | 3 |
| 1554 | dinucleotide-length | 1 |
| 1555 | dioxocine | 1 |
| 1556 | distal/extensive | 1 |
| 1557 | domain-inverted | 1 |
| 1558 | double-cyclized | 1 |
| 1559 | drb1*11 | 1 |
| 1560 | drug-manufacturing | 1 |
| 1561 | drug/metabolite | 2 |
| 1562 | dyscoordinated | 1 |
| 1563 | dyspenic | 1 |
| 1564 | e*3-leiden | 2 |
| 1565 | e749-57 | 1 |
| 1566 | easibreathe | 1 |
| 1567 | echocardographic | 1 |
| 1568 | ee2-induced | 1 |
| 1569 | efflux-containing | 1 |
| 1570 | efv/ftc/tdf-treated | 1 |
| 1571 | el-free | 2 |
| 1572 | embryonal/botryoid | 1 |
| 1573 | enalapril-fa | 4 |
| 1574 | enrolling1506 | 1 |
| 1575 | envolvidos | 1 |
| 1576 | enzyme-linked-immunospot | 1 |
| 1577 | ep+lc | 1 |
| 1578 | ewca | 1 |
| 1579 | exit-an | 1 |
| 1580 | f-fdg-labeled | 3 |
| 1581 | f-fluoromisonidazole | 3 |
| 1582 | f-fluoropropansulfonyl | 1 |
| 1583 | f-labeled | 23 |
| 1584 | f-labelled | 2 |
| 1585 | f-radiolabeled | 1 |
| 1586 | f-sodium | 8 |
| 1587 | factsheets-a | 1 |
| 1588 | fama-based | 1 |
| 1589 | fe-core-labeled | 1 |
| 1590 | fe-oxyhydroxide | 1 |
| 1591 | fe-particle-induced | 1 |
| 1592 | fiber-coating | 1 |
| 1593 | flor-opal® | 1 |
| 1594 | fluorodeoxy | 1 |
| 1595 | fo+ | 1 |
| 1596 | for-avn-abl | 1 |
| 1597 | fourth-fifth-order | 1 |
| 1598 | ftc-treated | 2 |
| 1599 | fullerene-based | 1 |
| 1600 | furoxan-3-carbonitrile | 1 |
| 1601 | g-positive | 1 |
| 1602 | g4™ | 2 |
| 1603 | ga-based | 1 |
| 1604 | ga-labeled | 6 |
| 1605 | gaata | 1 |
| 1606 | gemifloxacin-treated | 1 |
| 1607 | gene-carrying | 1 |
| 1608 | genes-namely | 1 |
| 1609 | genetically-targeted | 1 |
| 1610 | genotype-corrected | 1 |
| 1611 | gik/control | 1 |
| 1612 | glycyl | 1 |
| 1613 | goldblatt | 5 |
| 1614 | gorgonensis | 1 |
| 1615 | group/d | 1 |
| 1616 | gtp-γ-s | 1 |
| 1617 | gullon | 2 |
| 1618 | gyraseb | 1 |
| 1619 | h-cholesterol-labeled | 1 |
| 1620 | h-cholesterol-labelled | 1 |
| 1621 | h-derived | 1 |
| 1622 | h-digoxin | 1 |
| 1623 | h-labeled | 7 |
| 1624 | h-labelled | 1 |
| 1625 | h-steered | 1 |
| 1626 | haematodermic | 1 |
| 1627 | harbourd | 1 |
| 1628 | hbeag-seronegative | 1 |
| 1629 | head-head | 1 |
| 1630 | heat-powered | 1 |
| 1631 | heated/ | 1 |
| 1632 | hexachloridostannate | 1 |
| 1633 | hexanylpiperazine | 1 |
| 1634 | hfd-lab | 1 |
| 1635 | hg-u133-plus-2.0 | 1 |
| 1636 | hg-u219 | 1 |
| 1637 | hhp+hae | 1 |
| 1638 | hhp+non-hae | 1 |
| 1639 | high-repetitive | 1 |
| 1640 | hklm-stimulated | 1 |
| 1641 | holstein/friesian | 1 |
| 1642 | homo-arm | 1 |
| 1643 | hoxyb0.05nbo4 | 1 |
| 1644 | hydroborato | 1 |
| 1645 | hydromagnetic | 1 |
| 1646 | hyperglycemia/insulin | 1 |
| 1647 | hyperpolarised | 4 |
| 1648 | hypertension/no | 1 |
| 1649 | hypo-active | 1 |
| 1650 | hypomethylate | 1 |
| 1651 | i-alone | 1 |
| 1652 | i-beta-methyl-iodophenyl | 1 |
| 1653 | i-beta-methyl-p-iodophenyl | 1 |
| 1654 | i-coumarin | 3 |
| 1655 | i-fit | 1 |
| 1656 | i-higf-i | 4 |
| 1657 | i-labeled | 4 |
| 1658 | i-labelled | 3 |
| 1659 | i-radiolabeled | 1 |
| 1660 | i13/2 | 3 |
| 1661 | ib-producing | 1 |
| 1662 | ide-naive | 2 |
| 1663 | ide-naïve | 5 |
| 1664 | il-17-secreting | 1 |
| 1665 | immmunosorbent | 1 |
| 1666 | immune-absorbent | 1 |
| 1667 | immune-adsorbent | 1 |
| 1668 | immune-sorbent | 2 |
| 1669 | immunesorbent | 1 |
| 1670 | immuno-sorbent | 4 |
| 1671 | immunoabsorbent | 5 |
| 1672 | immunoadsorbent | 10 |
| 1673 | immunoadsordent | 1 |
| 1674 | immunometric | 13 |
| 1675 | immunosorbant | 9 |
| 1676 | immunosorbent | 1,242 |
| 1677 | immunospecific | 1 |
| 1678 | immunospot | 27 |
| 1679 | immunumetric | 1 |
| 1680 | in-diethylenetriaminepentaacetic | 2 |
| 1681 | in-labeled | 11 |
| 1682 | in101consecutive | 1 |
| 1683 | inclused | 1 |
| 1684 | incontinuous | 1 |
| 1685 | induced-scd14 | 1 |
| 1686 | infants-a | 1 |
| 1687 | inhaler.seven | 1 |
| 1688 | inhibitedcaspase-3 | 1 |
| 1689 | inhibitors-specifically | 1 |
| 1690 | injection-dosing | 1 |
| 1691 | inperi-operative | 1 |
| 1692 | intercladding | 1 |
| 1693 | intra-abdominal-inguinal | 1 |
| 1694 | iodomoeba | 1 |
| 1695 | ipro™2 | 1 |
| 1696 | iv-based | 2 |
| 1697 | j-difference | 1 |
| 1698 | j.-e. | 1 |
| 1699 | k-a-binding | 1 |
| 1700 | k-k373d | 2 |
| 1701 | k-mr | 2 |
| 1702 | k-pkb-foxo | 2 |
| 1703 | k-ras-positive | 1 |
| 1704 | k14-creer2 | 1 |
| 1705 | kalül | 1 |
| 1706 | kinase-ii-induced | 1 |
| 1707 | knee-muscle | 1 |
| 1708 | kyn2 | 1 |
| 1709 | l-mtad | 1 |
| 1710 | laryngoscope-specific | 2 |
| 1711 | laxative-treated | 1 |
| 1712 | lectinosorbent | 1 |
| 1713 | levels⩾17.9 | 1 |
| 1714 | lib/illa | 1 |
| 1715 | lid+potassium | 1 |
| 1716 | lidocaine-experimental | 1 |
| 1717 | literacy-appropriate | 1 |
| 1718 | lithe | 1 |
| 1719 | lt-polyphenol | 1 |
| 1720 | lu-imp288 | 3 |
| 1721 | lu-labeled | 4 |
| 1722 | lysis-causing | 1 |
| 1723 | m-free | 7 |
| 1724 | m1-null | 1 |
| 1725 | mab-defined | 1 |
| 1726 | macro-fingerprinting | 1 |
| 1727 | malachra | 1 |
| 1728 | marcin | 1 |
| 1729 | markovnikov-type | 1 |
| 1730 | massextend | 1 |
| 1731 | mems-based | 1 |
| 1732 | mercaptopropionyl | 1 |
| 1733 | methane-ligated | 1 |
| 1734 | methanide | 2 |
| 1735 | methaniminium | 1 |
| 1736 | methanol-water-glacial | 1 |
| 1737 | methionine-labeled | 4 |
| 1738 | methyl-3,4,5 | 1 |
| 1739 | micro/macro | 1 |
| 1740 | microbouquet | 2 |
| 1741 | mid-laser | 1 |
| 1742 | mitochondria-based | 1 |
| 1743 | mkp-l | 1 |
| 1744 | mnc-like | 1 |
| 1745 | mol/microg | 1 |
| 1746 | monomol | 1 |
| 1747 | moribund.the | 1 |
| 1748 | mother-allotted | 1 |
| 1749 | mpv17-like | 1 |
| 1750 | mycorradicin | 1 |
| 1751 | n-labeled | 7 |
| 1752 | n-labeling | 3 |
| 1753 | n3h | 1 |
| 1754 | n7-methyl | 3 |
| 1755 | n=1-5 | 1 |
| 1756 | nanocube-assembled | 1 |
| 1757 | nanodandelion | 1 |
| 1758 | nanofibre | 1 |
| 1759 | narcotic-related | 1 |
| 1760 | nasicon-related | 1 |
| 1761 | naïve/experienced | 1 |
| 1762 | ne30d | 5 |
| 1763 | needle-insertion | 2 |
| 1764 | nh- | 2 |
| 1765 | niedenzu | 1 |
| 1766 | nijmegen-bethesda | 2 |
| 1767 | nitrogen-ligand | 1 |
| 1768 | nivolumab-treated | 1 |
| 1769 | nmoles/g | 2 |
| 1770 | no-based | 3 |
| 1771 | non-haia | 1 |
| 1772 | non-hhp+hae | 1 |
| 1773 | non-nitric | 1 |
| 1774 | non-original | 1 |
| 1775 | non-platinum-containing | 1 |
| 1776 | non-sugared | 1 |
| 1777 | nonazole | 1 |
| 1778 | nonvitrified | 1 |
| 1779 | non–placebo-controlled | 1 |
| 1780 | norbornane-2-carboxylate | 1 |
| 1781 | normal-group | 1 |
| 1782 | normal/reactive | 1 |
| 1783 | northern-hemisphere | 1 |
| 1784 | nps-induced | 1 |
| 1785 | nws-based | 1 |
| 1786 | nπ∗ | 4 |
| 1787 | o-0.24 | 1 |
| 1788 | o-forming | 1 |
| 1789 | o-isotope | 1 |
| 1790 | o-labeled | 3 |
| 1791 | o-labeling | 1 |
| 1792 | o-mediated | 1 |
| 1793 | o-stimulated | 2 |
| 1794 | o2/ar | 1 |
| 1795 | o3-0.3pbtio3 | 1 |
| 1796 | oa+attend | 1 |
| 1797 | oasis-treated | 1 |
| 1798 | og1 | 2 |
| 1799 | oil-resistant | 1 |
| 1800 | omeprazole/sodium | 1 |
| 1801 | omt+medication | 1 |
| 1802 | onphotosynthetic | 1 |
| 1803 | organosiloxane | 1 |
| 1804 | osmogent | 1 |
| 1805 | outcomes-illicit | 1 |
| 1806 | outer-ring | 1 |
| 1807 | over-secretes | 1 |
| 1808 | oxide-bridged | 1 |
| 1809 | oxyethyl | 1 |
| 1810 | oxyhydroxy | 1 |
| 1811 | p-binding | 7 |
| 1812 | p-catalyzed | 2 |
| 1813 | p-exposed | 1 |
| 1814 | p-induced | 10 |
| 1815 | p-labeled | 4 |
| 1816 | p-mri | 1 |
| 1817 | p-postlabeling | 3 |
| 1818 | p2-dependent | 2 |
| 1819 | p2-metabolizing | 1 |
| 1820 | p2-positive | 1 |
| 1821 | p2-related | 1 |
| 1822 | p2-specific | 3 |
| 1823 | p3-based | 1 |
| 1824 | p3-btk | 1 |
| 1825 | p3-degrading | 1 |
| 1826 | p3-independent | 1 |
| 1827 | papilionoid | 1 |
| 1828 | park-director | 1 |
| 1829 | patients.analgesia-based | 1 |
| 1830 | patients.forty | 1 |
| 1831 | pc100 | 1 |
| 1832 | pdtc-treated | 2 |
| 1833 | pegloticase-treated | 1 |
| 1834 | pennvax®-b | 1 |
| 1835 | perfusion-imaging | 1 |
| 1836 | periodate-sensitive | 1 |
| 1837 | perovskite-structure | 1 |
| 1838 | perovskite/tio₂ | 1 |
| 1839 | phage-based | 1 |
| 1840 | pharmo-netherlands | 1 |
| 1841 | phenacyloxy- | 1 |
| 1842 | phenothiazin-5-ium | 1 |
| 1843 | phosphoesterase | 2 |
| 1844 | phosphorus-labeled | 1 |
| 1845 | pinkerton | 1 |
| 1846 | placebo+tc | 1 |
| 1847 | placebo-tested | 1 |
| 1848 | plaiv-primed | 1 |
| 1849 | plaque-forming | 33 |
| 1850 | plasma-pretreated | 1 |
| 1851 | pmd09 | 13 |
| 1852 | poisoning-induced | 1 |
| 1853 | polymerase-related | 1 |
| 1854 | posivite | 1 |
| 1855 | post-primary/adjuvant | 1 |
| 1856 | postcystolic | 1 |
| 1857 | posteducational | 1 |
| 1858 | postmeeting | 1 |
| 1859 | pourable | 1 |
| 1860 | pre-electrophoretic | 1 |
| 1861 | precursor.the | 1 |
| 1862 | prelabeling | 1 |
| 1863 | prolamin-primed | 1 |
| 1864 | propane-dinitrile | 1 |
| 1865 | prostaglandin-treated | 1 |
| 1866 | pseudobinary | 1 |
| 1867 | psychophysically-anchored | 2 |
| 1868 | pt-treated | 1 |
| 1869 | ptx™ | 1 |
| 1870 | purospher | 2 |
| 1871 | p₂-mediated | 1 |
| 1872 | questionnaire.we | 1 |
| 1873 | r-induced | 3 |
| 1874 | r-mediated | 8 |
| 1875 | r-overexpressing | 2 |
| 1876 | r-related | 1 |
| 1877 | r/csq | 1 |
| 1878 | radical-bridged | 2 |
| 1879 | ranibizumab-naïve | 1 |
| 1880 | rc/cl | 2 |
| 1881 | re-labeled | 2 |
| 1882 | re-rume | 1 |
| 1883 | reabsorbs | 1 |
| 1884 | reactor-three | 1 |
| 1885 | real-time™ | 1 |
| 1886 | receptor-evoked | 3 |
| 1887 | receptor-than | 1 |
| 1888 | reducing/eliminating | 2 |
| 1889 | refined-wheat | 1 |
| 1890 | registretion | 1 |
| 1891 | regranex-treated | 1 |
| 1892 | release.forty-six | 1 |
| 1893 | replication-another | 1 |
| 1894 | repressor-encoding | 1 |
| 1895 | respectively.interpersonal | 1 |
| 1896 | responded.seventy-two | 1 |
| 1897 | reviews-the | 1 |
| 1898 | reñma | 1 |
| 1899 | risk.ezetimibe | 1 |
| 1900 | rpv/ftc/tdf-treated | 1 |
| 1901 | rr-bound | 1 |
| 1902 | rti-sparing | 1 |
| 1903 | rvi-negative | 1 |
| 1904 | s-labeled | 1 |
| 1905 | s-producing | 2 |
| 1906 | s2n2o2 | 1 |
| 1907 | scan-based | 1 |
| 1908 | score-driven | 1 |
| 1909 | se-labeled | 1 |
| 1910 | self-aggregating | 1 |
| 1911 | self-drying | 1 |
| 1912 | sequencial | 1 |
| 1913 | severity-by-duration | 1 |
| 1914 | sf33-infected | 1 |
| 1915 | sham+medication | 1 |
| 1916 | sham+pdtc | 2 |
| 1917 | si-nmr | 2 |
| 1918 | silane+bonding | 1 |
| 1919 | simpson- | 1 |
| 1920 | skinmedica® | 1 |
| 1921 | sn0.99 | 1 |
| 1922 | sn=0-100 | 1 |
| 1923 | sn=25-90 | 1 |
| 1924 | sn=36-8 | 1 |
| 1925 | sn=58-96 | 1 |
| 1926 | sn=60-67 | 1 |
| 1927 | snar-terminated | 1 |
| 1928 | snu182 | 1 |
| 1929 | software.five | 1 |
| 1930 | software.we | 1 |
| 1931 | spectrosocopy | 1 |
| 1932 | spiramycin-treated | 1 |
| 1933 | st30 | 1 |
| 1934 | states.typically | 1 |
| 1935 | std6 | 2 |
| 1936 | steric/chemical | 1 |
| 1937 | sterols/steroid | 1 |
| 1938 | stiffness-pathophysiologic | 1 |
| 1939 | store-depleting | 1 |
| 1940 | study-contacted | 1 |
| 1941 | subporphyrazine | 1 |
| 1942 | t2w-ssfse | 1 |
| 1943 | t309g | 1 |
| 1944 | tablets-two | 1 |
| 1945 | tc-antimicrobial | 1 |
| 1946 | tc-diethylenetriaminepenta | 1 |
| 1947 | tc-dpd | 11 |
| 1948 | tc-ethylcysteinate | 1 |
| 1949 | tc-hmpao-labelled | 3 |
| 1950 | tc-hynic-octreotide | 1 |
| 1951 | tc-labeled | 18 |
| 1952 | tc-labelled | 6 |
| 1953 | tc-maa | 2 |
| 1954 | tc-radiolabeled | 2 |
| 1955 | tc-radiometal | 1 |
| 1956 | tc-ubiquicidin-derived | 1 |
| 1957 | tekensis | 1 |
| 1958 | test—the | 1 |
| 1959 | tetrathiafulvalene | 2 |
| 1960 | texture-nutrient | 1 |
| 1961 | tfa/acetonitrile/water | 1 |
| 1962 | tg-agtko | 4 |
| 1963 | third-/fourth-line | 1 |
| 1964 | tolterodine.fesoterodine | 1 |
| 1965 | toma6-negative | 1 |
| 1966 | toxic-related | 1 |
| 1967 | translocation-generated | 1 |
| 1968 | travelling-wave-tube | 1 |
| 1969 | tri-carbide | 1 |
| 1970 | tridoped | 1 |
| 1971 | triethoxysilane-treated | 2 |
| 1972 | trihydride | 1 |
| 1973 | trimethine | 4 |
| 1974 | trimethyltransferase | 1 |
| 1975 | trivial-to-small | 1 |
| 1976 | trophoblast-specific | 1 |
| 1977 | tso-treated | 1 |
| 1978 | turbidity-reducing | 1 |
| 1979 | type1a | 1 |
| 1980 | u74av2 | 1 |
| 1981 | unassessed | 3 |
| 1982 | unfired | 1 |
| 1983 | units·the | 1 |
| 1984 | v-like-as03 | 1 |
| 1985 | vacuum-cast | 6 |
| 1986 | valvular-arterial | 1 |
| 1987 | vif-infected | 1 |
| 1988 | vip1-7 | 1 |
| 1989 | viserosomatic | 1 |
| 1990 | vlv | 1 |
| 1991 | vre/g | 2 |
| 1992 | vslatanoprost/timolol | 1 |
| 1993 | weighing-based | 1 |
| 1994 | witrür | 1 |
| 1995 | xe-washout | 1 |
| 1996 | y-ibritumomab | 14 |
| 1997 | y-it-treated | 1 |
| 1998 | y-labeled | 2 |
| 1999 | yalo3 | 1 |
| 2000 | zr-conjugated | 2 |
| 2001 | zr2p3o12 | 2 |
| 2002 | ±pep | 1 |
| 2003 | µg/108 | 4 |
| 2004 | ···ar | 2 |
| 2005 | ×fasting | 1 |
| 2006 | ×ho | 2 |
| 2007 | å. | 15 |
| 2008 | α-positive | 1 |
| 2009 | β1.3-induced | 2 |
| 2010 | β₃ | 29 |
| 2011 | β₃-dxtl-pd | 5 |
| 2012 | β₃-expressing | 1 |
| 2013 | β₃-mediated | 1 |
| 2014 | β₃-pfc | 1 |
| 2015 | δ1 | 4 |
| 2016 | π0g | 3 |
| 2017 | π1,2 | 1 |
| 2018 | ππ∗ | 4 |
| 2019 | πω | 2 |
| 2020 | ‑2,5‑diphenyl | 1 |
| 2021 | ‑2,5‑diphenyltetrazolium | 2 |
| 2022 | ‑depleted | 1 |
| 2023 | ‑expressing | 1 |
| 2024 | ‑induced | 4 |
| 2025 | ‑stimulated | 3 |
| 2026 | ‑β‑induced | 1 |
| 2027 | –lowering | 1 |
| 2028 | –with | 1 |
| 2029 | “some | 1 |
| 2030 | ₂d₃-induced | 4 |
| 2031 | ₂d₃-treated | 1 |
| 2032 | ₂so₄ | 2 |
| 2033 | ₃o₄ | 1 |
| 2034 | ₈-barrel | 1 |
| 2035 | €12.50-worth | 1 |
| 2036 | →b*+ | 2 |
| 2037 | ↔ | 10 |
| 2038 | ≤2.4-steered | 1 |
| 2039 | ≤two | 1 |
| 2040 | h | 7 |
| 1 | →b*+ | 2 |
| 2 | /+ | 12 |
| 3 | ahr+/+ | 1 |
| 4 | /h+ | 1 |
| 5 | -li+ | 1 |
| 6 | fo+ | 1 |
| 7 | ,2- | 1 |
| 8 | -diol-3- | 1 |
| 9 | -1-ethoxycarbonyl-3- | 1 |
| 10 | -5-phenyl-1,3,4- | 1 |
| 11 | -2,5- | 2 |
| 12 | -oxadiazole-5- | 1 |
| 13 | -delta8'-7-acetoxy-3,4,3',5'-tetramethoxy-8- | 1 |
| 14 | ayurvedic- | 1 |
| 15 | -sensitive- | 1 |
| 16 | nh- | 2 |
| 17 | simpson- | 1 |
| 18 | aceto- | 1 |
| 19 | allopathy- | 1 |
| 20 | phenacyloxy- | 1 |
| 21 | :852-861. | 1 |
| 22 | :147. | 1 |
| 23 | j.-e. | 1 |
| 24 | -r. | 1 |
| 25 | å. | 15 |
| 26 | 2.3/ | 1 |
| 27 | heated/ | 1 |
| 28 | /akt/ | 1 |
| 29 | hg-u133-plus-2.0 | 1 |
| 30 | 44.00±64.00 | 1 |
| 31 | sn=0-100 | 1 |
| 32 | count/100 | 1 |
| 33 | pc100 | 1 |
| 34 | 12-400 | 4 |
| 35 | -7:00 | 1 |
| 36 | br10 | 1 |
| 37 | st30 | 1 |
| 38 | -as160 | 1 |
| 39 | /p70 | 1 |
| 40 | -tween-80 | 2 |
| 41 | sn=25-90 | 1 |
| 42 | 1/2/p90 | 1 |
| 43 | /fat-1 | 3 |
| 44 | -001 | 1 |
| 45 | -0401 | 1 |
| 46 | 9601 | 1 |
| 47 | b*5701 | 1 |
| 48 | drb1*11 | 1 |
| 49 | 36,711 | 1 |
| 50 | 37+/-2.31 | 1 |
| 51 | /141 | 1 |
| 52 | 3.98+/-2.51 | 1 |
| 53 | =151 | 2 |
| 54 | 3.24+/-2.71 | 1 |
| 55 | care.81 | 1 |
| 56 | :81 | 2 |
| 57 | 2/et3n/1:1 | 1 |
| 58 | -ca1 | 1 |
| 59 | -dqa1 | 1 |
| 60 | /mll-aff1 | 1 |
| 61 | -g1 | 1 |
| 62 | og1 | 2 |
| 63 | -cin1 | 1 |
| 64 | -zmrfp1 | 1 |
| 65 | -lmp1 | 1 |
| 66 | /ps1 | 1 |
| 67 | δ1 | 4 |
| 68 | π1,2 | 1 |
| 69 | -isolaricireinol-2 | 1 |
| 70 | -a/vegfr-2 | 1 |
| 71 | -erk1/2 | 1 |
| 72 | /erk1/2 | 1 |
| 73 | =-3/2 | 1 |
| 74 | i13/2 | 3 |
| 75 | 09.02 | 1 |
| 76 | zr2p3o12 | 2 |
| 77 | =82.0-0.62 | 1 |
| 78 | 7,462 | 1 |
| 79 | snu182 | 1 |
| 80 | -ampkalpha2 | 1 |
| 81 | -pge2 | 1 |
| 82 | /th2 | 2 |
| 83 | 1/th2 | 5 |
| 84 | kyn2 | 1 |
| 85 | /o2 | 4 |
| 86 | s2n2o2 | 1 |
| 87 | -tio2 | 2 |
| 88 | k14-creer2 | 1 |
| 89 | -s2 | 1 |
| 90 | -33/st2 | 1 |
| 91 | u74av2 | 1 |
| 92 | 2-θσ2 | 1 |
| 93 | ipro™2 | 1 |
| 94 | -9,19-cyclolanosta-3 | 1 |
| 95 | inhibitedcaspase-3 | 1 |
| 96 | /stat-3 | 1 |
| 97 | +flt-3 | 1 |
| 98 | 1.3.3 | 6 |
| 99 | -1/3 | 1 |
| 100 | -smad2/3 | 2 |
| 101 | -l2/3 | 1 |
| 102 | 90203 | 2 |
| 103 | -as03 | 2 |
| 104 | v-like-as03 | 1 |
| 105 | /il-23 | 2 |
| 106 | -k373 | 1 |
| 107 | -293 | 2 |
| 108 | -2h3 | 3 |
| 109 | 3l3 | 1 |
| 110 | -γ-fe2o3 | 4 |
| 111 | /cr2o3 | 1 |
| 112 | o3-0.3pbtio3 | 1 |
| 113 | yalo3 | 1 |
| 114 | 2-kbro3 | 1 |
| 115 | -αvβ3 | 1 |
| 116 | induced-scd14 | 1 |
| 117 | o-0.24 | 1 |
| 118 | -vps34 | 1 |
| 119 | -hd4 | 1 |
| 120 | -cullin4 | 1 |
| 121 | al2o4 | 4 |
| 122 | hoxyb0.05nbo4 | 1 |
| 123 | -ahsv4 | 4 |
| 124 | 2⋅4 | 1 |
| 125 | methyl-3,4,5 | 1 |
| 126 | n=1-5 | 1 |
| 127 | /hzsm-5 | 3 |
| 128 | cells/1.5 | 1 |
| 129 | 3.38-5.05 | 1 |
| 130 | :0.005 | 2 |
| 131 | 322-325 | 7 |
| 132 | -555 | 1 |
| 133 | -gemmenos65 | 1 |
| 134 | -c5 | 9 |
| 135 | -yd5 | 5 |
| 136 | -14±5 | 1 |
| 137 | c*6 | 1 |
| 138 | 26866138-mmy-3006 | 1 |
| 139 | enrolling1506 | 1 |
| 140 | =316 | 1 |
| 141 | /th66 | 1 |
| 142 | clones/8386 | 1 |
| 143 | sn=58-96 | 1 |
| 144 | std6 | 2 |
| 145 | boc4h6 | 2 |
| 146 | /s6 | 2 |
| 147 | vip1-7 | 1 |
| 148 | -27±6.7 | 1 |
| 149 | 9907 | 2 |
| 150 | aml17 | 1 |
| 151 | -m17 | 4 |
| 152 | ctn-0037 | 2 |
| 153 | /cd137 | 1 |
| 154 | =193.537 | 1 |
| 155 | 17.937 | 1 |
| 156 | e749-57 | 1 |
| 157 | sn=60-67 | 1 |
| 158 | /ki-67 | 3 |
| 159 | sn=36-8 | 1 |
| 160 | µg/108 | 4 |
| 161 | ded142808 | 1 |
| 162 | -16/18 | 11 |
| 163 | /p38 | 3 |
| 164 | =178 | 1 |
| 165 | lu-imp288 | 3 |
| 166 | -6t8 | 1 |
| 167 | =13.9 | 1 |
| 168 | levels⩾17.9 | 1 |
| 169 | pmd09 | 13 |
| 170 | hg-u219 | 1 |
| 171 | sn0.99 | 1 |
| 172 | 5,199 | 1 |
| 173 | factsheets-a | 1 |
| 174 | infants-a | 1 |
| 175 | .a | 38 |
| 176 | cases.a | 1 |
| 177 | -agonists.a | 1 |
| 178 | type1a | 1 |
| 179 | -atpase-2a | 1 |
| 180 | -6a | 1 |
| 181 | tc-maa | 2 |
| 182 | iodomoeba | 1 |
| 183 | -methanocarba | 5 |
| 184 | -reca | 1 |
| 185 | ewca | 1 |
| 186 | /pda | 1 |
| 187 | nijmegen-bethesda | 2 |
| 188 | -urea | 3 |
| 189 | c-urea | 56 |
| 190 | -n'-phenylthiourea | 1 |
| 191 | -cts-sea | 2 |
| 192 | enalapril-fa | 4 |
| 193 | benga | 1 |
| 194 | -ampkalpha | 4 |
| 195 | /∆pgi∆zwf∆usha | 2 |
| 196 | non-haia | 1 |
| 197 | anti-t-lymphoma/leukemia | 1 |
| 198 | -via | 1 |
| 199 | /ataxia | 1 |
| 200 | /trka | 1 |
| 201 | -amygdala | 2 |
| 202 | -ila | 1 |
| 203 | lib/illa | 1 |
| 204 | /emphysema | 1 |
| 205 | alpha/delta/gamma | 1 |
| 206 | dc-pmma | 1 |
| 207 | /glaucoma | 1 |
| 208 | -thymoma | 1 |
| 209 | reñma | 1 |
| 210 | -ifna | 1 |
| 211 | /alumina | 1 |
| 212 | /mpa | 1 |
| 213 | malachra | 1 |
| 214 | /tpra | 2 |
| 215 | /intra | 1 |
| 216 | -mrsa | 2 |
| 217 | gaata | 1 |
| 218 | -accbeta | 3 |
| 219 | -nta | 8 |
| 220 | tc-diethylenetriaminepenta | 1 |
| 221 | -tta | 1 |
| 222 | pennvax®-b | 1 |
| 223 | cells/b | 1 |
| 224 | -11b | 2 |
| 225 | -5b | 2 |
| 226 | -28b | 3 |
| 227 | -aab | 1 |
| 228 | hfd-lab | 1 |
| 229 | .abciximab | 1 |
| 230 | -ibritumomab | 2 |
| 231 | y-ibritumomab | 14 |
| 232 | -κappab | 1 |
| 233 | /non-gcb | 1 |
| 234 | -hcb | 1 |
| 235 | gyraseb | 1 |
| 236 | /sb | 3 |
| 237 | -multi-hivb | 2 |
| 238 | -nf-κb | 1 |
| 239 | /nf-κb | 1 |
| 240 | /c-c | 1 |
| 241 | 2/c | 1 |
| 242 | -202a/c | 1 |
| 243 | coronary/cardiac | 1 |
| 244 | -tac | 4 |
| 245 | 82bc | 1 |
| 246 | =cgmcc | 1 |
| 247 | -dc | 1 |
| 248 | 5ec | 5 |
| 249 | β₃-pfc | 1 |
| 250 | -specific | 112 |
| 251 | p2-specific | 3 |
| 252 | laryngoscope-specific | 2 |
| 253 | .phase-specific | 1 |
| 254 | -iia/nptii-specific | 1 |
| 255 | trophoblast-specific | 1 |
| 256 | -stereospecific | 2 |
| 257 | immunospecific | 1 |
| 258 | and/orspecific | 1 |
| 259 | cognitive-behavioral/pharmacologic | 1 |
| 260 | attention-control/pharmacologic | 1 |
| 261 | stiffness-pathophysiologic | 1 |
| 262 | .hematologic | 1 |
| 263 | -adrenergic | 207 |
| 264 | -noradrenergic | 3 |
| 265 | -aderergic | 1 |
| 266 | echocardographic | 1 |
| 267 | colonographic | 1 |
| 268 | -cyclic | 2 |
| 269 | /cyclic | 4 |
| 270 | /heterocyclic | 1 |
| 271 | -hilic | 1 |
| 272 | -beta-d-glucopyranoside-oleanolic | 1 |
| 273 | postcystolic | 1 |
| 274 | -3,4:9,10-perylenetetra-carboxylic | 1 |
| 275 | -photodynamic | 2 |
| 276 | -thalassemic | 1 |
| 277 | .systemic | 3 |
| 278 | -mimic | 1 |
| 279 | haematodermic | 1 |
| 280 | /cryptogenic | 1 |
| 281 | dyspenic | 1 |
| 282 | -antihistaminic | 2 |
| 283 | -muscarinic | 1 |
| 284 | /ionic | 1 |
| 285 | /chronic | 3 |
| 286 | -2g-o-α-d-xylopyranosyl-2h-geranilan-8',10'-dioic | 1 |
| 287 | -4,5-dihydro-1h-pyrazole-1-carbothioic | 1 |
| 288 | -4-oxobut-2-enoic | 1 |
| 289 | /ectopic | 1 |
| 290 | /α-sarcomeric | 1 |
| 291 | .isocaloric | 1 |
| 292 | colometric | 1 |
| 293 | immunometric | 13 |
| 294 | immunumetric | 1 |
| 295 | non-nitric | 1 |
| 296 | viserosomatic | 1 |
| 297 | +metastatic | 1 |
| 298 | -diabetic | 6 |
| 299 | in-diethylenetriaminepentaacetic | 2 |
| 300 | -1,4,7,10-tetraazacyclododecane-1,4,7-triacetic | 1 |
| 301 | -sympathetic | 1 |
| 302 | onphotosynthetic | 1 |
| 303 | -mimetic | 2 |
| 304 | -sympathomimetic | 1 |
| 305 | hydromagnetic | 1 |
| 306 | pre-electrophoretic | 1 |
| 307 | .antibiotic | 1 |
| 308 | .anastomotic | 1 |
| 309 | -hypnotic | 1 |
| 310 | /pro-apoptotic | 1 |
| 311 | /aortic | 2 |
| 312 | /follicular/oxyphilic/anaplastic | 1 |
| 313 | /mechanistic | 1 |
| 314 | .therapeutic | 1 |
| 315 | .paralytic | 1 |
| 316 | /hemolytic | 1 |
| 317 | /normoxic | 1 |
| 318 | ep+lc | 1 |
| 319 | -mpc | 2 |
| 320 | aampc | 1 |
| 321 | /popc | 2 |
| 322 | 1ysa/ysarbrc | 1 |
| 323 | placebo+tc | 1 |
| 324 | sham+pdtc | 2 |
| 325 | -luc | 2 |
| 326 | -cprggsvc | 5 |
| 327 | /cxc | 1 |
| 328 | group/d | 1 |
| 329 | ne30d | 5 |
| 330 | k-k373d | 2 |
| 331 | -ad | 9 |
| 332 | head-head | 1 |
| 333 | -smad | 1 |
| 334 | /smad | 4 |
| 335 | -β1/smad | 1 |
| 336 | l-mtad | 1 |
| 337 | 3-adsorbed | 1 |
| 338 | /spliced | 1 |
| 339 | -enhanced | 23 |
| 340 | defence-enhanced | 1 |
| 341 | naïve/experienced | 1 |
| 342 | -β-glucanase-silenced | 2 |
| 343 | -reduced | 9 |
| 344 | /reduced | 2 |
| 345 | -induced | 1,277 |
| 346 | ee2-induced | 1 |
| 347 | +h2o2-induced | 1 |
| 348 | β1.3-induced | 2 |
| 349 | -tlr3-induced | 1 |
| 350 | /e7-induced | 1 |
| 351 | 8-induced | 1 |
| 352 | -17a-induced | 1 |
| 353 | -alpha-induced | 2 |
| 354 | -c-induced | 1 |
| 355 | /lipopolysaccharide-induced | 1 |
| 356 | dihydrochloride-induced | 2 |
| 357 | fe-particle-induced | 1 |
| 358 | amine-induced | 1 |
| 359 | -oxidative-induced | 1 |
| 360 | poisoning-induced | 1 |
| 361 | kinase-ii-induced | 1 |
| 362 | -shogaol-induced | 1 |
| 363 | p-induced | 10 |
| 364 | r-induced | 3 |
| 365 | ar-induced | 1 |
| 366 | nps-induced | 1 |
| 367 | -stress-induced | 1 |
| 368 | -diet-induced | 1 |
| 369 | -salt-induced | 3 |
| 370 | -agonist-induced | 2 |
| 371 | ₂d₃-induced | 4 |
| 372 | -rg₃-induced | 1 |
| 373 | -α-induced | 3 |
| 374 | -1β-induced | 1 |
| 375 | -γ-induced | 1 |
| 376 | ‑induced | 4 |
| 377 | ‑β‑induced | 1 |
| 378 | -loaded | 9 |
| 379 | /degraded | 1 |
| 380 | -added | 4 |
| 381 | -sided | 1 |
| 382 | -guided | 159 |
| 383 | -expanded | 3 |
| 384 | -recommended | 7 |
| 385 | /recommended | 1 |
| 386 | -intended | 1 |
| 387 | .extended | 1 |
| 388 | /extended | 1 |
| 389 | -funded | 18 |
| 390 | -encoded | 3 |
| 391 | -fed | 20 |
| 392 | -managed | 1 |
| 393 | -staged | 2 |
| 394 | -bridged | 4 |
| 395 | oxide-bridged | 1 |
| 396 | radical-bridged | 2 |
| 397 | -tagged | 9 |
| 398 | -exchanged | 1 |
| 399 | -challenged | 10 |
| 400 | csa-challenged | 1 |
| 401 | c-hed | 5 |
| 402 | -attached | 1 |
| 403 | -enriched | 48 |
| 404 | c-enriched | 6 |
| 405 | -matched | 15 |
| 406 | committee-established | 1 |
| 407 | -diminished | 2 |
| 408 | better-specified | 1 |
| 409 | -modified | 21 |
| 410 | /modified | 1 |
| 411 | -amplified | 2 |
| 412 | -verified | 1 |
| 413 | -vitrified | 1 |
| 414 | nonvitrified | 1 |
| 415 | -purified | 1 |
| 416 | -quantified | 1 |
| 417 | -gfp-identified | 1 |
| 418 | -certified | 2 |
| 419 | -fortified | 5 |
| 420 | -soaked | 2 |
| 421 | -linked | 27 |
| 422 | -atpase-linked | 1 |
| 423 | -evoked | 21 |
| 424 | /motor-evoked | 1 |
| 425 | receptor-evoked | 3 |
| 426 | -marked | 2 |
| 427 | -led | 6 |
| 428 | c-labaled | 1 |
| 429 | -healed | 1 |
| 430 | .inhaled | 2 |
| 431 | nanocube-assembled | 1 |
| 432 | -labeled | 46 |
| 433 | ga-labeled | 6 |
| 434 | c-labeled | 33 |
| 435 | tc-labeled | 18 |
| 436 | cysteine-labeled | 1 |
| 437 | methionine-labeled | 4 |
| 438 | -methionine-labeled | 1 |
| 439 | re-labeled | 2 |
| 440 | fe-core-labeled | 1 |
| 441 | se-labeled | 1 |
| 442 | f-labeled | 23 |
| 443 | f-fdg-labeled | 3 |
| 444 | h-labeled | 7 |
| 445 | i-labeled | 4 |
| 446 | cholesterol-labeled | 1 |
| 447 | -cholesterol-labeled | 1 |
| 448 | h-cholesterol-labeled | 1 |
| 449 | n-labeled | 7 |
| 450 | in-labeled | 11 |
| 451 | o-labeled | 3 |
| 452 | p-labeled | 4 |
| 453 | cr-labeled | 4 |
| 454 | s-labeled | 1 |
| 455 | phosphorus-labeled | 1 |
| 456 | cu-labeled | 2 |
| 457 | lu-labeled | 4 |
| 458 | y-labeled | 2 |
| 459 | tc-radiolabeled | 2 |
| 460 | f-radiolabeled | 1 |
| 461 | i-radiolabeled | 1 |
| 462 | -tailed | 4 |
| 463 | -filed | 1 |
| 464 | /multi-walled | 2 |
| 465 | -labelled | 8 |
| 466 | tc-labelled | 6 |
| 467 | f-labelled | 2 |
| 468 | h-labelled | 1 |
| 469 | i-labelled | 3 |
| 470 | cholesterol-labelled | 2 |
| 471 | h-cholesterol-labelled | 1 |
| 472 | tc-hmpao-labelled | 3 |
| 473 | -propelled | 5 |
| 474 | -filled | 2 |
| 475 | -killed | 2 |
| 476 | -controlled | 51 |
| 477 | non–placebo-controlled | 1 |
| 478 | -cooled | 1 |
| 479 | .pooled | 4 |
| 480 | -coupled | 10 |
| 481 | -decoupled | 1 |
| 482 | -primed | 2 |
| 483 | corticosteroid-primed | 1 |
| 484 | prolamin-primed | 1 |
| 485 | plaiv-primed | 1 |
| 486 | -programmed | 2 |
| 487 | -confirmed | 12 |
| 488 | .confirmed | 1 |
| 489 | /unconfirmed | 1 |
| 490 | -transformed | 10 |
| 491 | -sweetened | 1 |
| 492 | -retained | 1 |
| 493 | -contained | 1 |
| 494 | -stained | 5 |
| 495 | -combined | 3 |
| 496 | -defined | 28 |
| 497 | mab-defined | 1 |
| 498 | -mb-defined | 1 |
| 499 | -determined | 8 |
| 500 | -lesioned | 1 |
| 501 | -conditioned | 1 |
| 502 | -poisoned | 1 |
| 503 | -doped | 71 |
| 504 | -co-doped | 1 |
| 505 | tridoped | 1 |
| 506 | -codoped | 14 |
| 507 | -capped | 2 |
| 508 | -entrapped | 1 |
| 509 | non-sugared | 1 |
| 510 | -rendered | 1 |
| 511 | -engineered | 1 |
| 512 | -steered | 3 |
| 513 | ≤2.4-steered | 1 |
| 514 | h-steered | 1 |
| 515 | -triggered | 20 |
| 516 | -filtered | 3 |
| 517 | -centered | 2 |
| 518 | -registered | 1 |
| 519 | -administered | 6 |
| 520 | -delivered | 7 |
| 521 | -covered | 4 |
| 522 | heat-powered | 1 |
| 523 | unfired | 1 |
| 524 | -sired | 1 |
| 525 | -acquired | 11 |
| 526 | /acquired | 11 |
| 527 | -anchored | 4 |
| 528 | psychophysically-anchored | 2 |
| 529 | -sponsored | 12 |
| 530 | -vectored | 1 |
| 531 | -monitored | 2 |
| 532 | -stored | 2 |
| 533 | -centred | 1 |
| 534 | -configured | 1 |
| 535 | -injured | 6 |
| 536 | 1-favoured | 1 |
| 537 | -measured | 7 |
| 538 | -based | 697 |
| 539 | p3-based | 1 |
| 540 | -alfa-based | 1 |
| 541 | ga-based | 1 |
| 542 | mitochondria-based | 1 |
| 543 | patients.analgesia-based | 1 |
| 544 | fama-based | 1 |
| 545 | phage-based | 1 |
| 546 | center-based/home-based | 1 |
| 547 | fullerene-based | 1 |
| 548 | weighing-based | 1 |
| 549 | -phytantriol-based | 1 |
| 550 | scan-based | 1 |
| 551 | no-based | 3 |
| 552 | mems-based | 1 |
| 553 | /baculovirus-based | 1 |
| 554 | nws-based | 1 |
| 555 | iv-based | 2 |
| 556 | -α-based | 2 |
| 557 | 2-biased | 1 |
| 558 | -functionalised | 1 |
| 559 | -mobilised | 1 |
| 560 | -agonist-randomised | 1 |
| 561 | /micronised | 1 |
| 562 | hyperpolarised | 4 |
| 563 | -sensitised | 3 |
| 564 | -pulsed | 2 |
| 565 | -licensed | 1 |
| 566 | -condensed | 1 |
| 567 | -diagnosed | 2 |
| 568 | -composed | 1 |
| 569 | -exposed | 30 |
| 570 | p-exposed | 1 |
| 571 | -processed | 3 |
| 572 | /processed | 1 |
| 573 | -suppressed | 1 |
| 574 | -stressed | 1 |
| 575 | -assessed | 9 |
| 576 | unassessed | 3 |
| 577 | -caused | 2 |
| 578 | inclused | 1 |
| 579 | -catalysed | 7 |
| 580 | -medicated | 3 |
| 581 | -modificated | 1 |
| 582 | -replicated | 1 |
| 583 | -intoxicated | 2 |
| 584 | -truncated | 2 |
| 585 | -created | 1 |
| 586 | -treated | 244 |
| 587 | -phor21-treated | 2 |
| 588 | bms-936557-treated | 1 |
| 589 | amx/ca-treated | 2 |
| 590 | nivolumab-treated | 1 |
| 591 | 3tc-treated | 2 |
| 592 | pdtc-treated | 2 |
| 593 | ftc-treated | 2 |
| 594 | blockade-treated | 1 |
| 595 | ceftriaxone/cefuroxime-treated | 1 |
| 596 | triethoxysilane-treated | 2 |
| 597 | cicletanine-treated | 1 |
| 598 | -nootkatone-treated | 1 |
| 599 | pegloticase-treated | 1 |
| 600 | laxative-treated | 1 |
| 601 | efv/ftc/tdf-treated | 1 |
| 602 | rpv/ftc/tdf-treated | 1 |
| 603 | cl-treated | 1 |
| 604 | ampicillin/sulbactam-treated | 1 |
| 605 | balugrastim-treated | 1 |
| 606 | -arm-treated | 1 |
| 607 | gemifloxacin-treated | 1 |
| 608 | spiramycin-treated | 1 |
| 609 | daptomycin-treated | 1 |
| 610 | prostaglandin-treated | 1 |
| 611 | -temospho-treated | 1 |
| 612 | tso-treated | 1 |
| 613 | comp-treated | 1 |
| 614 | dinp-treated | 3 |
| 615 | oasis-treated | 1 |
| 616 | y-it-treated | 1 |
| 617 | pt-treated | 1 |
| 618 | regranex-treated | 1 |
| 619 | ₂d₃-treated | 1 |
| 620 | -pretreated | 7 |
| 621 | plasma-pretreated | 1 |
| 622 | -glucan-pretreated | 1 |
| 623 | -gated | 19 |
| 624 | -ligated | 1 |
| 625 | methane-ligated | 1 |
| 626 | -conjugated | 12 |
| 627 | 11-conjugated | 1 |
| 628 | zr-conjugated | 2 |
| 629 | -associated | 180 |
| 630 | -1-associated | 2 |
| 631 | -b27-associated | 1 |
| 632 | -receptor-associated | 1 |
| 633 | -irradiated | 2 |
| 634 | -mediated | 295 |
| 635 | -1-mediated | 2 |
| 636 | 2-mediated | 11 |
| 637 | 1.2-mediated | 1 |
| 638 | /i2-mediated | 1 |
| 639 | -3-mediated | 1 |
| 640 | 3a-mediated | 1 |
| 641 | algae-mediated | 1 |
| 642 | -one-mediated | 1 |
| 643 | -signalling-mediated | 1 |
| 644 | -salicin-mediated | 1 |
| 645 | o-mediated | 1 |
| 646 | r-mediated | 8 |
| 647 | -adrenoceptor-mediated | 1 |
| 648 | p₂-mediated | 1 |
| 649 | β₃-mediated | 1 |
| 650 | -α-mediated | 4 |
| 651 | -gβγ-mediated | 1 |
| 652 | -initiated | 7 |
| 653 | -differentiated | 2 |
| 654 | -chelated | 2 |
| 655 | -related | 240 |
| 656 | /ste20/sps1-related | 1 |
| 657 | 1/2-related | 1 |
| 658 | p2-related | 1 |
| 659 | .asthma-related | 2 |
| 660 | narcotic-related | 1 |
| 661 | toxic-related | 1 |
| 662 | .suicide-related | 2 |
| 663 | polymerase-related | 1 |
| 664 | catechin-related | 2 |
| 665 | /cdc42/actin-related | 1 |
| 666 | nasicon-related | 1 |
| 667 | r-related | 1 |
| 668 | /hs-related | 1 |
| 669 | -calculated | 4 |
| 670 | -inoculated | 1 |
| 671 | -modulated | 3 |
| 672 | -regulated | 19 |
| 673 | /signal-regulated | 1 |
| 674 | /calmodulin-regulated | 1 |
| 675 | -up-regulated | 1 |
| 676 | -stimulated | 133 |
| 677 | arachidonate-stimulated | 1 |
| 678 | hklm-stimulated | 1 |
| 679 | o-stimulated | 2 |
| 680 | -α-stimulated | 1 |
| 681 | ‑stimulated | 3 |
| 682 | -encapsulated | 3 |
| 683 | chitosan-encapsulated | 1 |
| 684 | -superovulated | 1 |
| 685 | -dimethylated | 1 |
| 686 | -fluoroalkylated | 1 |
| 687 | c3-arylated | 1 |
| 688 | -phosphorylated | 2 |
| 689 | -impregnated | 3 |
| 690 | -vaccinated | 3 |
| 691 | -cmx-vaccinated | 1 |
| 692 | -coordinated | 6 |
| 693 | dyscoordinated | 1 |
| 694 | /citrullinated | 1 |
| 695 | -contaminated | 10 |
| 696 | -dominated | 1 |
| 697 | snar-terminated | 1 |
| 698 | -coated | 23 |
| 699 | /ag-coated | 2 |
| 700 | -receptor-coated | 1 |
| 701 | -rated | 2 |
| 702 | -separated | 2 |
| 703 | -hydrated | 1 |
| 704 | -generated | 4 |
| 705 | translocation-generated | 1 |
| 706 | -decorated | 2 |
| 707 | -incorporated | 2 |
| 708 | -saturated | 12 |
| 709 | -facilitated | 2 |
| 710 | -mutated | 12 |
| 711 | -attenuated | 3 |
| 712 | -elevated | 2 |
| 713 | -activated | 93 |
| 714 | /lymphokine-activated | 2 |
| 715 | /mitogen-activated | 4 |
| 716 | /akt/mitogen-activated | 1 |
| 717 | -α-activated | 1 |
| 718 | /mitogen‑activated | 1 |
| 719 | study-contacted | 1 |
| 720 | -affected | 2 |
| 721 | -infected | 140 |
| 722 | -1-infected | 2 |
| 723 | sf33-infected | 1 |
| 724 | vif-infected | 1 |
| 725 | -coinfected | 1 |
| 726 | /hsv-2-coinfected | 1 |
| 727 | -monoinfected | 1 |
| 728 | -transfected | 3 |
| 729 | ar-transfected | 1 |
| 730 | -injected | 10 |
| 731 | -unselected | 2 |
| 732 | -connected | 20 |
| 733 | -directed | 8 |
| 734 | -corrected | 9 |
| 735 | genotype-corrected | 1 |
| 736 | -detected | 7 |
| 737 | -protected | 1 |
| 738 | -restricted | 5 |
| 739 | 0201-restricted | 1 |
| 740 | -targeted | 40 |
| 741 | 1.3-targeted | 1 |
| 742 | genetically-targeted | 1 |
| 743 | -deleted | 3 |
| 744 | -depleted | 7 |
| 745 | ‑depleted | 1 |
| 746 | -grafted | 2 |
| 747 | -weighted | 29 |
| 748 | *-weighted | 2 |
| 749 | -inhibited | 4 |
| 750 | -elicited | 5 |
| 751 | -accredited | 3 |
| 752 | .limited | 3 |
| 753 | -adjuvanted | 54 |
| 754 | -oriented | 6 |
| 755 | -supplemented | 14 |
| 756 | -augmented | 9 |
| 757 | -documented | 3 |
| 758 | -stented | 1 |
| 759 | -printed | 1 |
| 760 | -imprinted | 4 |
| 761 | -promoted | 8 |
| 762 | domain-inverted | 1 |
| 763 | .reported | 1 |
| 764 | -supported | 4 |
| 765 | -digested | 1 |
| 766 | placebo-tested | 1 |
| 767 | -assisted | 26 |
| 768 | -boosted | 7 |
| 769 | mother-allotted | 1 |
| 770 | -substituted | 14 |
| 771 | -1,4-dihydro-2,6-dimethyl-1-substituted | 1 |
| 772 | -3-substituted | 1 |
| 773 | -4-substituted | 1 |
| 774 | co-substituted | 1 |
| 775 | -cluster-substituted | 1 |
| 776 | -received | 1 |
| 777 | -derived | 101 |
| 778 | ap3b1-derived | 1 |
| 779 | -2-derived | 1 |
| 780 | h-derived | 1 |
| 781 | tc-ubiquicidin-derived | 1 |
| 782 | -involved | 2 |
| 783 | -approved | 42 |
| 784 | -starved | 2 |
| 785 | -preserved | 8 |
| 786 | -indexed | 3 |
| 787 | -complexed | 3 |
| 788 | 3-complexed | 1 |
| 789 | -eyed | 1 |
| 790 | -standardized | 2 |
| 791 | -localized | 3 |
| 792 | -colocalized | 2 |
| 793 | -normalized | 2 |
| 794 | -functionalized | 4 |
| 795 | -hospitalized | 2 |
| 796 | double-cyclized | 1 |
| 797 | -mobilized | 5 |
| 798 | -immobilized | 2 |
| 799 | -solubilized | 1 |
| 800 | -immunized | 4 |
| 801 | -polarized | 2 |
| 802 | 17-polarized | 1 |
| 803 | -sensitized | 18 |
| 804 | -adrenoceptor-desensitized | 1 |
| 805 | -catalyzed | 87 |
| 806 | 2-catalyzed | 2 |
| 807 | /pcy3-catalyzed | 1 |
| 808 | 4-catalyzed | 4 |
| 809 | bromide-catalyzed | 2 |
| 810 | cobalamin-catalyzed | 1 |
| 811 | p-catalyzed | 2 |
| 812 | -acid | 3 |
| 813 | -solid | 1 |
| 814 | -heremans-schmid | 1 |
| 815 | -propofol-opioid | 1 |
| 816 | 4-myeloid | 1 |
| 817 | papilionoid | 1 |
| 818 | sterols/steroid | 1 |
| 819 | /corticosteroid | 2 |
| 820 | embryonal/botryoid | 1 |
| 821 | /lipid | 2 |
| 822 | -child | 1 |
| 823 | .mild | 2 |
| 824 | -gold | 1 |
| 825 | -and | 43 |
| 826 | aand | 1 |
| 827 | nitrogen-ligand | 1 |
| 828 | -strand | 11 |
| 829 | -single-strand | 1 |
| 830 | oa+attend | 1 |
| 831 | massextend | 1 |
| 832 | -bound | 13 |
| 833 | -phosphine-bound | 1 |
| 834 | rr-bound | 1 |
| 835 | /δblood | 1 |
| 836 | β₃-dxtl-pd | 5 |
| 837 | ak/pd | 1 |
| 838 | tc-dpd | 11 |
| 839 | -copd | 1 |
| 840 | harbourd | 1 |
| 841 | /std | 2 |
| 842 | -bzd | 1 |
| 843 | -3-1e | 2 |
| 844 | +hae | 1 |
| 845 | hhp+hae | 1 |
| 846 | non-hhp+hae | 1 |
| 847 | hhp+non-hae | 1 |
| 848 | davydovae | 1 |
| 849 | risk.ezetimibe | 1 |
| 850 | travelling-wave-tube | 1 |
| 851 | -fluorescence | 1 |
| 852 | -seroprevalence | 1 |
| 853 | j-difference | 1 |
| 854 | /absence | 1 |
| 855 | -induce | 1 |
| 856 | -made | 1 |
| 857 | .custom-made | 1 |
| 858 | -grade | 2 |
| 859 | tri-carbide | 1 |
| 860 | -enolide | 1 |
| 861 | benzylamide | 1 |
| 862 | -nicotinamide | 3 |
| 863 | /nicotinamide | 1 |
| 864 | di-imide | 1 |
| 865 | -n'-ethylcarbodiimide | 1 |
| 866 | -1-ethylcarbodiimide | 1 |
| 867 | -n-ethylcarbodiimide | 1 |
| 868 | -3,5-di-phenytetrazoliumromide | 3 |
| 869 | methanide | 2 |
| 870 | anilinide | 1 |
| 871 | .ciclesonide | 1 |
| 872 | trihydride | 1 |
| 873 | -ginsenoside | 1 |
| 874 | tc-hynic-octreotide | 1 |
| 875 | -oxide | 6 |
| 876 | -hydroxide | 8 |
| 877 | -oxyhydroxide | 2 |
| 878 | fe-oxyhydroxide | 1 |
| 879 | -diode | 3 |
| 880 | -photodiode | 1 |
| 881 | /photodiode | 1 |
| 882 | -2-furancarboxaldehyde | 2 |
| 883 | -free | 62 |
| 884 | el-free | 2 |
| 885 | m-free | 7 |
| 886 | /free | 4 |
| 887 | reactor-three | 1 |
| 888 | .three | 20 |
| 889 | .average | 2 |
| 890 | -storage | 1 |
| 891 | c-percentage | 2 |
| 892 | -stage | 3 |
| 893 | -the | 29 |
| 894 | reviews-the | 1 |
| 895 | .the | 411 |
| 896 | moribund.the | 1 |
| 897 | precursor.the | 1 |
| 898 | easibreathe | 1 |
| 899 | lithe | 1 |
| 900 | -agonistthe | 1 |
| 901 | test—the | 1 |
| 902 | units·the | 1 |
| 903 | /low-calorie | 1 |
| 904 | -like | 151 |
| 905 | 612-like | 1 |
| 906 | mpv17-like | 1 |
| 907 | mnc-like | 1 |
| 908 | /lectin-like | 1 |
| 909 | cagelike | 2 |
| 910 | -female | 1 |
| 911 | /absorbable | 1 |
| 912 | -traceable | 1 |
| 913 | -comparable | 2 |
| 914 | pourable | 1 |
| 915 | -undetectable | 1 |
| 916 | -inhibitable | 1 |
| 917 | .unstable | 1 |
| 918 | -inducible | 7 |
| 919 | -eligible | 3 |
| 920 | acas-ineligible | 2 |
| 921 | -suppressible | 1 |
| 922 | -compatible | 1 |
| 923 | -susceptible | 7 |
| 924 | -soluble | 4 |
| 925 | /soluble | 1 |
| 926 | knee-muscle | 1 |
| 927 | /muscle | 1 |
| 928 | compatibility-single | 1 |
| 929 | .single | 3 |
| 930 | propane-dinitrile | 1 |
| 931 | -quinoxaline-2-carbonitrile | 1 |
| 932 | furoxan-3-carbonitrile | 1 |
| 933 | bisbenzimidazole | 2 |
| 934 | f-fluoromisonidazole | 3 |
| 935 | -one-1,3,4-oxadiazole | 1 |
| 936 | -1h-1,2,4-triazole | 1 |
| 937 | nonazole | 1 |
| 938 | 3,4-dimethylpyrazole | 1 |
| 939 | -5-hydroxypyrazole | 3 |
| 940 | -3-phenylisoxazole | 1 |
| 941 | 5-aminoisoxazole | 1 |
| 942 | -tubule | 2 |
| 943 | -style | 3 |
| 944 | “some | 1 |
| 945 | cytome | 7 |
| 946 | re-rume | 1 |
| 947 | -pyridino-phane | 1 |
| 948 | -octane | 1 |
| 949 | /thromboxane | 1 |
| 950 | aminomethyl-1,4-benzodioxane | 1 |
| 951 | /siloxane | 1 |
| 952 | organosiloxane | 1 |
| 953 | -fluoren-9-ylidene | 1 |
| 954 | -chlorhexidene | 1 |
| 955 | 92-gene | 1 |
| 956 | andpparαgene | 1 |
| 957 | -graphene | 4 |
| 958 | -thiophene | 2 |
| 959 | -cycloocta-1,3-diene | 1 |
| 960 | -alkene | 4 |
| 961 | -2,3-oxidosqualene | 2 |
| 962 | tetrathiafulvalene | 2 |
| 963 | -polyethylene | 3 |
| 964 | -propylene | 2 |
| 965 | -polypropylene | 2 |
| 966 | -polystylene | 1 |
| 967 | -carene | 1 |
| 968 | /methoprene | 1 |
| 969 | -mepivacaine | 1 |
| 970 | cadmium+betaine | 1 |
| 971 | -cine | 1 |
| 972 | dioxocine | 1 |
| 973 | -3,4-dihydropyrimidine | 1 |
| 974 | /acridine | 1 |
| 975 | carbamoyl-4-aryl-1,4-dihydropyridine | 1 |
| 976 | /dihydropyridine | 1 |
| 977 | -quinolizidine | 2 |
| 978 | -3-hydroxy-4-oxoquinaldine | 1 |
| 979 | tolterodine.fesoterodine | 1 |
| 980 | -machine | 1 |
| 981 | trimethine | 4 |
| 982 | /chemokine | 1 |
| 983 | -line | 3 |
| 984 | third-/fourth-line | 1 |
| 985 | -hydrosaline | 1 |
| 986 | /baseline | 1 |
| 987 | -dianiline | 1 |
| 988 | /methacholine | 1 |
| 989 | chloride-phenanthroline | 1 |
| 990 | /exproline | 1 |
| 991 | -oxadiazoline | 1 |
| 992 | 3-diethylenetriamine | 1 |
| 993 | -alcohol-diethylamine | 1 |
| 994 | .dopamine | 2 |
| 995 | -2,5-dimethoxy-4-iodoamphetamine | 1 |
| 996 | -histamine | 4 |
| 997 | -5-methyl-10,11-dihydro-5h-debenzocyclhepten-5,10-imine | 1 |
| 998 | .twenty-nine | 1 |
| 999 | .nine | 4 |
| 1000 | -nitro-l-arginine | 67 |
| 1001 | -l-nitro-arginine | 2 |
| 1002 | -nitroarginine | 7 |
| 1003 | /serine-threonine | 2 |
| 1004 | c-methionine | 1 |
| 1005 | -benzodiazepine | 10 |
| 1006 | /benzodiazepine | 2 |
| 1007 | at-anti-murine | 1 |
| 1008 | -3'-thioguanosine | 1 |
| 1009 | /adenosine | 3 |
| 1010 | /nitrotyrosine | 1 |
| 1011 | /bovine | 2 |
| 1012 | -corynoxine | 2 |
| 1013 | -1,2,4-benzotriazine | 1 |
| 1014 | hexanylpiperazine | 1 |
| 1015 | subporphyrazine | 1 |
| 1016 | .cetirizine | 1 |
| 1017 | +one | 1 |
| 1018 | -2,3-dihydro-1h-indol-2-one | 1 |
| 1019 | .twenty-one | 1 |
| 1020 | .thirty-one | 2 |
| 1021 | .one | 57 |
| 1022 | -1,3,4-oxazepine-4,7-dione | 1 |
| 1023 | i-alone | 1 |
| 1024 | -quinolone | 1 |
| 1025 | -5,7,5'-trihydroxyflavanone | 1 |
| 1026 | -pyridazinone | 1 |
| 1027 | /cochaperone | 1 |
| 1028 | -progesterone | 1 |
| 1029 | /progesterone | 2 |
| 1030 | +/progesterone | 1 |
| 1031 | -/progesterone | 1 |
| 1032 | .dexamethasone | 1 |
| 1033 | /prednisone | 1 |
| 1034 | /sir/prednisone | 1 |
| 1035 | /acetone | 1 |
| 1036 | aryl-monothio-1,3-diketone | 1 |
| 1037 | /histone | 1 |
| 1038 | -alkylidyne | 1 |
| 1039 | o-isotope | 1 |
| 1040 | -type | 74 |
| 1041 | 1/th2/th17-type | 1 |
| 1042 | bi-type | 1 |
| 1043 | -protopanaxadiol-type | 4 |
| 1044 | -protopanaxatriol-type | 1 |
| 1045 | markovnikov-type | 1 |
| 1046 | -nrf2/are | 1 |
| 1047 | nanofibre | 1 |
| 1048 | northern-hemisphere | 1 |
| 1049 | /core | 1 |
| 1050 | -more | 1 |
| 1051 | better/more | 1 |
| 1052 | -hhtre | 1 |
| 1053 | perovskite-structure | 1 |
| 1054 | carrière | 1 |
| 1055 | -release | 8 |
| 1056 | cr-release | 6 |
| 1057 | /p38/mitf/tyrosinase | 1 |
| 1058 | -ppase | 1 |
| 1059 | -luciferase | 3 |
| 1060 | trimethyltransferase | 1 |
| 1061 | -glucanosyltransferase | 1 |
| 1062 | phosphoesterase | 2 |
| 1063 | -desaturase | 6 |
| 1064 | /obese | 2 |
| 1065 | .these | 15 |
| 1066 | /japanese | 1 |
| 1067 | t2w-ssfse | 1 |
| 1068 | /less-dense | 1 |
| 1069 | -ribose | 3 |
| 1070 | /glucose | 1 |
| 1071 | benzodiazepine-dose | 1 |
| 1072 | /low-dose | 1 |
| 1073 | /anhydroxylose | 1 |
| 1074 | .adverse | 15 |
| 1075 | -to-mouse | 1 |
| 1076 | -phosphate | 10 |
| 1077 | chlorophosphate | 1 |
| 1078 | literacy-appropriate | 1 |
| 1079 | -thiolate | 1 |
| 1080 | -1,2,3,4-tetrazolate | 1 |
| 1081 | hypomethylate | 1 |
| 1082 | norbornane-2-carboxylate | 1 |
| 1083 | tc-ethylcysteinate | 1 |
| 1084 | cell-alginate | 1 |
| 1085 | hexachloridostannate | 1 |
| 1086 | -heteroscorpionate | 1 |
| 1087 | -mevalonate | 11 |
| 1088 | c-octanoate | 1 |
| 1089 | aminobenzoate | 1 |
| 1090 | -camphorate | 2 |
| 1091 | c-acetate | 20 |
| 1092 | -replete | 4 |
| 1093 | drug/metabolite | 2 |
| 1094 | posivite | 1 |
| 1095 | /acute | 7 |
| 1096 | -electrolyte | 3 |
| 1097 | -secretagogue | 1 |
| 1098 | -naive | 31 |
| 1099 | ide-naive | 2 |
| 1100 | .fifty-five | 1 |
| 1101 | .twenty-five | 1 |
| 1102 | .five | 12 |
| 1103 | software.five | 1 |
| 1104 | -olive | 3 |
| 1105 | all-invasive | 1 |
| 1106 | /pervasive | 1 |
| 1107 | /hyperactive-impulsive | 1 |
| 1108 | .intensive | 1 |
| 1109 | -hypertensive | 2 |
| 1110 | distal/extensive | 1 |
| 1111 | -responsive | 10 |
| 1112 | /non-erosive | 1 |
| 1113 | /progressive | 1 |
| 1114 | -suppressive | 5 |
| 1115 | /oxidative | 1 |
| 1116 | -negative | 211 |
| 1117 | -positive/her2-negative | 1 |
| 1118 | toma6-negative | 1 |
| 1119 | rvi-negative | 1 |
| 1120 | colposcopically-negative | 1 |
| 1121 | hbeag-seronegative | 1 |
| 1122 | inperi-operative | 1 |
| 1123 | .operative | 1 |
| 1124 | .perioperative | 1 |
| 1125 | .postoperative | 2 |
| 1126 | -active | 4 |
| 1127 | hypo-active | 1 |
| 1128 | -reactive | 10 |
| 1129 | -c-reactive | 5 |
| 1130 | /c-reactive | 2 |
| 1131 | normal/reactive | 1 |
| 1132 | -immunoreactive | 3 |
| 1133 | -selective | 40 |
| 1134 | -ii-selective | 1 |
| 1135 | -adrenoceptor-selective | 2 |
| 1136 | /reflective | 1 |
| 1137 | -protective | 2 |
| 1138 | .cognitive | 3 |
| 1139 | /cognitive | 1 |
| 1140 | -sensitive | 54 |
| 1141 | periodate-sensitive | 1 |
| 1142 | -independent/dids-sensitive | 1 |
| 1143 | -positive | 354 |
| 1144 | -2-positive | 2 |
| 1145 | p2-positive | 1 |
| 1146 | -6-positive | 1 |
| 1147 | /p16-positive | 1 |
| 1148 | -glucanase-positive | 1 |
| 1149 | g-positive | 1 |
| 1150 | -tetramer-positive | 1 |
| 1151 | k-ras-positive | 1 |
| 1152 | colposcopy-positive | 1 |
| 1153 | α-positive | 1 |
| 1154 | -seropositive | 8 |
| 1155 | high-repetitive | 1 |
| 1156 | -competitive | 1 |
| 1157 | in101consecutive | 1 |
| 1158 | -constitutive | 1 |
| 1159 | /valve | 1 |
| 1160 | -naïve | 11 |
| 1161 | ranibizumab-naïve | 1 |
| 1162 | ide-naïve | 5 |
| 1163 | -blocker-naïve | 2 |
| 1164 | antituberulosis-naïve | 1 |
| 1165 | .we | 88 |
| 1166 | software.we | 1 |
| 1167 | questionnaire.we | 1 |
| 1168 | .electronicwe | 1 |
| 1169 | +exe | 1 |
| 1170 | -eye | 1 |
| 1171 | /naf | 4 |
| 1172 | /c/f/taf | 1 |
| 1173 | -adf | 2 |
| 1174 | -tdf | 1 |
| 1175 | /tdf | 5 |
| 1176 | -vegf | 2 |
| 1177 | /vegf | 1 |
| 1178 | /fgf | 1 |
| 1179 | /hf | 1 |
| 1180 | /p38/mitf | 1 |
| 1181 | vre/g | 2 |
| 1182 | nmoles/g | 2 |
| 1183 | π0g | 3 |
| 1184 | -n111g | 1 |
| 1185 | t309g | 1 |
| 1186 | -hurag | 1 |
| 1187 | 0.05/kg | 1 |
| 1188 | 3.57ml/kg | 1 |
| 1189 | 141+/-12fmol/mg | 1 |
| 1190 | -yang | 2 |
| 1191 | -absorbing | 2 |
| 1192 | -enhancing | 8 |
| 1193 | -reducing | 19 |
| 1194 | turbidity-reducing | 1 |
| 1195 | -inducing | 5 |
| 1196 | -producing | 115 |
| 1197 | -22-producing | 1 |
| 1198 | -gamma-producing | 1 |
| 1199 | ib-producing | 1 |
| 1200 | s-producing | 2 |
| 1201 | -loading | 4 |
| 1202 | -degrading | 5 |
| 1203 | p3-degrading | 1 |
| 1204 | intercladding | 1 |
| 1205 | -binding | 75 |
| 1206 | k-a-binding | 1 |
| 1207 | -dna-binding | 2 |
| 1208 | -citalopram-binding | 1 |
| 1209 | p-binding | 7 |
| 1210 | silane+bonding | 1 |
| 1211 | acetone+bonding | 1 |
| 1212 | -responding | 1 |
| 1213 | -coding | 1 |
| 1214 | -encoding | 6 |
| 1215 | repressor-encoding | 1 |
| 1216 | .regarding | 1 |
| 1217 | perfusion-imaging | 1 |
| 1218 | -bridging | 2 |
| 1219 | -scavenging | 11 |
| 1220 | descrbiing | 1 |
| 1221 | -qinglishengjing | 1 |
| 1222 | -speaking | 1 |
| 1223 | -locking | 1 |
| 1224 | -blocking | 10 |
| 1225 | 1.7-blocking | 1 |
| 1226 | adrenoceptor-blocking | 1 |
| 1227 | -drinking | 1 |
| 1228 | -scaling | 1 |
| 1229 | -handling | 14 |
| 1230 | c-labeling | 4 |
| 1231 | n-labeling | 3 |
| 1232 | o-labeling | 1 |
| 1233 | prelabeling | 1 |
| 1234 | p-postlabeling | 3 |
| 1235 | -failing | 1 |
| 1236 | -signalling | 2 |
| 1237 | .community-dwelling | 1 |
| 1238 | plaque-forming | 33 |
| 1239 | o-forming | 1 |
| 1240 | colony-forming | 399 |
| 1241 | colonyforming | 1 |
| 1242 | -containing | 143 |
| 1243 | b-48-containing | 1 |
| 1244 | non-platinum-containing | 1 |
| 1245 | -domain-containing | 1 |
| 1246 | efflux-containing | 1 |
| 1247 | -sustaining | 1 |
| 1248 | -defining | 3 |
| 1249 | /learning | 1 |
| 1250 | -pumping | 3 |
| 1251 | -typing | 2 |
| 1252 | outer-ring | 1 |
| 1253 | cycloaddition/ring | 1 |
| 1254 | -bearing | 8 |
| 1255 | -clearing | 1 |
| 1256 | .comparing | 6 |
| 1257 | -sparing | 9 |
| 1258 | rti-sparing | 1 |
| 1259 | -lowering | 123 |
| 1260 | –lowering | 1 |
| 1261 | -harboring | 1 |
| 1262 | -receptor-preferring | 2 |
| 1263 | drug-manufacturing | 1 |
| 1264 | -releasing | 17 |
| 1265 | 2.increasing | 1 |
| 1266 | -raising | 3 |
| 1267 | -sensing | 1 |
| 1268 | -dosing | 1 |
| 1269 | injection-dosing | 1 |
| 1270 | -expressing | 29 |
| 1271 | cr1-expressing | 1 |
| 1272 | /mdr1-expressing | 1 |
| 1273 | 65-expressing | 1 |
| 1274 | beta5-expressing | 1 |
| 1275 | 1.8-expressing | 1 |
| 1276 | ar-expressing | 1 |
| 1277 | β₃-expressing | 1 |
| 1278 | -1β-expressing | 1 |
| 1279 | -overexpressing | 5 |
| 1280 | -2-overexpressing | 1 |
| 1281 | r-overexpressing | 2 |
| 1282 | ‑expressing | 1 |
| 1283 | -causing | 1 |
| 1284 | lysis-causing | 1 |
| 1285 | co-heating | 2 |
| 1286 | self-aggregating | 1 |
| 1287 | -mediating | 1 |
| 1288 | .initiating | 1 |
| 1289 | -chelating | 2 |
| 1290 | -accumulating | 4 |
| 1291 | reducing/eliminating | 2 |
| 1292 | fiber-coating | 1 |
| 1293 | -generating | 4 |
| 1294 | -elevating | 3 |
| 1295 | -activating | 8 |
| 1296 | /long-acting | 4 |
| 1297 | -interacting | 5 |
| 1298 | -receptor-interacting | 1 |
| 1299 | -detecting | 1 |
| 1300 | -conducting | 2 |
| 1301 | postmeeting | 1 |
| 1302 | -targeting | 3 |
| 1303 | 3.2-targeting | 1 |
| 1304 | store-depleting | 1 |
| 1305 | -secreting | 4 |
| 1306 | il-17-secreting | 1 |
| 1307 | -γ-secreting | 1 |
| 1308 | -inhibiting | 11 |
| 1309 | /dose-limiting | 1 |
| 1310 | macro-fingerprinting | 1 |
| 1311 | 1-promoting | 1 |
| 1312 | -transporting | 2 |
| 1313 | ×fasting | 1 |
| 1314 | -receiving | 1 |
| 1315 | -growing | 1 |
| 1316 | -modifying | 2 |
| 1317 | -1α-modifying | 1 |
| 1318 | -detoxifying | 2 |
| 1319 | self-drying | 1 |
| 1320 | gene-carrying | 1 |
| 1321 | -mobilizing | 4 |
| 1322 | -utilizing | 1 |
| 1323 | -metabolizing | 2 |
| 1324 | p2-metabolizing | 1 |
| 1325 | -sensitizing | 3 |
| 1326 | -among | 2 |
| 1327 | mol/microg | 1 |
| 1328 | .tg | 1 |
| 1329 | =ccug | 2 |
| 1330 | 3.75mug | 1 |
| 1331 | /drug | 1 |
| 1332 | -h/n-h | 1 |
| 1333 | -h/s-h | 1 |
| 1334 | -2,5-diphenyl-2h | 2 |
| 1335 | n3h | 1 |
| 1336 | -rich | 58 |
| 1337 | -heatsynch | 1 |
| 1338 | -patch | 2 |
| 1339 | -watch | 1 |
| 1340 | /nadh | 2 |
| 1341 | -gapdh | 7 |
| 1342 | /high | 13 |
| 1343 | -ph | 1 |
| 1344 | /machado-joseph | 1 |
| 1345 | bnnt-sh | 2 |
| 1346 | dinucleotide-length | 1 |
| 1347 | –with | 1 |
| 1348 | .both | 7 |
| 1349 | €12.50-worth | 1 |
| 1350 | .non-bismuth | 1 |
| 1351 | -mouth | 3 |
| 1352 | h | 7 |
| 1353 | i-higf-i | 4 |
| 1354 | -sestamibi | 1 |
| 1355 | -golgi | 1 |
| 1356 | /chi | 6 |
| 1357 | /igf-ii | 5 |
| 1358 | /angiotensin-ii | 1 |
| 1359 | -i/ii | 2 |
| 1360 | -camkii | 2 |
| 1361 | -mi | 7 |
| 1362 | -imi | 1 |
| 1363 | -qi | 4 |
| 1364 | -folfiri | 1 |
| 1365 | p-mri | 1 |
| 1366 | /mri | 1 |
| 1367 | 30scha/j | 1 |
| 1368 | c57br/cdj | 1 |
| 1369 | c57bl/10scnj | 1 |
| 1370 | .feedback | 1 |
| 1371 | /rank | 1 |
| 1372 | -pk | 3 |
| 1373 | -mapk | 1 |
| 1374 | -ampk | 1 |
| 1375 | /erk | 1 |
| 1376 | -risk | 6 |
| 1377 | -1-risk | 1 |
| 1378 | p3-btk | 1 |
| 1379 | /pvk | 3 |
| 1380 | mkp-l | 1 |
| 1381 | 20mmol/l | 1 |
| 1382 | -20mmol/l | 1 |
| 1383 | -helical | 5 |
| 1384 | steric/chemical | 1 |
| 1385 | -clinical | 3 |
| 1386 | /clinical | 2 |
| 1387 | /atypical | 3 |
| 1388 | -physical | 2 |
| 1389 | delivered/theoretical | 1 |
| 1390 | /vocal | 1 |
| 1391 | -trinodal | 1 |
| 1392 | -meal | 1 |
| 1393 | between-areal | 1 |
| 1394 | tc-antimicrobial | 1 |
| 1395 | acetonitrile-glacial | 1 |
| 1396 | methanol-water-glacial | 1 |
| 1397 | -artificial | 1 |
| 1398 | sequencial | 1 |
| 1399 | .bronchial | 1 |
| 1400 | /endothelial | 2 |
| 1401 | -mitochondrial | 2 |
| 1402 | .material | 2 |
| 1403 | -arterial | 5 |
| 1404 | valvular-arterial | 1 |
| 1405 | .multifactorial | 1 |
| 1406 | -interstitial | 2 |
| 1407 | +partial | 2 |
| 1408 | .partial | 2 |
| 1409 | /minimal | 1 |
| 1410 | .00713optimal | 1 |
| 1411 | /maximal | 1 |
| 1412 | /thermal | 1 |
| 1413 | .final | 1 |
| 1414 | non-original | 1 |
| 1415 | -terminal | 24 |
| 1416 | /non-luminal | 1 |
| 1417 | intra-abdominal-inguinal | 1 |
| 1418 | .regional | 1 |
| 1419 | .educational | 2 |
| 1420 | posteducational | 1 |
| 1421 | /national | 3 |
| 1422 | -gestational | 1 |
| 1423 | .additional | 1 |
| 1424 | respectively.interpersonal | 1 |
| 1425 | -internal | 1 |
| 1426 | .antiretroviral | 1 |
| 1427 | .oral | 1 |
| 1428 | /oral | 2 |
| 1429 | 'coral | 1 |
| 1430 | .behavioural | 1 |
| 1431 | /universal | 1 |
| 1432 | -to-metal | 1 |
| 1433 | tc-radiometal | 1 |
| 1434 | lidocaine-experimental | 1 |
| 1435 | -to-total | 1 |
| 1436 | .total | 5 |
| 1437 | /total | 12 |
| 1438 | -akt/total | 1 |
| 1439 | -distal | 1 |
| 1440 | .gradual | 1 |
| 1441 | .individual | 2 |
| 1442 | /premenstrual | 1 |
| 1443 | /usual | 1 |
| 1444 | for-avn-abl | 1 |
| 1445 | -pz-cl | 2 |
| 1446 | rc/cl | 2 |
| 1447 | -acl | 2 |
| 1448 | -cscl | 2 |
| 1449 | /ucl | 1 |
| 1450 | -channel | 24 |
| 1451 | -clopidogrel | 3 |
| 1452 | -barrel | 5 |
| 1453 | ₈-barrel | 1 |
| 1454 | .sildenafil | 1 |
| 1455 | /clearfil | 2 |
| 1456 | .remifentanil | 1 |
| 1457 | +anti-rankl | 1 |
| 1458 | .all | 15 |
| 1459 | trivial-to-small | 1 |
| 1460 | /small | 1 |
| 1461 | -cell | 8 |
| 1462 | /t-cell | 4 |
| 1463 | -null | 6 |
| 1464 | m1-null | 1 |
| 1465 | -6-null | 1 |
| 1466 | 1.1-ml | 1 |
| 1467 | 1.3-ml | 1 |
| 1468 | /100ml | 1 |
| 1469 | +propofol | 1 |
| 1470 | -diol | 3 |
| 1471 | vslatanoprost/timolol | 1 |
| 1472 | monomol | 1 |
| 1473 | -2,5-diphenol | 1 |
| 1474 | lt-polyphenol | 1 |
| 1475 | -lariciresinol | 2 |
| 1476 | c-retinol | 1 |
| 1477 | /nitinol | 1 |
| 1478 | -guaiacylglycerol | 2 |
| 1479 | /control | 6 |
| 1480 | gik/control | 1 |
| 1481 | .misoprostol | 1 |
| 1482 | -sql | 4 |
| 1483 | -bontl | 1 |
| 1484 | but-3-en-1-yl | 12 |
| 1485 | -3,4-dihydro-2h-1-benzopyran-3-yl | 1 |
| 1486 | ,24-dien-3beta-yl | 1 |
| 1487 | -3-hydroxyacyl-acyl | 1 |
| 1488 | glycyl | 1 |
| 1489 | -3-methyl | 1 |
| 1490 | -3-aminomethyl-5-methyl | 1 |
| 1491 | n7-methyl | 3 |
| 1492 | -1,3-dimethyl | 1 |
| 1493 | -2,5-dimethyl | 1 |
| 1494 | -monomethyl | 6 |
| 1495 | -2-octyloxymethyl | 2 |
| 1496 | -3-octyloxymethyl | 3 |
| 1497 | amino-2-oxoethyl | 1 |
| 1498 | oxyethyl | 1 |
| 1499 | -alkyl | 2 |
| 1500 | *-allyl | 1 |
| 1501 | benzimidazolyl | 1 |
| 1502 | -bromanyl | 1 |
| 1503 | -se-phenyl | 1 |
| 1504 | -2,5-diphenyl | 24 |
| 1505 | ‑2,5‑diphenyl | 1 |
| 1506 | i-beta-methyl-iodophenyl | 1 |
| 1507 | i-beta-methyl-p-iodophenyl | 1 |
| 1508 | -difluorophenyl | 1 |
| 1509 | -butadienyl | 1 |
| 1510 | -butenyl | 1 |
| 1511 | -ethinyl | 1 |
| 1512 | /ethinyl | 1 |
| 1513 | /polyvinyl | 1 |
| 1514 | -carbonyl | 3 |
| 1515 | -2-en-1,4-dicarbonyl | 1 |
| 1516 | f-fluoropropansulfonyl | 1 |
| 1517 | mercaptopropionyl | 1 |
| 1518 | -bornyl | 1 |
| 1519 | -eicosapentaenoyl | 1 |
| 1520 | -docosahexaenoyl | 1 |
| 1521 | -propanehydrazonoyl | 1 |
| 1522 | -3-methoxy-3-oxo-2-stearamidopropyl | 2 |
| 1523 | -mercaptopropyl | 1 |
| 1524 | -3-aryl | 1 |
| 1525 | 3,6-bridged-glycosyl | 1 |
| 1526 | -9'-heptyl | 1 |
| 1527 | -3-isobutyl | 1 |
| 1528 | -1,2,3-trihydroxybutyl | 1 |
| 1529 | -hydroxyl | 4 |
| 1530 | 4-carboxylatobenzoxyl | 1 |
| 1531 | kalül | 1 |
| 1532 | -99m | 2 |
| 1533 | -foam | 1 |
| 1534 | .disulfiram | 1 |
| 1535 | /tam | 1 |
| 1536 | =vkm | 5 |
| 1537 | homo-arm | 1 |
| 1538 | =hg/arm | 1 |
| 1539 | -1h-pyrrolidin-1-ium | 2 |
| 1540 | -1h-imidazol-3-ium | 5 |
| 1541 | phenothiazin-5-ium | 1 |
| 1542 | -calcium | 1 |
| 1543 | /calcium | 3 |
| 1544 | -tricalcium | 1 |
| 1545 | /β-tricalcium | 1 |
| 1546 | /propidium | 1 |
| 1547 | +sodium | 1 |
| 1548 | -sodium | 3 |
| 1549 | f-sodium | 8 |
| 1550 | omeprazole/sodium | 1 |
| 1551 | -1-ethyl-3-methylimidazolium | 2 |
| 1552 | -3-butylimidazolium | 1 |
| 1553 | benzimidazolium | 2 |
| 1554 | -1h-5,6-dimethyl-benzimidazolium | 1 |
| 1555 | -2,5-diphenyl-2-h-tetrazolium | 1 |
| 1556 | -2,5-diphenyl-2h-tetrazolium | 5 |
| 1557 | -2,5-diphenyl-tetrazolium | 7 |
| 1558 | -2,5-diphenyltetrazolium | 107 |
| 1559 | -dimethylthiazoy1-3,5-diphenyltetrazolium | 1 |
| 1560 | ‑2,5‑diphenyltetrazolium | 2 |
| 1561 | -1-methylpyrrolidinium | 1 |
| 1562 | -1-methylpiperidinium | 1 |
| 1563 | /cetylpyridinium | 1 |
| 1564 | -3,5-lutidinium | 1 |
| 1565 | -4-picolinium | 1 |
| 1566 | -4-methylmorpholinium | 2 |
| 1567 | methaniminium | 1 |
| 1568 | -quinazoliniminium | 1 |
| 1569 | -triethylammonium | 1 |
| 1570 | -1,1,3,3-tetramethyluronium | 1 |
| 1571 | arsonium | 1 |
| 1572 | benzene-diazonium | 1 |
| 1573 | benzendiazonium | 1 |
| 1574 | lid+potassium | 1 |
| 1575 | /minimum | 4 |
| 1576 | -platinum | 4 |
| 1577 | .serum | 2 |
| 1578 | a-gypsum | 1 |
| 1579 | =19.34μm | 1 |
| 1580 | -15n | 1 |
| 1581 | +an | 1 |
| 1582 | -an | 8 |
| 1583 | exit-an | 1 |
| 1584 | .an | 7 |
| 1585 | /urban | 1 |
| 1586 | /american | 14 |
| 1587 | cytoscan | 1 |
| 1588 | /european | 7 |
| 1589 | receptor-than | 1 |
| 1590 | -mammalian | 2 |
| 1591 | /mammalian | 11 |
| 1592 | /akt/mammalian | 11 |
| 1593 | /italian | 1 |
| 1594 | holstein/friesian | 1 |
| 1595 | bearman | 1 |
| 1596 | /human | 3 |
| 1597 | analogue/human | 1 |
| 1598 | -positive/human | 2 |
| 1599 | /dextran | 1 |
| 1600 | /triclosan | 1 |
| 1601 | 3*leiden | 1 |
| 1602 | e*3-leiden | 2 |
| 1603 | -green | 1 |
| 1604 | -to-green | 1 |
| 1605 | .nineteen | 1 |
| 1606 | .thirteen | 4 |
| 1607 | .fourteen | 2 |
| 1608 | -fibrinogen | 1 |
| 1609 | .when | 25 |
| 1610 | .ten | 1 |
| 1611 | -molten | 1 |
| 1612 | .eleven | 3 |
| 1613 | .twenty-seven | 2 |
| 1614 | .seven | 4 |
| 1615 | inhaler.seven | 1 |
| 1616 | -driven | 19 |
| 1617 | score-driven | 1 |
| 1618 | ampk/mtor-driven | 1 |
| 1619 | -proven | 5 |
| 1620 | .proven | 1 |
| 1621 | -ifn | 2 |
| 1622 | /long-chain | 3 |
| 1623 | -6a-hydroxymaackiain | 1 |
| 1624 | .main | 1 |
| 1625 | /niacin | 1 |
| 1626 | .solifenacin | 1 |
| 1627 | mycorradicin | 1 |
| 1628 | .oxytocin | 1 |
| 1629 | marcin | 1 |
| 1630 | -neomycin | 1 |
| 1631 | -chloromethyl-2',7'-dichlorodihydrofluorescein | 1 |
| 1632 | -chloromethyl-2',7'-dichlorofluorescein | 1 |
| 1633 | /protein | 19 |
| 1634 | -olefin | 1 |
| 1635 | -2-olefin | 1 |
| 1636 | batio₃-paraffin | 2 |
| 1637 | -origin | 1 |
| 1638 | -knockin | 2 |
| 1639 | /cyclin | 1 |
| 1640 | /β-catenin/cyclin | 1 |
| 1641 | /calmodulin | 8 |
| 1642 | hyperglycemia/insulin | 1 |
| 1643 | -renin | 2 |
| 1644 | /beta-catenin | 1 |
| 1645 | /β-catenin | 2 |
| 1646 | /lignin | 1 |
| 1647 | -digitonin | 1 |
| 1648 | /genipin | 1 |
| 1649 | i-coumarin | 3 |
| 1650 | /heparin | 2 |
| 1651 | -ninhydrin | 1 |
| 1652 | -β/ribavirin | 1 |
| 1653 | -b/gastrin | 2 |
| 1654 | /adiponutrin | 1 |
| 1655 | /cryopyrin | 1 |
| 1656 | /angiotensin | 20 |
| 1657 | -inhibitor/angiotensin | 1 |
| 1658 | -plus-statin | 1 |
| 1659 | aminocombretastatin | 1 |
| 1660 | /lovastatin | 2 |
| 1661 | c-methacetin | 2 |
| 1662 | -hydroperoxyflavin | 1 |
| 1663 | -annexin | 1 |
| 1664 | h-digoxin | 1 |
| 1665 | b/ann | 1 |
| 1666 | -on | 12 |
| 1667 | -2β-carbon | 1 |
| 1668 | 3/carbon | 1 |
| 1669 | -ion | 3 |
| 1670 | nanodandelion | 1 |
| 1671 | /million | 5 |
| 1672 | -expansion | 1 |
| 1673 | sham+medication | 1 |
| 1674 | omt+medication | 1 |
| 1675 | -association | 1 |
| 1676 | .combination | 1 |
| 1677 | -proliferation | 1 |
| 1678 | -generation | 1 |
| 1679 | severity-by-duration | 1 |
| 1680 | antimineralisation | 1 |
| 1681 | decolorisation | 1 |
| 1682 | -restriction | 4 |
| 1683 | -induction | 1 |
| 1684 | -depletion | 1 |
| 1685 | registretion | 1 |
| 1686 | -prevention | 3 |
| 1687 | .intervention | 1 |
| 1688 | needle-insertion | 2 |
| 1689 | -substitution | 1 |
| 1690 | gullon | 2 |
| 1691 | -retrotransposon | 1 |
| 1692 | 1-person | 1 |
| 1693 | /fenton | 1 |
| 1694 | pinkerton | 1 |
| 1695 | -tpn | 1 |
| 1696 | /c-jun | 2 |
| 1697 | 3·1.5h2o | 1 |
| 1698 | crt+placebo | 1 |
| 1699 | -amido | 1 |
| 1700 | -α-kdo | 2 |
| 1701 | 3/hgo | 1 |
| 1702 | /who | 3 |
| 1703 | ×ho | 2 |
| 1704 | tg-agtko | 4 |
| 1705 | -ribulo | 1 |
| 1706 | -xylulo | 1 |
| 1707 | /mo | 1 |
| 1708 | con-no | 1 |
| 1709 | .no | 52 |
| 1710 | brevetoxin/no | 1 |
| 1711 | hypertension/no | 1 |
| 1712 | -propano | 1 |
| 1713 | -methylenamino | 1 |
| 1714 | /mno | 4 |
| 1715 | +lipo | 2 |
| 1716 | micro/macro | 1 |
| 1717 | -1,2,3,4-tetra-hydro | 1 |
| 1718 | -9'-fluoro | 1 |
| 1719 | cao-xsro | 1 |
| 1720 | -hydroxycarboxylato | 2 |
| 1721 | -formato | 1 |
| 1722 | hydroborato | 1 |
| 1723 | /6-keto | 1 |
| 1724 | tablets-two | 1 |
| 1725 | responded.seventy-two | 1 |
| 1726 | .two | 42 |
| 1727 | ≤two | 1 |
| 1728 | -oxo | 3 |
| 1729 | k-pkb-foxo | 2 |
| 1730 | -peroxo | 1 |
| 1731 | /map | 3 |
| 1732 | /dbp | 2 |
| 1733 | /βcdp | 2 |
| 1734 | ±pep | 1 |
| 1735 | cr1-gfp | 4 |
| 1736 | -amp | 1 |
| 1737 | -gmp | 2 |
| 1738 | -chop | 6 |
| 1739 | /atp | 3 |
| 1740 | normal-group | 1 |
| 1741 | /b3lyp | 2 |
| 1742 | 2tcnq | 2 |
| 1743 | r/csq | 1 |
| 1744 | -h···nh2-r | 1 |
| 1745 | -ar | 77 |
| 1746 | o2/ar | 1 |
| 1747 | -vascular | 2 |
| 1748 | /neurovascular | 1 |
| 1749 | /eular | 1 |
| 1750 | /extracellular | 10 |
| 1751 | -mitogen/extracellular | 1 |
| 1752 | /akt/extracellular | 1 |
| 1753 | /multicellular | 1 |
| 1754 | -wistar | 1 |
| 1755 | ···ar | 2 |
| 1756 | '-ib-cr | 1 |
| 1757 | -pcr | 39 |
| 1758 | /pcr | 2 |
| 1759 | -tcr | 2 |
| 1760 | /cancer | 2 |
| 1761 | -inducer | 1 |
| 1762 | .older | 1 |
| 1763 | -responder | 1 |
| 1764 | fourth-fifth-order | 1 |
| 1765 | /buffer | 1 |
| 1766 | /larger | 2 |
| 1767 | purospher | 2 |
| 1768 | .other | 6 |
| 1769 | /other | 3 |
| 1770 | replication-another | 1 |
| 1771 | .another | 1 |
| 1772 | /mer | 1 |
| 1773 | /triclosan/copolymer | 1 |
| 1774 | /copper | 1 |
| 1775 | mid-laser | 1 |
| 1776 | /laser | 1 |
| 1777 | tfa/acetonitrile/water | 1 |
| 1778 | .after | 9 |
| 1779 | -reporter | 1 |
| 1780 | -booster | 1 |
| 1781 | /liver | 1 |
| 1782 | /silver | 2 |
| 1783 | -observer | 1 |
| 1784 | .fewer | 1 |
| 1785 | /lower | 3 |
| 1786 | -prlr | 9 |
| 1787 | k-mr | 2 |
| 1788 | si-nmr | 2 |
| 1789 | cnmr | 4 |
| 1790 | .for | 56 |
| 1791 | -chelator | 1 |
| 1792 | -effector | 1 |
| 1793 | park-director | 1 |
| 1794 | /non-inhibitor | 1 |
| 1795 | /akt/mtor | 2 |
| 1796 | .motor | 1 |
| 1797 | -favor | 1 |
| 1798 | .our | 6 |
| 1799 | .four | 17 |
| 1800 | witrür | 1 |
| 1801 | /fcμr | 1 |
| 1802 | gtp-γ-s | 1 |
| 1803 | -r30°-ch3s | 1 |
| 1804 | -mas | 2 |
| 1805 | /mas | 7 |
| 1806 | reabsorbs | 1 |
| 1807 | -acs | 5 |
| 1808 | c-metabolomics | 1 |
| 1809 | -smads | 2 |
| 1810 | /smads | 1 |
| 1811 | /cds | 2 |
| 1812 | /aids | 6 |
| 1813 | pharmo-netherlands | 1 |
| 1814 | -towards | 1 |
| 1815 | -non-yds | 1 |
| 1816 | -changes | 1 |
| 1817 | -4-aryl-6-indolylnicotinonitriles | 1 |
| 1818 | -sometimes | 1 |
| 1819 | -2,4-dinitrobenzeneamines | 1 |
| 1820 | -1-arylethanones | 1 |
| 1821 | -1,4-naphthoquinones | 2 |
| 1822 | clarires | 1 |
| 1823 | -4-carboxylates | 1 |
| 1824 | over-secretes | 1 |
| 1825 | /lgs | 1 |
| 1826 | .this | 28 |
| 1827 | .ascaris | 1 |
| 1828 | tekensis | 1 |
| 1829 | gorgonensis | 1 |
| 1830 | -to-lewis | 1 |
| 1831 | -prophylaxis | 2 |
| 1832 | benzene-1,3-diols | 1 |
| 1833 | -rtms | 2 |
| 1834 | envolvidos | 1 |
| 1835 | -p53-ros | 1 |
| 1836 | adaptativos | 1 |
| 1837 | cncps | 1 |
| 1838 | /sps | 2 |
| 1839 | .irs | 1 |
| 1840 | /pulseless | 1 |
| 1841 | .antidepressants | 1 |
| 1842 | -ius | 1 |
| 1843 | /haemophilus | 2 |
| 1844 | -venus | 1 |
| 1845 | .percutaneous | 3 |
| 1846 | -homologous | 1 |
| 1847 | /intravenous | 1 |
| 1848 | -cancerous | 1 |
| 1849 | -ferrous | 3 |
| 1850 | -continuous | 2 |
| 1851 | incontinuous | 1 |
| 1852 | -adenovirus | 1 |
| 1853 | -at | 8 |
| 1854 | -ccaat | 1 |
| 1855 | refined-wheat | 1 |
| 1856 | -rat | 1 |
| 1857 | /lsat | 1 |
| 1858 | .act | 2 |
| 1859 | =cect | 1 |
| 1860 | -connect | 1 |
| 1861 | .direct | 1 |
| 1862 | /direct | 2 |
| 1863 | -protect | 1 |
| 1864 | ct/hrct | 1 |
| 1865 | -1/et | 1 |
| 1866 | /c-met | 1 |
| 1867 | /met | 8 |
| 1868 | -ret | 1 |
| 1869 | microbouquet | 2 |
| 1870 | -shift | 2 |
| 1871 | .twenty-eight | 2 |
| 1872 | .eight | 3 |
| 1873 | /right | 1 |
| 1874 | outcomes-illicit | 1 |
| 1875 | i-fit | 1 |
| 1876 | -akt | 15 |
| 1877 | -v-akt | 1 |
| 1878 | /akt | 65 |
| 1879 | delta/akt | 1 |
| 1880 | -salt | 13 |
| 1881 | -adult | 3 |
| 1882 | .pfmt | 1 |
| 1883 | immunosorbant | 9 |
| 1884 | .significant | 2 |
| 1885 | -antioxidant | 2 |
| 1886 | .antioxidant | 1 |
| 1887 | -compliant | 6 |
| 1888 | .recombinant | 1 |
| 1889 | -tolerant | 4 |
| 1890 | -resistant | 78 |
| 1891 | oil-resistant | 1 |
| 1892 | -mutant | 5 |
| 1893 | -gene-mutant | 1 |
| 1894 | post-primary/adjuvant | 1 |
| 1895 | /cnt | 5 |
| 1896 | immune-sorbent | 2 |
| 1897 | immuno-sorbent | 4 |
| 1898 | immune-absorbent | 1 |
| 1899 | immunoabsorbent | 5 |
| 1900 | immune-adsorbent | 1 |
| 1901 | immunoadsorbent | 10 |
| 1902 | immunesorbent | 1 |
| 1903 | lectinosorbent | 1 |
| 1904 | immunosorbent | 1,242 |
| 1905 | immmunosorbent | 1 |
| 1906 | .recent | 1 |
| 1907 | -percent | 1 |
| 1908 | -resident | 3 |
| 1909 | -dependent | 302 |
| 1910 | -1-dependent | 1 |
| 1911 | p2-dependent | 2 |
| 1912 | 1.3-dependent | 1 |
| 1913 | 2/3-dependent | 1 |
| 1914 | /myd88-dependent | 1 |
| 1915 | -κb-dependent | 1 |
| 1916 | c-ii-dependent | 1 |
| 1917 | -calmodulin-dependent | 2 |
| 1918 | /calcium-calmodulin-dependent | 1 |
| 1919 | /calmodulin-dependent | 10 |
| 1920 | /calcineurin-dependent | 2 |
| 1921 | /amp-dependent | 1 |
| 1922 | /akt-dependent | 1 |
| 1923 | p3-independent | 1 |
| 1924 | immunoadsordent | 1 |
| 1925 | osmogent | 1 |
| 1926 | -deficient | 71 |
| 1927 | cr1-deficient | 2 |
| 1928 | -receptor-deficient | 1 |
| 1929 | texture-nutrient | 1 |
| 1930 | -equivalent | 2 |
| 1931 | -ligament | 1 |
| 1932 | -enrichment | 2 |
| 1933 | .multiple-component | 1 |
| 1934 | -consistent | 1 |
| 1935 | -underwent | 1 |
| 1936 | 6274not | 1 |
| 1937 | -dpot | 1 |
| 1938 | immunospot | 27 |
| 1939 | enzyme-linked-immunospot | 1 |
| 1940 | /ipt | 1 |
| 1941 | /heart | 2 |
| 1942 | -short | 1 |
| 1943 | -transport | 2 |
| 1944 | vacuum-cast | 6 |
| 1945 | .most | 7 |
| 1946 | -first | 7 |
| 1947 | artery/first | 1 |
| 1948 | -menc-tt | 1 |
| 1949 | goldblatt | 5 |
| 1950 | 4mtt | 1 |
| 1951 | cattt | 1 |
| 1952 | xe-washout | 1 |
| 1953 | -knockout | 4 |
| 1954 | ar-knockout | 1 |
| 1955 | niedenzu | 1 |
| 1956 | +bv | 1 |
| 1957 | /anti-hdv | 1 |
| 1958 | /iv | 1 |
| 1959 | /hiv | 13 |
| 1960 | -lv | 2 |
| 1961 | -to-lv | 2 |
| 1962 | vlv | 1 |
| 1963 | /uv | 6 |
| 1964 | .few | 2 |
| 1965 | .low | 1 |
| 1966 | /low | 9 |
| 1967 | /hollow | 1 |
| 1968 | -2/2x | 1 |
| 1969 | -helix | 6 |
| 1970 | release.forty-six | 1 |
| 1971 | .six | 7 |
| 1972 | -to-bnx | 1 |
| 1973 | +npx | 1 |
| 1974 | /reflux | 1 |
| 1975 | -bay | 3 |
| 1976 | 75-day | 1 |
| 1977 | -stay | 2 |
| 1978 | /high-frequency | 2 |
| 1979 | .study | 2 |
| 1980 | /healthy | 1 |
| 1981 | genes-namely | 1 |
| 1982 | -family | 2 |
| 1983 | 1-family | 1 |
| 1984 | /family | 1 |
| 1985 | inhibitors-specifically | 1 |
| 1986 | states.typically | 1 |
| 1987 | .generally | 4 |
| 1988 | .early | 2 |
| 1989 | spectrosocopy | 1 |
| 1990 | .secondary | 9 |
| 1991 | .primary | 2 |
| 1992 | pseudobinary | 1 |
| 1993 | .multidisciplinary | 1 |
| 1994 | -military | 1 |
| 1995 | -regulatory | 4 |
| 1996 | -pro-inflammatory | 1 |
| 1997 | /inspiratory | 2 |
| 1998 | -refractory | 25 |
| 1999 | -inhibitory | 5 |
| 2000 | -symmetry | 1 |
| 2001 | /glassy | 1 |
| 2002 | /safety | 1 |
| 2003 | .low-quality | 5 |
| 2004 | -polarity | 1 |
| 2005 | .thirty | 1 |
| 2006 | patients.forty | 1 |
| 2007 | fluorodeoxy | 1 |
| 2008 | -3-methoxy | 2 |
| 2009 | -3,4'-dimethoxy | 1 |
| 2010 | benzo-yloxy | 1 |
| 2011 | -9-hydroxy | 1 |
| 2012 | oxyhydroxy | 1 |
| 2013 | /bdz | 1 |
| 2014 | -detrz | 1 |
| 2015 | -hctz | 1 |
| 2016 | /4π | 1 |
| 2017 | /naf/sncl₂ | 1 |
| 2018 | /tio₂ | 1 |
| 2019 | perovskite/tio₂ | 1 |
| 2020 | /wo₃ | 1 |
| 2021 | β₃ | 29 |
| 2022 | ₂so₄ | 2 |
| 2023 | ₃o₄ | 1 |
| 2024 | πω | 2 |
| 2025 | ↔ | 10 |
| 2026 | nπ∗ | 4 |
| 2027 | ππ∗ | 4 |
| 2028 | .authors’ | 1 |
| 2029 | .• | 9 |
| 2030 | g4™ | 2 |
| 2031 | real-time™ | 1 |
| 2032 | /floortime™ | 1 |
| 2033 | +prometrium™ | 1 |
| 2034 | ptx™ | 1 |
| 2035 | skinmedica® | 1 |
| 2036 | flor-opal® | 1 |
| 2037 | cytogenetics® | 1 |
| 2038 | -6rα | 1 |
| 2039 | -aβ | 3 |
| 2040 | a″ | 2 |